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Abstract  
Helicobacter pylori is regarded as the most important risk factor for peptic ulcer 
disease and gastric cancer. In Kurdistan region, northern Iraq, gastric cancer is 
rare (5/100,000). To investigate some possible reasons for this, the prevalence 
of H. pylori infection, gastric mucosal histopathological changes in H. pylori 
infected subjects, and virulence factor genotypes (especially dupA) of 
colonising strains were studied. The immune response to H. pylori infection, 
focusing on genes associated with T-helper (Th) and regulatory T-cell (Treg) 
cells, was also investigated.    
It was found that 79% of 163 adults and 37% of 120 children were seropositive 
for H. pylori (p<0.0001). For infected people, gastric lymphocyte infiltration 
was more prominent in the antrum (p=0.01).   
71% of Iraqi H. pylori strains were positive for cagA and its presence was 
significantly associated with peptic ulcer disease (PUD) (p<0.01). cagA genes 
encoding four or more tyrosine phosphorylation motifs could not be found in 
any of the Iraqi strains. Isolates possessing the i1 form of vacA were 
significantly associated with GU (p<0.02). 32% of Iraqi H. pylori isolates were 
dupA-positive and presence of this gene was associated with PUD (p<0.01).   
The levels of IFN , IL-12 p35, IL-10, IL-4 and FOXP3 mRNA were found to be 
elevated in gastric mucosal samples from H. pylori-infected patients compared 
to those from H. pylori-negative patients (median increase 7-fold p=0.001; 17-
fold p=0.002; 1320-fold p=0.001; 1184-fold p=0.001; and 3-fold p=0.01, 
respectively), indicating a predominant IL-4 and IL-10 (Th2) response. 
Interestingly, IFN mRNA levels were 16-fold higher in tissues taken from 17 
infected smokers than found in tissues taken from 18 infected non-smokers 
(p=0.009). IL-4 mRNA levels in tissues from 20 infected females were 40-fold 
higher than in tissues from 15 males (p=0.005).  
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Nucleotide sequencing of the dupA 3' region from 32 strains showed that dupA 
commonly had additional single base insertions or deletions that either truncated 
or extended the open reading frame (ORF). We have therefore classified dupA 
into two main groups: the common extended ORF within jhp0917-19 (dupA1), 
and dupA with an early stop codon to truncate the ORF (dupA2). ELISA 
performed on supernatants from H. pylori-infected gastric epithelial cell lines 
found no significant differences in IL-8 production between strains that 
possessed or lacked dupA.  In comparison to wild-type H. pylori, disruption of 
dupA significantly reduced IL-12, IFN , TNF and IL-8 production by 
peripheral blood mononuclear cells (PBMCs) in 2/4 strains.  For the remaining 
2 strains, where gene sequencing revealed a frame shift resulting in truncated 
dupA in the wild-type, the level of these cytokines was unchanged by dupA 
mutation.  
H. pylori infection is common in Kurdistan region and acquired at a young age. 
The low cancer rate may be partially explained by a predominant lymphocyte 
infiltration in the antrum rather than the corpus, which has been reported to be 
associated with reduced risk of gastric adenocarcinoma. An absence of the more 
toxic cagA genotype with four or more tyrosine phosphorylation motifs in the 
Iraqi strains, and the predominance of Th2 cytokine expression rather than a 
more pro-inflammatory Th1 response to H. pylori could also contribute to a 
reduced incidence of cancer. dupA1 appears to play an important role in 
promoting the inflammatory response of leukocytes to H. pylori.         
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1. Introduction
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1.1 Overview 
Helicobacter pylori is a spiral shaped, Gram-negative rod with 5-7 flagella at one 
end. This bacterium is sensitive to oxygen, and requires a microaerobic atmosphere, 
i.e., about 5% O2 and 5-10% CO2. Bacteria of the Helicobacter genus are very 
similar to those of the Campylobacter genus. Both are motile, catalase positive and 
have curved cell bodies (Andersen and Wadström, 2001). H. pylori causes gastritis 
and peptic ulcers (Marshall and Warren, 1984, Marshall and Warren, 2001, 
Whitfield, 2003). Consequently, there has been a pivotal move in mainstream ulcer 
treatment from the widespread use of acid-reducing drugs (which heal ulcers but do 
not prevent their recurrence) to the "treatment" of gastritis and ulcers with potent 
antibiotics which eradicate H. pylori (Walsh and Peterson, 1995).    
Helicobacter pylori was originally called Campylobacter pyloridis, but after 
correction to the Latin grammar  the organism was renamed as C. pylori. In 1989, 
DNA sequencing data showed that the bacterium did not belong to the 
Campylobacter genus. Hence, it was placed in its own genus, Helicobacter 
(Marshall and Warren, 2001). The name pylori originates from the Latin word 
pylorus, which means gatekeeper, and refers to the pyloric valve between the 
stomach and duodenum.   
The inside of the stomach is exposed to litres of gastric juice every day. Gastric 
juice is composed of digestive enzymes and concentrated hydrochloric acid. 
Bacteria, viruses, and other microorganisms are destroyed in this deadly bath of 
chemicals. It was thought that the stomach was sterile, but the discovery of H. 
pylori changed this idea. Acid resistance is crucial in the gastric niche, and more 
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than 300 genes are acid regulated or acid affected (McGowan et al., 2003). Also 
large amounts of a potent, multi-subunit urease enzyme are produced by H. pylori. 
This converts urea to ammonia and CO2 leading to neutralisation of the surrounding 
environment (Melchers et al., 1998), the bacteria is surrounded by a layer of 
ammonia that neutralises hydrogen ions before lowering the intracellular pH to 
above acidic levels (Melchers et al., 1998). This allows H. pylori to survive in 
gastric acid so that it is able to colonise the gastric mucosa (Marshall et al., 1990).  
H. pylori induces an infiltrate of T lymphocytes, plasma cells, mononuclear 
phagocytes, and neutrophils and stimulates the expression of proinflammatory 
cytokines, such as tumour necrosis factor- (TNF- ), interleukin-1 (IL-1 ), 
interferon gamma (IFN ), IL-4 and IL-8 (Atherton, 2006, Bergman et al., 2004, 
Crabtree et al., 1995, Mohammadi et al., 1997, Sawai et al., 1999, Smythies et al., 
2000, Yamamoto et al., 2004, Yamaoka et al., 2006). Despite a specific humoral 
and cellular immune response, the infection shows lifelong persistence in a 
majority of cases (Atherton, 2006). The inability to eliminate H. pylori may be due 
to bacterial virulence determinants and immune evasive strategies as well as an 
inappropriate host immune response. Gastric pathology appears closely associated 
with H. pylori virulence genes (Atherton, 2006, Kidd et al., 2001a, Kidd et al., 
2001b, Qiao et al., 2003). The two most important virulence factors are encoded by 
the vacuolating cytotoxin gene (vacA) and the cytotoxin associated gene (cag) 
pathogenicity island (PAI) (Atherton, 2006, Atherton, 1998).    
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1.2 Epidemiology and Transmission 
H. pylori colonises all human populations worldwide (Cover et al., 2001). The 
socioeconomic status, geographic area and age are important factors and play a 
crucial role in the risk of colonisation and disease development. Initial colonisation 
is thought to occur during early childhood, particularly in developing countries 
(Cover et al., 2001).  
Although the infection is almost ubiquitous in Third world countries, in developed 
countries H. pylori infects 30 50% of adults (Atherton, 2006, Cover et al., 2001). 
The decrease in H. pylori infection rate associated with industrialization and 
improvements in socioeconomic levels is due to the improvements in sanitation, 
and reduced crowding. The higher prevalence of H. pylori in individuals over 40 
years of age is considered to be due to a birth cohort effect rather than a continuous 
risk of being infected (Atherton, 2006, Blaser et al., 2007, Cover et al., 2001).  
No significant reservoirs of H. pylori exists outside the human stomach (Blaser and 
Atherton, 2004), since it has a rather small genome which does not support all 
metabolic pathways necessary for a nonparasitic life style (Alm et al., 1999, Blaser 
and Atherton, 2004, Cover et al., 2001, Tomb et al., 1997). Person to person contact 
involving ingestion of H. pylori from saliva, vomitus, faeces or recently 
contaminated foods would be the most likely mode of transmission (Blaser and 
Atherton, 2004, De Schryver et al., 2006, Delport and van der Merwe, 2007, 
Lehours and Yilmaz, 2007, Perry et al., 2006). Serological and DNA fingerprinting 
analyses have shown that person to person transmission occurs mainly within 
families i.e. vertical transmission instead of horizontal transmission (Drumm et al., 
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1990, Nguyen et al., 2006). In support of this, the same strain is frequently shared 
between mothers and their children, but less frequently between spouses. 
Interestingly, transmission is less common between fathers and their children (Han 
et al., 2000, Kivi et al., 2003).                   
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1.3 Infection and Gastric Diseases 
1.3.1 Gastritis 
Healthy stomach mucosa contains very few inflammatory cells. However, when H. 
pylori colonises the stomach, polymorphonuclear cells and neutrophils migrate to 
the area resulting in an acute inflammatory response (Atherton, 2006). 
Hypochlohydira, or reduced gastric acidity, results from the acute infection. If these 
initial responses fail to clear the infection, neutrophils, T cells, B cells and 
macrophages accumulate in the gastric mucosa (Brandt et al., 2005, Tham et al., 
2001), which is a characteristic histological picture of chronic active gastritis 
(Atherton, 2006). Most strains of H. pylori persist lifelong if not eradicated with 
antibiotics and all cause gastric inflammation (Atherton, 2006). The vast majority 
of patients stay asymptomatic without further progression. However, 15% of 
infections result in peptic ulceration and 0.5% 2% in gastric adenocarcinoma 
(Atherton, 2006, Dixon, 2000, Everett et al., 2002, Goldstone et al., 1996, Graham, 
1997, Hida et al., 1999). Three factors interact together to determine whether 
subjects develop such diseases; the virulence of the infecting H. pylori  strain, the 
type and the extent of the host immune response to infection, and modulating 
cofactors such as smoking and diet (Atherton, 2006, Graham, 1997).   
1.3.2 Gastric Ulcer 
Gastric ulceration (GU) is associated with a pan-gastritic inflammation pattern and 
reduced or normal acid production (Atherton, 2006, Dixon, 2001, Dixon, 2000). 
GU develops most commonly at the transitional zone between antrum and body on 
the lesser gastric curve. H. pylori is found in 80% of patients with gastric ulcer 
(Atherton, 2006, Dixon, 2001, Dixon, 2000). In individuals with normal or high 
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acid secretion, H. pylori does not normally colonise the corpus because of the low 
pH. However, when there is low acid secretion, the colonisation will be 
consistently spread throughout gastric mucosa (Dixon, 2001, Dixon, 2000). 
Colonisation by H. pylori leads to progressive inflammatory cell infiltration, and 
rising exfoliation of the epithelial cells. These changes lead to ineffective mucin 
and bicarbonate production, which weakens the mucus barrier and the tissue 
becomes more susceptible to ulceration (Atherton, 2006, Dixon, 2001, Dixon, 
2000).   
1.3.3 Duodenal Ulcer 
Duodenal ulcer (DU) is associated with dense H. pylori infection and severe 
inflammation but only when inflammation is largely confined to the antrum, 
probably as a result of increased basal acid output and a heightened parietal cell 
response to stimulation. H. pylori is found in 95% of patients with duodenal ulcers 
(Atherton, 2006, Dixon, 2001, Dixon, 2000, Fikret et al., 2001). Excessive acid 
secretion into the duodenal lumen promotes the migration of gastric mucosa into 
the duodenum a condition which is called gastric metaplasia (Fikret et al., 2001). 
The appearance of gastric epithelial cells in the duodenum allows colonisation by 
H. pylori, which will establish a chronic inflammatory response (Fikret et al., 
2001). The inflammation process and bacterial effect on the epithelial cells render 
the duodenal mucosa sensitive to gastric acidity, and thus predisposes it to 
ulceration (Atherton, 2006, Dixon, 2001, Dixon, 2000, Fikret et al., 2001).    
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1.3.4 Gastric Cancer 
Gastric adenocarcinoma is the second highest cause of cancer deaths worldwide 
(Atherton, 2006, GLOBOCAN, 2002). A possible explanation is the high 
prevalence of H. pylori infection (Correa, 2003, Correa et al., 1990, GLOBOCAN, 
2002, Meining et al., 1998). Distal gastric adenocarcinoma (Correa, 2003, Correa et 
al., 1990, GLOBOCAN, 2002), which is H. pylori associated, is more common 
than the proximal form. In addition, H. pylori causes MALToma or B cell mucosa-
associated lymphoid tissue (MALT) (Du and Atherton, 2006) lymphoma of the 
stomach (Bandipalliam, 2006, Iida et al., 2007, Moss and Malfertheiner, 2007). 
Gastric cancer arises as an outcome of long term gastric mucosal infection and 
chronic inflammation (Asaka et al., 1997, Blaser et al., 2007, Egi et al., 2007, 
Goldstone et al., 1996). Atrophic gastritis, intestinal metaplasia and dysplasia are 
preceding conditions of gastric cancer (Fikret et al., 2001). The difference in 
prevalence of infection versus incidence in gastric cancer (approx. 1%) suggests a 
multifactorial etiology such as differences in bacterial strains, host genotypes, and 
environmental conditions (Atherton, 2006, Peek and Blaser, 2002). In particular, 
strains that carry the cag PAI and virulent types of the vacuolating cytotoxin gene 
(vacA) are significantly associated with disease (reviewed in (Atherton, 2006)). 
Individual differences in host responses are also of major importance, and 
polymorphism in the pro-inflammatory cytokine interleukin IL-1 was the first 
described host risk factor for H. pylori associated gastric cancer (El-Omar et al., 
2000, El-Omar et al., 2001). IL-1 is the most powerful inhibitor of gastric acid 
secretion known, and individuals who are colonised by H. pylori and possess high 
expression alleles of IL-1 run an increased risk of developing hypochlorhydria, 
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gastric atrophy and gastric adenocarcinoma (El-Omar et al., 2000, El-Omar et al., 
2001).   
On the other hand, there is some evidence against the association of H. pylori with 
gastric cancer. The strongest evidence comes from the unexplained African and 
Asian enigma where there is high H. pylori infection rate and low gastric cancer 
rate (Holcombe, 1992, Singh and Ghoshal, 2006). In a study conducted in two 
regions in China where there is high and low prevalence of gastric cancer, the 
prevalence of H. pylori infection was similar (Hu et al., 1995).  Similarly, studies in 
some countries, Italy (Palli et al., 1993) and Costa Rica (Sierra et al., 1992), did not 
show a higher prevalence of infection among people living in regions with a high 
prevalence of gastric cancer.   
Thus, both host and bacterial factors contribute to development of disease. Immune 
response to H. pylori also plays a major role.  This will be discussed later. 
Furthermore, different environmental factors such as high salt intake and 
inadequate consumption of fruits and vegetables containing vitamin C has been 
regarded as risk a factor for development of gastric cancer (Asaka et al., 1997, 
Correa et al., 1998).       
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1.4 Histological Changes 
1.4.1 Overview 
Acute gastritis due to H. pylori is rarely seen in biopsy material because the 
infection is usually either asymptomatic or accompanied by minor gastrointestinal 
discomfort. The histological features include conspicuous pit abscesses and 
exudation of neutrophils into the surface epithelium (Owen, 2004). This is 
accompanied by marked epithelial degeneration and regeneration, which may be 
syncytial in type. The mucosa shows a dense infiltrate of chronic inflammatory 
cells, in which plasma cells are especially prominent. Lymphoid follicles with 
germinal centres are usually seen, particularly in the deeper portion of the mucosa. 
This finding is virtually pathognomonic for the presence of H. pylori (Owen, 2004). 
The surface and pit lining epithelium is infiltrated by neutrophils, which may be so 
prominent that pit abscesses are formed. This neutrophil infiltration is termed 
active gastritis and is seen predominantly in areas where the Helicobacter 
organisms are most abundant and most readily identified (Owen, 2004). The 
Modified Sydney system is used for the classification of gastritis (Misiewicz, 
1991). This system introduces a semiquantitative grading system from 0 to 3, 
according to the severity, for H. pylori, neutrophil granulocyte, mononuclear 
cellular infiltration, atrophy and intestinal metaplasia. There are some limitations to 
this system such as difficulties of its usage in routine and every day reporting in a 
busy histopathology laboratory (Guarner et al., 1999). However, the system has 
been found useful and reproducible for treatment protocols and research purposes 
(Guarner et al., 1999).  
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In North America and Western Europe, most individuals with H. pylori infection 
have an active superficial gastritis, largely confined to the antrum, in which 
organisms are easily identified (diffuse antral gastritis or DAG) (Meining et al., 
1998). This type of gastritis may result in duodenal ulcer formation, probably as a 
result of increased basal acid output and a heightened parietal cell response to 
stimulation (Dixon, 2000, Meining et al., 1998, Sotoudeh et al., 2008). It may also 
cause non ulcer dyspepsia, although this association is controversial (Atherton, 
2006). In contrast, individuals in underdeveloped countries typically have an 
atrophic gastritis (multifocal atrophic gastritis), which is patchy in distribution and 
involves botH pyloric and fundal mucosa (Meining et al., 1998, Sotoudeh et al., 
2008). H.  pylori organisms may be sparser in this form of gastritis, which is 
associated with gastric ulcer and gastric carcinoma (Egi et al., 2007, Meining et al., 
1998, Sotoudeh et al., 2008). The reasons for this geographic difference are 
unclear. One possibility is that individuals in Third World countries acquire the 
infection at an earlier age: progression from non atrophic superficial gastritis to an 
atrophic gastritis simply relates to the duration of infection or the increased 
susceptibility of children s stomachs to sustain damage (Asaka et al., 1998, 
Atherton, 2006). Another plausible explanation is that additional, but as yet 
unspecified, dietary factors may be required to mediate damage leading to atrophy 
and intestinal metaplasia (Atherton, 2006).   
Treatment of H. pylori gastritis with appropriate antibiotics will usually result in 
rapid elimination of organisms and abolition of the neutrophilic infiltrate. Chronic 
inflammation, however, may persist for several years before disappearing (Kubben 
et al., 2007, Malfertheiner et al., 2006, Romero-Gallo et al., 2008).  
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1.4.2 Intestinal Metaplasia 
Intestinal metaplasia is defined as transformation of gastric epithelial cells into 
goblet cells, which normally line the surface of colonic tissue (Fikret et al., 2001). 
These changes appear most often as a consequence of continuous regeneration of 
tissue and abnormal stimulation of growth during chronic inflammation (Fikret et 
al., 2001). Both atrophic gastritis and intestinal metaplasia occur during long term 
(decades of) H. pylori infection and both are considered to be risk factors for 
development of cancer (Asaka et al., 1998, Fikret et al., 2001).  
1.4.3 Atrophic Gastritis 
Gradual loss of gastric glandular tissue as a consequence of long term mucosal 
destruction is called atrophic gastritis (Asaka et al., 1997, Atherton, 2006). The 
tissue damage may involve progressive loss of all specific mucosal cells including 
the acid producing parietal cells, pepsinogen producing chief cells and mucus 
producing gland cells (Asaka et al., 1997, Atherton, 2006, Sipponen, 1998, Tham et 
al., 2001). When these cell types have shrunk, the protective mucus layer will 
gradually disappear and acid secretion will cease (Atherton, 2006, Sipponen, 1998). 
Such pathological changes increase the risk of gastric ulceration and development 
of gastric adenocarcinoma (Fikret et al., 2001). However, this protects against 
duodenal ulcers because of low acid secretion (Atherton, 2006).     
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1.5 Virulence Factors 
1.5.1 The cag PAI and cagA gene  
The cytotoxin associated gene A (CagA) protein, which is encoded by the cagA 
gene, is a highly immunogenic protein. H. pylori strains possessing cagA are 
associated with a significantly increased risk for the development of atrophic 
gastritis, peptic ulcer diseases and gastric cancer (Atherton, 1998, Atherton, 1999, 
Atherton, 2000, Peek et al., 1997, Rokkas et al., 1999). The cagA gene is situated at 
one end of a 40 kb DNA insertion called the cag PAI and may have been acquired 
from a non-Helicobacter origin (Atherton, 2000, Censini et al., 1996). The cag PAI 
contains approximately 30 genes which are multicistronic. The difference in the 
ability of H. pylori strains to trigger chemokines from gastric mucosa depends upon 
the expression of genes within the cag PAI (Atherton, 2000, Censini et al., 1996, 
Tomb et al., 1997) .   
Many of the genes in the PAI are thought to encode components of a bacterial type 
IV secretion system (T4SS) (Censini et al., 1996). Recent studies have shown that 
CagA is directly introduced into epithelial cells via the type IV secretion system, 
becomes phosphorylated on tyrosine residues by host cell Src family kinases and 
then stimulates cell signalling pathways (Censini et al., 1996, Stein et al., 2000). 
This, in vitro, leads to clear changes in cell shape resulting in what is called the 
hummingbird phenotype (elongated cell with long processes) (Bourzac et al., 
2007, Kurashima et al., 2008, Ren et al., 2006, Segal et al., 1999, Tsutsumi et al., 
2003). Such cytoskeletal changes might be induced via the activation of the 
hepatocyte growth factor receptor c-Met which is an oncogene (Churin et al., 
2003).  Furthermore, it was recently shown that phosphorylated CagA forms a 
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physical complex with SHP-2 phosphatase which is known to have a positive role 
in mitogenic signal transduction, and deregulates its enzymatic activity (Higashi et 
al., 2002b). Deregulation of SHP-2 by CagA may stimulate abnormal proliferation 
and movement of gastric epithelial cells through the activation of c-Fos and c-Jun 
(Meyer-ter-Vehn et al., 2000). In addition, the phosphorylation of CagA has a 
negative feedback loop by which the activated CagA inhibits Src kinase preventing 
unregulated signalling (Atherton, 2006, Stein et al., 2002). It is worth mentioning 
that un-phosphorylated CagA can disrupt the apical junctional complex between 
gastric epithelium cells possibly facilitating the acquisition of nutrients (Amieva et 
al., 2003).     
According to the sequence constituting the SHP-2 binding site, CagA proteins can 
be sub-categorised into Western (C motif) and East Asian (D motif) types. The East 
Asian type CagA possesses stronger SHP-2 binding and transforming activities 
than the Western-type CagA (Azuma et al., 2004).  CagA is translocated into 
epithelial cells where it becomes phosphorylated on tyrosine residues in EPIYA 
tyrosine phosphorylation motifs (TPMs). EPIYA motifs are frequently repeated 
within the variable region of the protein (Higashi et al., 2005, Naito et al., 2006). 
Strains possessing CagA with greater numbers of these repeats have been more 
closely associated with gastric carcinogenesis (Argent et al., 2004, Zhang et al., 
2005). Phosphorylated CagA leads to epithelial cell elongation, which is dependent 
on the number of variable-region EPIYA motifs (Argent et al., 2004, Zhang et al., 
2005). Thus, determination of the degree of CagA phosphorylation and the number 
of EPIYA motifs appears to be more important than detection of cagA alone 
(Argent et al., 2004, Argent et al., 2005, Zhang et al., 2005).  
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The C-X-C chemokine family, which comprises the polymorphonuclear cells 
(PMNL) chemo-attractant IL-8, is an important factor in the immunopathogenesis 
of gastritis (Crabtree et al., 1995, Hofman et al., 2000). High levels of gastric IL-8 
are found in patients infected with cagA positive strains of H. pylori (Crabtree et 
al., 1995). Initial studies revealed that inactivation of 14 genes in the cag PAI 
reduced IL-8 secretion in epithelial cells (Crabtree et al., 1995), whereas the cagA 
gene seemed to be irrelevant (Crabtree et al., 1995, Sharma et al., 1998). However, 
a recent paper demonstrated that cagA could play a role in the induction of IL-8 
secretion via a Ras-Raf-Mek-Erk-NF-kB signalling pathway in a SHP-2 and c-Met 
independent manner (Brandt et al., 2005). Another paper has shown that the T4SS 
facilitates the translocation of peptidoglycan into the host cell cytosol where it 
activates NOD1 which in turn activates the expression of IL-8 (Viala et al., 2004).  
1.5.2 Vacuolating Cytotoxin  
The vacuolating cytotoxin (VacA) is another H. pylori virulence factor (Atherton, 
1998). VacA can induce apoptosis in epithelial cells, affect B lymphocyte antigen 
presentation, inhibit the activation and proliferation of T lymphocytes, and 
modulate the T cell-mediated cytokine response (Gebert et al., 2004). The toxin 
also induces the formation of large cytoplasmic vacuoles in epithelial cells (Cover, 
1996). To a large extent, the function of this cytotoxin depends upon pH. At neutral 
pH, VacA congregates into large, water-soluble oligomeric complexes comprising 
12 or 14 identical monomers (Cover et al., 1997). When exposed to acidic or 
alkaline pH, these oligomeric complexes disassemble into component monomers 
(Cover et al., 1997). Acid activated VacA can be integrated into lipid bilayers and 
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the plasma membrane of eukaryotic cells to form anion and urea selective 
membrane channels (Czajkowsky et al., 1999). This urea permease activity may 
help acid survival through supplying a substrate for urease (Atherton, 2006).  
Moreover, a recent study has demonstrated that VacA increased the permeability of 
the epithelial barrier, probably by acting at the tight junction level (Papini et al., 
1998). However, VacA is not involved in H. pylori induced polymorphic nuclear 
lymphocytes (PMNL) migration across a tight epithelial barrier (Hofman et al., 
2000).    
Unlike cagA, almost all H. pylori strains posses the vacuolating cytotoxin gene 
(vacA) (Atherton, 2006). vacA is translated into a prepro-protein which is an 
autotransporter that undergoes N- and C-terminal cleavage during its secretion. The 
mature secreted VacA toxin comprises 2 subunits; p37 and p58, linked via a 
flexible loop region. It has a molecular mass of 88 kDa and consists of about 821 
amino acids (Reyrat et al., 2000). Vacuole formation in HeLa cells can be induced 
by transfecting these cells with vacA-containing plasmids. Expression of the amino-
terminal 422 amino acids, comprising the p37 domain and a part of the p58 domain, 
is sufficient to induce vacuole formation (de Bernard et al., 1998, Ye et al., 1999). 
Rabbit antiserum induced against a recombinant peptide containing amino acids 
476 to 803 of VacA inhibits the binding of VacA to cells and neutralizes toxin 
activity (Ye et al., 1999). These data suggest that a carboxy-terminal VacA p58 
domain performs binding of the toxin to cells and an amino-terminal domain 
mediates the intracellular activity of VacA (Nguyen et al., 2001, Ye et al., 1999).   
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The vacA gene contains at least two variable parts, the signal and middle regions. 
For the signal region, two sequence families, called s1 and s2, have been identified 
in different isolates. Among s1 strains, subtypes s1a, s1b, and s1c have been 
identified (van Doorn et al., 1998). Subtypes s1a and s1b differ in five amino acids 
(Ala18Val, Val20Ala, Val24Ile, Ile26Ala/Ser, and Thr27Ile). Subtype s1c differs 
from subtype s1a at two positions (Ala22Leu and Gln30Lys) and from s1b at seven 
positions (Ala18Val, Val20Ala, Ala22Leu, Ile24Val, Ala/Ser26Ile, Ile27Thr, and 
Glu/Gln30Lys) (van Doorn et al., 1998).  Two alleles, m1 and m2, of the mid-
region of the vacA gene have been described, and the m2 cytotoxin is inactive in 
the in vitro HeLa cell assay.   
Vacuolating cytotoxin activity is related to the mosaic structure of vacA. In general, 
type s1/m1 and s1/m2 strains produce high and moderate levels of toxin activity, 
respectively, whereas s2/m2 strains produce no vaculating activity (Atherton et al., 
1995). A 12-amino-acid hydrophilic amino-terminal segment, present in type s2 but 
absent from type s1 VacA proteins, slows the capacity of VacA to form membrane 
channels and abolishes vacuolation. Some type s1/m2 VacA toxins show cytotoxic 
activity toward selected cell types, including RK-13, but relatively little activity for 
HeLa or AGS cells (Atherton et al., 1995, Letley et al., 1999, van Doorn et al., 
1998). Heterogeneity among vacA alleles may be an important factor in 
understanding variations in clinical manifestations among H. pylori -infected 
subjects. Several studies have demonstrated that gastric infection with H. pylori  
strains containing type s1 vacA alleles are associated with a higher risk for 
development of peptic ulcer disease than infection with strains containing type s2 
vacA alleles (Atherton et al., 1995). This relation is not seen in Asia as an Asian 
 20
strains are vacA type s1 (Atherton et al., 1995, Han et al., 1998, Ito et al., 1997, Pan 
et al., 1998). Thus in these countries, s1 cannot be used as a marker for the presence 
of peptic ulcer disease because the prevalence of the s1 genotype is uniformly high.  
Rhead and colleagues have described a novel determinant of VacA toxicity,  called 
the intermediate or i-region (Joanne et al., 2007). They showed that two allelic 
variants of this region existed, i1, and i2. Furthermore, only s1/m2 strains varied in 
i-type; s1/m1 and s2/m2 strains were exclusively i1 and i2 respectively. This novel 
region determines vacuolating activity among these s1/m2 strains. More 
importantly, a significant correlation has been established between the i1 region 
and gastric cancer (Joanne et al., 2007). In contrast to Rhead et al., no disease 
association between vacA i genotypes and outcome was found in East Asian and 
Southeast Asian countries (Ogiwara et al., 2008). More studies, from other 
countries, are needed to determine whether this region is a true virulence 
determinant.           
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Figure 1. 1 Polymorphisms in VacA.  
The vacA gene varies most markedly in the signal region (encoding the signal 
peptide), which may be type s1 or s2, and in the mid-region (encoding part of the 
p58 binding subunit). This may be type m1 or m2. Three types of toxin are 
commonly found: s1/m1, s1/m2, and s2/m2 (the s2/m1 combination occurs but is 
rare). (Atherton 2006).    
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1.5.3 Blood Group Antigen Binding Adhesin A 
The BabA adhesin of H. pylori is an outer membrane protein that attaches to the 
fucosylated Lewis b histo-blood group antigen on the surface of gastric epithelial 
cells (Boren et al., 1993, Ilver, 1998). Within the gastric mucosa, H. pylori lies 
within the mucus layer and may also bind to gastric epithelial cells. Adherence to 
the epithelium is assumed to help protect the bacteria from gastric acidity, as well 
as from displacement due to peristalsis (Rad et al., 2002). Lewis b-dependent 
attachment of H. pylori to gastric epithelial cells is associated with increased 
severity of inflammation, development of parietal cell autoantibodies, and parietal 
cell loss (Rad et al., 2002). Two genes encoding BabA have been cloned: babA1 
and babA2, but only the babA2 gene is functionally active. Only about half of the 
H. pylori strains tested produced a detectable BabA protein (Bjornham et al., 2005, 
Hennig et al., 2004, Pride et al., 2001). Among H. pylori strains that produce a 
detectable BabA protein, there is considerable variation in binding to Lewis b 
(Bjornham et al., 2005).  In a study conducted in Brazil, a strong relationship 
between babA2 and duodenal ulcer or gastric carcinoma was detected, even after 
adjusting for confounding factors, such as age, gender, and cagA status (Kim et al., 
2001, Oliveira et al., 2003). Studies in Western countries have also revealed a 
strong relationship between babA2-positive status and duodenal ulcer and gastric 
carcinoma (Gerhard, 1999). However, in Asian countries, most of the circulating H. 
pylori strains are babA2 positive, whether or not they were isolated from 
asymptomatic or diseased patients (Kim et al., 2001, Lai et al., 2002, Mizushima et 
al., 2001). In addition to these differences between Western and Eastern countries, 
the prevalence of babA2-positive H. pylori strains varies among Western 
populations, being much lower in subjects from Portugal (Oleastro et al., 2003) 
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than in those from Germany (Gerhard, 1999), or the United States (Backstrom et 
al., 2004). Triple positive phenotype strains (babA2, cagA, and vacAs1) are 
associated with a high prevalence of ulcer and adenocarcinoma (Gerhard, 1999, 
Hennig et al., 2004, Kim et al., 2001, Oliveira et al., 2003).   
1.5.4 Outer Inflammatory Protein A 
The H. pylori outer inflammatory protein, OipA, is a virulence factor associated 
with increased IL-8 secretion and augmented inflammation in vitro as well as the 
clinically important presentation of peptic ulcer (Yamaoka et al., 2000, Yamaoka et 
al., 2006) although some have failed to show this association (Akanuma et al., 
2002). The gene oipA is found in all strains, although, variable numbers of 
dinucleotide repeats in its 5´ region mean that an active protein may or may not be 
produced; this adaptation system is called phase variation and is based on the 
slipped-strand repair mechanism. Switch on status is functional and off status 
is non-functional. Such status may affect bacterial characteristics such as virulence. 
Strains possessing the cag pathogenicity island typically also have OipA with 
functional status on (Kudo et al., 2004). PCR-based sequencing of the signal 
region of the gene is sometimes used to imply the presence of a functional OipA 
protein (Kudo et al., 2004). However, sequencing of the 5´ region of the gene does 
not guarantee that no mutations are present downstream that would prevent 
production of the protein, so detection of OipA expression by western blot analysis 
should also be performed.     
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1.5.5 Duodenal Ulcer Promoting Gene A (dupA)  
Recently, duodenal ulcer promoting gene A, dupA, has been identified and shown 
to play a role in provoking IL-8 secretion (Lu et al., 2005a). The dupA gene is 
located in a region of the bacterial genome that encodes surface proteins and it is a 
VirB4 homologue (Lu et al., 2005a). Lu et al. showed that the presence of dupA 
was significantly associated with duodenal ulceration, but negatively associated 
with gastric cancer, in populations from South Korea, Japan, and Colombia. They 
also showed that it increased IL-8 secretion (Lu et al., 2005a). A population from 
northern India also demonstrated a significant association between the presence of 
dupA and duodenal ulceration, although no patients with gastric cancer were 
included in the study (Arachchi et al., 2007). In contrast, in a population from 
Brazil, no significant association between dupA prevalence and ulceration or cancer 
was found (Gomes et al., 2007). It was recently found, however, that dupA was not 
significantly associated with duodenal ulceration in populations from Belgium, 
South Africa, China, and the USA, but was significantly associated with gastric 
cancer development (Argent et al., 2007). This association with duodenal ulceration 
in some populations and gastric cancer in others is similar to the association of the 
cag PaI with disease. The cag PaI is thought to induce increased gastric 
inflammation largely through increasing IL-8 secretion from epithelial cells 
(Crabtree et al., 1995). Finally, an association between dupA-negative strains of H. 
pylori and pre-malignant lesions was found in Iran (Douraghi et al., 2008). The 
variation in the results calls for additional studies of dupA to evaluate the role of 
this gene in disease processes.   
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1.6 Genomic Diversity 
H. pylori has a wide genetic diversity amongst isolates from different subjects. It is 
extremely difficult to find two isolates, from unrelated individual, with identical 
genomic fingerprints by methods such as random amplification of polymorphic 
DNA (RAPD) (Akopyanz et al., 1992). Additionally, genomic comparison of 
different strains has shown that 7% of the genes are specific for each strain (Alm et 
al., 1999). Such a diversity is conferred by many mechanisms, including point 
mutations, chromosomal rearrangements, strain specific restriction modification 
systems, horizontal gene transfer between strains, impaired DNA repair 
mechanisms, and an exceedingly high frequency of recombination (Blaser and 
Berg, 2001, Falush, 2001, Suerbaum and Josenhans, 2007). The recombination rate 
in H. pylori is the highest among all bacteria that have been studied so far 
(Suerbaum and Josenhans, 2007).   
H. pylori is naturally competent for transformation, which allows uptake of free 
DNA released from nearby strains in the local environment when they die. Foreign 
DNA fragments undergo recombination for integration into the chromosome. comB 
is believed to play an important role in the process of natural transformation 
(Hofreuter et al., 2001). Uptake of foreign DNA and subsequent homologous 
recombination results in genetic diversity. Interestingly, the average size of 
recombined fragments in H. pylori (about 400 bp) is much smaller than in other 
bacteria (Falush, 2001).   
The development of variation within the H. pylori population, followed by 
continuous selection for sub-clones with improved fitness for individual hosts over 
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years or even decades of infection, has led to an exceedingly diverse and most host 
adapted bacterial species.  
According to their geographical distinction, H. pylori  can be divided into four 
populations; hpAfrica 1, which is subclassified into hspWAfrica and hspSAfrica, 
hpAfrica 2, hpEastAsia, which is subdivided into hspAmernid, hspEAsia and 
hspMaori, and hpEurope. These modern populations derive their gene pools from 
five ancestral populations; Africa1, Africa2, EastAsia, Europe1 (AE1), and 
Europe2 (AE2). Human migration throughout history played the major role in 
subsequent spread (Falush et al., 2003).     
The vacA s1a or s1b genotypes are predominant in strains from Western countries, 
whereas s1c is highly prevalent in strains from East Asia (van Doorn et al., 1999). 
The vacA m1a and m2a genotypes are predominant in strains from Western 
countries, whereas the m1c genotype is predominant in strains from South Asia, 
and the m1b and m2b genotypes are predominant in strains from East Asia (van 
Doorn et al., 1999). Overall, strains from Western countries predominantly possess 
cagA, vacA s1a, s1b, or s2 and m1a or m2a genotypes (van Doorn et al., 1999). 
Strains from South Asia predominantly possess cagA and vacA s1a/m1c genotypes, 
whereas strains from East Asia predominantly possessed cagA, vacA s1c/m1b, or 
m2b genotypes (van Doorn et al., 1999). These variations in the global distribution 
of the cagA and vacA genotypes may explain the diversity of reports associating the 
cagA and vacA genotypes with the clinical outcome from different geographic 
regions (Atherton, 2006). Other preliminary studies have supported the finding that 
vacA s2 strains are rarely associated with ulcers but have also found that such 
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strains are uncommon in many populations (Atherton, 2006, Atherton et al., 1997). 
More than 80% of Africans are infected with H. pylori, (Holcombe, 1992). In 
Ethiopia, for example, the vacA gene was detected in all H. pylori strains and the 
vacA genotype s1/m1 was found in 48% of the strains and 79% were cagA positive 
(Asrat et al., 2004).  In spite of this, gastric cancer rates are lower than might be 
predicted based on this high prevalence which may indicating the presence of an 
enigma in this region (Holcombe, 1992).                  
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1.7 Immune Response 
1.7.1 T Helper cells 1 (Th1) and 2 (Th2) 
The Th-0 naïve cells may be differentiated into certain Th subsets (Th1, Th2, Th17, 
Treg) depending on the cytokine environment where antigen presentation occurs. 
Th cells are an important regulator of the immune system, for example they control 
inflammation and B-cell memory. Usually Th2 cells are responsible for dealing 
with extracellular bacterial and parasite infections, whereas intracellular infections, 
including viruses, are dealt with by Th1 cells.  Th1 cells, whose maturation is 
stimulated by interleukin-12 (IL-12), predominantly secrete interferon gamma 
(IFN ) and IL-2, whilst Th2 cells, which may be stimulated by IL-10, secrete IL-4, 
IL-5, IL-9, and IL-13 (Atherton, 2006, Bergman et al., 2004, Robinson et al., 2008, 
Smythies et al., 2000). Th1 and Th2 cells cross-regulate one another. IFN secreted 
by Th1 cells directly suppresses IL-4 production, and thus inhibits the 
differentiation of naïve  Th cells into Th2 cells (Gajewski and Fitch, 1988). In 
contrast, IL-4 inhibits the secretion of IFN and blocks the activity of Th1 cells 
(Ohmori and Hamilton, 1997).  
In H. pylori infection, although both Th1 and Th2 arms of the immune response are 
provoked, gastric mucosal cytokine profiles suggest that the Th1 response 
predominates (Andersen and Wadström, 2001, Atherton, 1998, Whitfield, 2003) 
Th1 cells are induced by the actions of IL-12 during antigen presentation to the 
naive T-cell.  H. pylori neutrophil-activating protein (HP-NAP) was shown to play 
an important role in stimulating IL-12 production from neutrophils and monocytes, 
biasing the immune response towards Th1 (Amedei et al., 2006). Studies in animal 
models and supportive data in humans show that a strong Th1 response increases 
 29
the severity of gastritis and cancer risk (Akhiani et al., 2002, Bamford et al., 1998, 
Blaser, 1992). In IFN knock-out mice a lesser inflammatory response to H. pylori 
was found in comparison to wild-type mice, indicating the importance of IFN for 
exacerbating gastritis (Akhiani et al., 2002). With H. pylori induced Th2 responses 
there is milder gastritis; a higher H. pylori colonisation density and lower risk of 
gastric cancer (Atherton, 2006) (Figure 1.1).   
H. pylori induces a strong T-cell mediated immune response yet it is ineffective in 
clearance. Atherton argued that such an intense immune response is deleterious to 
the bacteria and it might cause elimination of infecting micro-organisms in mice 
(Atherton, 2006, Kotloff, 1996). However in humans H. pylori  appears to 
downregulate the Th responses to avoid clearance (Atherton, 2006). This balance 
between the up and the downregulation of Th1 may be achieved via several 
mechanisms. Firstly, it was found that Lewis antigen can bind to the dendritic cell 
specific intracellular adhesion molecule-3 (ICAM3) binding nonintegrin (DC-
SIGN) lectin on gastric dendritic cells; this binding halts Th1 cell development. 
However, not all H. pylori carry Lewis antigens, therefore, it is expected that Lewis 
negative variants induce stronger Th1 response than Lewis positive variants 
(Atherton, 2006, Bergman et al., 2004, Rad et al., 2002) . Secondly, Th1 
polarisation can be diminished through H. pylori stimulated cyclooxygenase-2 
production by mononuclear cells (Byrne et al., 2003, Meyer et al., 2003, Wight et 
al., 2001). Thirdly, H. pylori can stimulate a regulatory T cells (Treg) response 
(Lundgren A et al., 2003). In the presence of the Treg cells, lower levels of IFN 
are secreted by memory Th cells in H. pylori infected subjects than those from H. 
pylori uninfected people (Atherton, 2006, Lundgren A et al., 2003). Finally, 
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external factors can play a role in downregulating the Th1 response. It has been 
shown that the coinfection of mice with Helicobacter felis, a Helicobacter species 
which has wider host range than H. pylori (Lee et al., 1990, Lee et al., 1988, 
Lockard and Boler, 1970), and helminths, leads to increased H. felis density, but 
reduced Th1 cytokine levels (Fox JG et al., 2000). On the other hand, the immune 
response in mice co-infected with H. felis and Toxoplasma gondii was pushed 
towards a Th1 biased response. Gastric mucosal IFN and IL-12 levels were 
significantly elevated and IL-10 expression was substantially reduced (Stoicov et 
al., 2004).   
There are reported variations in the immune response to H. pylori infection in 
different human populations. The immune response to H. pylori infection in an 
African population was predominantly Th2 and differed from that observed in 
subjects from Europe which was mainly Th1 (Mitchell et al., 2002). Other 
researchers have shown evidence of a Th2 response especially in children 
(Campbell et al., 2004). In addition, previous studies have shown that the Th2 
response is stronger in women (Ansar et al., 1985).          
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Figure 1. 2 The central role of the Th cell response to H. pylori infection.  
Th1, Th2, and regulatory T cells are activated, but the balance of the response 
varies between people owing to unknown factors. Studies in animal models and 
supportive data in humans show that a strong Th1 response increases severity of 
gastritis and cancer risk. Both H. pylori and the host downregulate this Th1 
response. This potentially benefits H. pylori by allowing more dense colonization 
and benefits the host by downregulating mucosal inflammation. (Atherton 2006).         
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1.7.2 Regulatory T cells (Treg) 
The immune system can distinguish between self and non-self antigens, preserving 
self-tolerance and preventing a damaging immune attack on the body s cells and 
tissues. This is achieved via several mechanisms. Firstly, potentially dangerous 
self-reactive T and B cells are clonally removed at primitive stages of their 
development or inactivated when encountering self-antigens. Secondly, a 
population of self-reactive CD4+ T cells, called regulatory T cells (Tregs), 
participate in the maintenance of peripheral self-tolerance by blocking the 
activation and expansion of damaging self-reactive T cells. Treg cells constitute 5
10% of CD4+ T cells and the vast majority of such naturally occurring CD4+ cells 
constitutively express high levels of CD25 (Hori et al., 2003, Sakaguchi, 2000, 
Sakaguchi et al., 1995, Sakaguchi et al., 2001).   
It has been shown that Treg cells are able to suppress the proliferation and cytokine 
production of both CD4 and CD8 T cells via a cell-cell contact-dependent 
mechanism and/or the secretion of anti-inflammatory cytokines such as IL-10 and 
transforming growth factor  (TGF ) (Sakaguchi et al., 2001). Additionally, the in 
vitro suppressive activity of Treg cells can be induced by several different types of 
antigens, including dietary, self, and foreign antigens (Taams et al., 2002). 
Furthermore, Treg cells have been demonstrated to be responsible for maintaining 
tolerance to food antigens (Lundin et al., 1999, Zhang et al., 2001) and to the 
normal intestinal flora (Singh et al., 2001). Experiments on mice have shown that 
the removal of this population of cells leads to spontaneous development of various 
autoimmune diseases in otherwise normal mice (Sakaguchi et al., 1995). This 
uncontrolled immune reaction has been noticed in humans as well. the best 
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example is IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-
linked syndrome) (Gambineri et al., 2003). The FOXP3 gene encodes a 
transcriptional repressor and acts as the master regulator in the development and 
function of Treg cells (Bennett et al., 2001, Brunkow et al., 2001, Chatila et al., 
2000, Fontenot et al., 2003, Hori et al., 2003, Khattri et al., 2003, Wildin et al., 
2001). Furthermore, transfusion of CD25+CD4+ T cells prepared from normal mice 
can prevent autoimmune disease in FOXP3-defective mice (Fontenot et al., 2003). 
Walker and colleagues argued that the discovery of FOXP3/FOXP3 as a marker for 
natural CD25+CD4+ cells made it possible to determine the origin and the 
developmental pathway of these cells (Walker et al., 2003). Unfortunately, FOXP3 
expression can be induced in non-Treg cells so it is not a completely specific and 
stable marker, however it is widely regarded as the best marker available at this 
time (Fontenot et al., 2003, Hori et al., 2003).   
Treg responses increase with age. Two theories explain the origin of CD25+CD4+ 
cells. One is that naive T cells can differentiate to CD25+CD4+ cells upon T-cells 
receptor stimulation, in a manner similar to that of Th1 and Th2 cells (Apostolou et 
al., 2002, Thorstenson and Khoruts, 2001). Another theory is that some of the 
functionally mature regulatory T cells produced by the thymus are CD25 or lose 
CD25 expression with retention of their suppressive function. In rodents, such 
CD25 cells become CD25+ when activated (Annacker et al., 2000, Gavin et al., 
2002) (Stephens and Mason, 2000).   
It was recently shown that Treg cells reduce H. pylori-induced gastritis in mice and 
humans (Couper et al., 2008, Grencis et al., 1991, Raghavan et al., 2003). These 
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cells can also halt the induction of colon cancer in mouse models by inhibiting the 
inflammatory response to H. hepaticus (Erdman et al., 2003). The induction of Treg 
cells may halt the process of disease progression by suppression of the damaging 
immune and inflammatory response. On the other hand, this suppression may allow 
bacterial persistence and the effectiveness of immunosurveillance against tumour 
cells may be diminished. In support of this, a relationship between Treg cells and 
the progression of  tumours was shown (Karanikas et al., 2008, Karube et al., 2004, 
Miller et al., 2006, Rao et al., 2006) and high levels of  these cells are regarded as a 
poor prognostic sign in cancer patients (Liu et al., 2008). Furthermore, Treg activity 
is a marker of tumour progression and metastasis in breast carcinoma (Gupta et al., 
2007).   
1.7.3 T helper cells-17 (Th17) 
Recently, a novel pathway of inflammation characterized by excessive production 
of IL-17 has been described in a variety of chronic inflammatory diseases such as 
multiple sclerosis (Weaver et al., 2007). Th17 cells differentiate and grow in the 
presence of a combination of TGF 1 and IL-6, together with IL-23 secreted from 
antigen presenting cells (Caruso et al., 2007, Di Sabatino et al., 2008). These CD4+ 
cells have been designated Th17 based on their production of IL-17 which is not 
produced by Th1 or Th2 cells. In addition, Th17 cells produce a range of other 
factors known to drive inflammatory responses, including tumor necrosis factor- 
(TNF ), IL-6, and granulocyte-macrophage colony-stimulating factor (GM-CSF) 
(Kolls and Linden, 2004, Park et al., 2005, Steinman, 2007, Weaver et al., 2007). In 
a study conducted using human cells, it was shown that Th17 cells share major 
trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T 
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cells (Lim et al., 2008).  The key contribution of the Th17 cell subset to immune 
responses against H. pylori remains undefined (Caruso et al., 2007). However, 
Kullberg et al. recently showed, in two models of H. hepaticus triggered T cell-
dependent colitis, that IL-23 drives both IFN and IL-17 responses that together 
synergize to trigger severe intestinal inflammation (Kullberg et al., 2006). In 
another experiment, it was shown that IL-23 is over-expressed in H. pylori-infected 
gastric mucosa where it could contribute to sustaining IL-17 production (Caruso et 
al., 2008).  In addition, it was shown that IL-23 enhances IFN synthesis in normal 
gastric lamina propria mononuclear cell (LPMC), and that anti-IL-23/p19 
diminishes the production of IFN in LPMC of H. pylori-infected patients (Caruso 
et al., 2008). More studies are needed to explore the role of Th17 in the disease 
development process in H. pylori infected patients.    
1.7.4 Interferon gamma and Interleukin-4  
Interferon gamma (IFN ) is a naturally occurring protein produced by Th1 cells to 
regulate and boost the immune system via its cellular axis (Atherton, 2006). H. 
pylori infection stimulates Th1 cells to produce IFN which in turn plays an 
important role in the disease process (Sommer et al., 2001, Yamamoto et al., 2004).  
H. pylori infected mice with defects in IFN expression (IFN null mice) develop 
less severe gastric inflammation and have higher bacterial colonization densities 
(Sommer et al., 2001, Yamamoto et al., 2004). The infusion of IFN alone can 
induce gastric inflammation and atrophy. However, the influence of this cytokine is 
enhanced with Helicobacter co-infection (Cui G, 2003). This implies that IFN 
plays a role in increased severity of H. pylori-induced gastric inflammation and 
also reduces bacterial colonization. In addition, IFN modulates the severity of 
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gastric inflammation indirectly via macrophage activation and also may down-
regulate the expression of anti-inflammatory factors such as transforming growth 
factor  (TGF ) (Strober et al., 1997, Yamamoto et al., 2004).   
Interleukin-4 (IL-4) is a protein produced by activated Th2 cells to promote 
antibody production. H. pylori-infected IL-4-/- mice developed more severe gastric 
inflammation than did H. pylori-infected wild-type mice implying that the Th 
balance was tipped towards Th1 in the absence of IL-4 leading to increased 
inflammation (Smythies et al., 2000). Similarly, H. felis-infected IL-4 null mice 
developed significantly more severe gastritis than did H. felis-infected wild-type 
mice (Mohammadi et al., 1997). These data suggested that IL-4 plays a role in 
down-regulating gastric inflammation.   
Gastrin, which is a hormone that stimulates gastric acid secretion, is stimulated by 
IFN . In contrast, the expression of somatostatin, a hormone that inhibits gastric 
acid secretion, is activated by IL-4 and inhibited by IFN and TNF (Beales et al., 
1997, Zavros et al., 2003). Hence, a Th1 response is expected to exacerbate gastrin 
production, whereas expression of IL-4 (a Th2 response) is expected to result in 
increased somatostatin production and reduced gastrin secretion.   
1.7.5 Interleukin-8  
Interleukin-8 (IL-8) is a powerful chemotactic factor for neutrophils and 
lymphocytes. This chemokine is secreted by antigen presenting cells and 
endothelial cells (Utgaard et al., 1998, Wolff et al., 1998).  IL-8 promotes the 
adhesion of neutrophils to vascular endothelial cells. Then neutrophils migrate and 
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enter the infected and inflamed tissue. When H. pylori comes into contact with 
epithelial cells, these cells start to produce cytokines such as IL-8 (Nozawa et al., 
2002).   The cag PaI is known to induce high levels of IL-8 secretion from the 
gastric epithelium (Censini et al., 1996, Crabtree et al., 1995, Keates et al., 1997). 
OipA has also been shown to contribute to IL-8 secretion (Yamaoka et al., 2002a, 
Yamaoka et al., 2002b, Yamaoka et al., 2000, Yamaoka et al., 2006), although 
some have failed to show this association (Akanuma et al., 2002). Recently, dupA 
has been suggested to be an IL-8 inducer (Lu et al., 2005a). Polymorphisms that 
increase expression of the IL-8 gene have been found to be associated with 
increased risk of duodenal ulcer and nasopharyngeal carcinoma (Ben Nasr et al., 
2007, Gyulai et al., 2004).  
1.7.6 Interleukin-12 (IL-12) 
Interleukin-12 (IL-12) is a heterodimeric cytokine produced by antigen presenting 
cells in response to intracellular pathogen infection. It helps in the differentiation of 
naïve T cells into Th1 cells, triggering the production of IFN . Together IFN and 
IL-12 not only induce the differentiation of Thl cells but also inhibit Th2 responses 
(Kubin et al., 1994, Ozmen et al., 1994, Trinchieri, 2003). In addition, vaccine-
induced protective immunity is IL-12 dependent (Akhiani et al., 2002). IL-12 is 
formed from two subunits: the p35 (also found in IL-6) and p40 (also found in IL-
23) subunits are encoded by IL-12A and IL-12B genes. The production of both 
subunits is required to form a biologically active heterodimer (p70) (D'Andrea et 
al., 1992, Harrington et al., 2006, Trinchieri, 2003). In addition, an association was 
found between IL-12 polymorphisms leading to increased expression and gastric 
cancer risk, but not with intestinal metaplasia (Navaglia et al., 2005). 
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Dendritic cells are a group of specialised antigen-presenting leukocytes that 
perform essential functions in the development of immune responses. These cells 
are found in the skin, lymphoid tissue and mucosa including the gastrointestinal 
mucosa. They represent the first line of the immune system that interacts with H. 
pylori, a reaction that elicits IL-12 secretion (Cutler et al., 2001, Wick, 2002, Yrlid 
and Wick, 2002). IL-12 upregulation in the gastric mucosa is associated with cag 
PAI-positive strains and leads to a Th1-biased response (Hida et al., 1999). A Th1 
oriented response has been implicated in perpetuating the inflammatory changes 
that lead to disease (Bergman et al., 2004, Smythies et al., 2000, Trinchieri, 2003).   
1.7.7 Interleukin-10  
Interleukin-10 (IL-10), formerly known as cytokine synthesis inhibitory factor, 
inhibits the synthesis of IFN , IL-2 (which stimulates the differentiation of naïve T 
cells into Th1), IL-3 (which supports growth and differentiation of T cells from the 
bone marrow) and TNF (which is involved in systemic inflammation and is a 
member of a group of cytokines that all stimulate the acute phase reaction). IL-10 
has  also been shown to have angiogenic activities (Keates et al., 2007). It is mainly 
secreted by Th2, monocytes and mast cells. However, it was recently shown that 
Th17, Treg and Th1 cells also can secret IL-10 (Couper et al., 2008, Steinman, 
2007). Additionally, IL-10 can downregulate the expression of the major 
histocompatibility complex molecules (Bogdan et al., 1991, D Andrea et al., 1993, 
de Waal Malefyt et al., 1991a, de Waal Malefyt et al., 1991b, Fiorentino et al., 
1991), thus interfering with antigen presentation.   
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Antibodies blocking IL-10 production enhance the production of IFN by PBMCs 
in response to microbial antigens (Carvalho et al., 1994, Flores Villanueva et al., 
1994). Additionally, H. felis-infected IL-10 knock-out mice develop a very severe 
gastritis (Berg et al., 1998). Furthermore, The inflammatory response in mice 
deficient in IL-10 is enough to clear H. pylori successfully and rapidly (Chen 
Wangxue  et al., 2001). Hence, IL-10 may promote the colonisation of H. pylori. 
Finally, IL-10 polymorphisms which cause lower than normal expression levels 
were associated with an increased risk of intestinal metaplasia (Zambon et al., 
2005).   
1.7.8 The Antibody Response to H. pylori Infection 
Antibodies are protein (immunoglobulin) molecules produced by plasma cells and 
are responsible for humoral immunity. Antibodies are made from different classes 
of immunoglobulins. In mammals there are five antibody classes known as IgA, 
IgD, IgE, IgG and IgM. H. pylori provokes the induction of specific antibody 
response that consists mainly of IgA and IgG (Bontkes et al., 1992). There is some 
argument in the literature about the role of IgA in the diagnosis of H. pylori. While 
Bhat et al. showed that the mucosal CagA-specific IgA antibodies are produced 
during the acute phase of gastric inflammation (Bhat et al., 2005, Kullavanijaya et 
al., 2004) and are of poor sensitivity, Matsukura et al. showed that the tissue H. 
pylori IgA antibody assay is useful for detection of local immunity against H. 
pylori in the stomach and during follow-up after treatment (Matsukura et al., 1995). 
Nearly all infected individuals (>90%) exhibit H. pylori-specific IgG antibodies 
(Blaser, 1992) and these can be used for diagnosis of infection (Lenzi et al., 2006). 
It was shown that the main human IgG subclasses antibodies associated with H. 
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pylori infection are IgG2 and IgG1 (Bontkes et al., 1992) which are considered 
markers of a Thl and Th2 immune response, respectively (Mitchell et al., 2002, 
Vorobjova et al., 2006).  The association between IgG subclasses and Th subset is 
stronger in mice than humans (Mosmann and Coffman, 1989, Yan et al., 2000).   
1.7.9 Sex Hormones and the Immune System 
As sex hormones differ between genders, many researchers have studied the effect 
of sex hormones on the immune response.  It has been shown that women produce 
a stronger Th2 cellular and humoral immune response and suffer from a higher 
incidence of Th2-associated autoimmune diseases e.g. multiple sclerosis (Ansar et 
al., 1985). Faas et al. argued that the production of IL-4 is significantly higher in 
the luteal phase of the menstrual cycle as compared with the follicular phase (Faas 
et al., 2000). In another study, no differences in the percentage of lymphocyte 
subtypes during the menstrual cycle could be found (Bouman et al., 2005). 
However, post-menopausal women showed a reduction of the number of total 
lymphocytes in comparison to fertile women implying a role for progesterone and 
oestrogen (Giglio et al., 1994, Yang et al., 2000).  In addition, T cell cytokine 
profiles could be modulated by pregnancy hormones: a high dose of progesterone 
present during pregnancy induces the production of IL-4 and biases the immune 
response towards a Th2 response (Zenclussen, 2006).  Recently it was shown that 
there is an increase in the number of Tregs during pregnancy and failure in this 
augmentation could result in immunological rejection of the foetus. This could be 
prevented by adoptively transferring CD4+/CD25+ Treg cells from normal 
pregnant mice into abortion-prone animals (Zenclussen, 2005).  
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Bouman et al. concluded that there are no major effects of sex hormones on 
lymphocyte IFN secretion, and no differences in the production of IFN by male 
lymphocytes as compared to female lymphocytes. There was also no variation in 
the production of IFN during different phases of the menstrual cycle (Bouman et 
al., 2005). On the other hand, it is agreed that T lymphocyte counts are lower in 
males as compared to females which, perhaps is due to the increased testosterone 
concentrations, as this is associated with apoptosis in T cells (McMurray et al., 
2001). In another study it was shown that oestrogen regulates the expression of 
IFN (Fox et al., 1991).  
To summarise, differences in hormone profiles might affect the immune responses, 
changing their behaviour towards microorganisms and might skew the immune 
response in a manner resulting in a better or worse prognosis.   
1.7.10 Smoking and Immune System 
It was shown that smokers are more prone to peptic ulceration and gastric cancer 
than non-smokers (Ko and Cho, 2000, Maity et al., 2003, Sonnenberg, 1988, 
Walker and Taylor, 1979). Probably, smoking is associated with those diseases 
because it modulates the immune system. In an in vitro study it was shown that 
tobacco exposed lymphocytes have reduced proliferative capacities, which might 
affect the ability of the production of protective immunoglobulins against oral 
pathogens (Barbour et al., 1997). In addition, smoking is considered as the most 
powerful independent risk factor for invasive pneumococcal disease amongst 
immunocompetent subjects suggesting that smoking might modulate defence 
mechanisms of the lung (Nuorti et al., 2000). In a case control study, the effect of 
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smoking on natural killer cells, serum and saliva immunoglobulin level was 
studied. It was shown that there was a significant increase in NK cells activity 
against cultured melanoma cells in subjects who ceased smoking. Serum IgG and 
IgM levels increased significantly in those who gave up smoking, but not IgA. In 
saliva, the level of IgA and IgG rose significantly in subjects who stopped smoking. 
These changes could not be observed in those who continued to smoke. In this 
study, the mechanism behind those changes was not studied (Hersey et al., 1983). 
Furthermore, in a study conducted using lung biopsies from patients with 
obstructive airway diseases, it was shown that the activation of the transcription 
factor signal transducer and activator of transcription (STAT)-4, which is critical 
for the differentiation of Th1 and the production of IFN , is associated with 
smoking (Di Stefano et al., 2004). The importance of this research comes from the 
fact that IFN is associates with gastric metaplasia and atrophy both of which are 
premalignant conditions. In another study, smoking was proven to lower CD8 cell 
counts in smokers (Fatima et al., 1991). Furthermore, epidemiological associations 
have been shown between smoking and gastric cancer. However, it is not clear why 
smoking might increase the risk of cancer.   
These findings suggest that there is an association of smoking with an increased 
incidence of certain malignant diseases probably through modulating the immune 
system.     
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1.8 Rationale and Aims 
The gastric cancer rate in Iraq and especially in Kurdistan region is very low 
(GLOBOCAN, 2002) (Figure 1.3). In support of this, examination of the medical 
records for the period 2005-2006 at two general hospitals, Sulaimanyia hospital and 
Azadi hospital (hospitals servicing 2 million people), showed that only 
approximately 40 gastric cancers were diagnosed during that period in both 
hospitals. No studies have been conducted in this. The most obvious explanation 
could be low H. pylori prevalence, and this was investigated first. In addition, H. 
pylori infections are usually acquired in childhood, resulting in pangastritis in 
adulthood which is associated with mucosal atrophy and intestinal metaplasia 
which are precancerous conditions (Asaka et al., 1997, Atherton, 2006). It was 
therefore next hypothesised that the H. pylori acquisition might occur later in life.  
This might explain why a high prevalence may be associated with a low cancer 
incidence. Pangastritis and corpus-predominant gastritis are associated with 
increased risk of gastric cancer (Asaka et al., 1998, Asaka et al., 1997, Atherton, 
2006, Blaser et al., 2007, Meining et al., 1998).  Nothing is known about the 
distribution of H. pylori-associated inflammation in Iraqi patients in Kurdistan 
region, or its severity. Antral-predominant gastritis could explain the low cancer 
rate. Thus, we assessed the degree and distribution of inflammation in the stomachs 
of Iraqi people in this region.  
H. pylori strains differ, and possession of specific virulence factors greatly 
increases the risk of disease. The best recognised of these are the cag pathogenicity 
island and active forms of the vacuolating cytotoxin VacA. dupA is a recently 
described gene shown to be associated with duodenal ulceration and protective 
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against gastric cancer (Lu et al., 2005a). In Iraq, no studies have yet been conducted 
to determine the prevalence of virulence factors of H. pylori, and their association 
with disease and histological findings. One objective of this project was therefore 
to investigate virulence factors of strains in a sample of patients undergoing upper 
GI endoscopy and any association with disease, and histopathological changes.   
As described earlier, H. pylori induced inflammation and Th1 responses are 
thought to be central to the pathogenesis of H. pylori associated diseases. 
Environmental factors are known to influence the balance of the T-helper response. 
It was hypothesised that a Th2 response might predominate in Kurdistan region 
thus explaining the low gastric cancer incidence. Thus another aim of this project 
was to study the immune response to H. pylori and its association with virulence 
factors, clinical outcomes and other factors such as smoking and gender.  
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Figure 1. 3  Map showing worldwide gastric cancer rates (per 100,000)
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2. Study of Age-Specific Helicobacter pylori Seropositivity Rates 
and H. pylori-Gastritis Patterns in Kurdistan region, Iraq. 
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Abstract 
Introduction: In Iraq and especially Kurdistan region, gastric cancer is rare 
(5/100,000). To look for reasons for this, we investigated whether Helicobacter 
pylori infection was uncommon, whether it occurred late in life and whether 
infected adults had the antral-predominant pattern of gastritis which does not 
predispose to cancer. Methods: We determined age-specific H. pylori 
seropositivity rates by ELISA in 283 subjects from Dohuk city in Kurdistan and 
evaluated histopathological changes by Sydney system scoring in gastric biopsies 
taken from 30 H. pylori-infected adult subjects without peptic ulcers. Results: 79% 
of 163 adults were infected with H. pylori, while 37% of 120 children were 
seropositive (p<0.0001). The prevalence in children of various age group was 
<6months:0%; 6-24months:27%; 2-18years:58%. Amongst adults, the 
seroprevalence was similar across age groups and between sexes. For infected 
people, gastric lymphocyte infiltration was more prominent in the antrum (p=0.01). 
Neutrophil infiltration was mild. Histological evidence of mucosal atrophy was 
seen in only 1/30 antral and 1/30 corpus samples, and in these it was grade 1 (mild). 
Conclusion: H. pylori infection is common in Kurdistan and acquired at a young 
age. However, in adults, lymphocyte infiltration is more predominant in the antrum 
than the corpus. Furthermore, neutrophil infiltration is mild and gastric mucosal 
atrophy is rare. The mild pathology may help explain the low cancer rate in 
Kurdistan region. Further work is needed to understand why infection results in an 
antral-predominant gastritis with little atrophy.          
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2.1 Introduction 
Helicobacter pylori is regarded as the most important risk factor for peptic ulcer 
disease and gastric cancer (Blaser et al., 1995, Correa, 1995, Correa, 2003). In 
Kurdistan region, northern Iraq, gastric cancer is rare (GLOBOCAN, 2002). 
Despite the geographical proximity of Iraq, Turkey and Iran the incidence of gastric 
cancer differs hugely amongst these countries; 5/105, 8.9 to 14.1/105 and 38 to 
69/105, respectively (GLOBOCAN, 2002, Nouraie et al., 2004, Sadjadi et al., 2003, 
Sadjadi et al., 2005, Yavari et al., 2006). One possible explanation for these 
differences would be similar differences in prevalence of H. pylori infection. 
However, data from Turkey and Iran do not support this idea: in Eastern Turkey, 
64% of the population were found to be seropositive for H. pylori (Ayse SelimoGlu 
et al., 2002) whereas in Iran, H. pylori seroprevalence was only 33% (Nassrolahei 
and Khalilian, 2004). In another study from Iran, H. pylori seropositivity was 48% 
in Ardebil province and 31% in Yazd province (Mikaeli et al., 1999). Gastric 
cancer is more common in Ardebil than Yazd, so here differences in H. pylori 
prevalence may be contributing to the difference. The prevalence of H. pylori in 
Kurdistan region is unknown.   
Diagnosis of H. pylori can be achieved by taking biopsies at endoscopy. However, 
this procedure is invasive and might not give accurate results if colonisation is 
patchy (Ormand and Talley., 1990). Furthermore, it does not suit population-based 
studies. For screening of populations, serodiagnosis remains the method of choice 
for measuring the prevalence of infection (Dooley et al., 1989). Systemic humoral 
immunoglobulin G (IgG) immune responses to the organism are developed by  
humans infected with H. pylori (Perez-Perez et al., 1988, Talley et al., 1991a, 
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Veenendaal et al., 1991). Serological tests are useful tools for the diagnosis of H. 
pylori infection because all H. pylori-infected patients produce an antibody 
response which can be detected in the serum (Perez-Perez et al., 1988). The 
technique of choice is currently ELISA because it is a simple, quick, and low-cost 
(Perez-Perez et al., 1988).  
Previous reports have shown that patients infected at a younger age have an 
increased risk of later developing gastric cancer (Asaka et al., 1998, Asaka et al., 
1997, Atherton, 2006, Blaser et al., 2007, Sepulveda et al., 2002). Early acquisition 
is associated with pangastritis in adulthood followed by gradual mucosal atrophy, 
intestinal metaplasia, dysplasia and gastric cancer (Asaka et al., 1998, Asaka et al., 
1997, Atherton, 2006, Blaser et al., 2007, Meining et al., 1998, Sepulveda et al., 
2002). Consistent with this, in Iran, H. pylori infection was shown to be 
significantly more prevalent amongst individuals of less than 20 years of age in 
areas with high incidence of gastric cancer compared with areas of low cancer 
incidence (Mikaeli et al., 1999). If infection occurred later in life in Iraq, this could 
potentially explain the low cancer rate. We investigated H. pylori prevalence in 
different age groups in children and in adults.  
Pangastritis and corpus-predominant gastritis are associated with increased risk of 
gastric mucosal atrophy and increased risk of cancer (Asaka et al., 1998, Asaka et 
al., 1997, Atherton, 2006, Blaser et al., 2007, Meining et al., 1998).  Nothing is 
known about the distribution of H. pylori-associated inflammation in Iraqi patients, 
or its severity. Potentially, the low cancer rate in Kurdistan region could be 
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explained by antral-predominant gastritis being the common pattern and/or by 
inflammation being mild.   
Thus, we now aimed to assess H. pylori seroprevalence in children and adults in 
Kurdistan region in northern Iraq and the degree and distribution of inflammation 
in the stomachs of Iraqi people.   
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2.2 Materials and Methods    
2.2.1 Patient-Derived Samples 
Serum samples from 283 subjects including 120 children and 163 adults admitted 
to the surgical and pediatric wards for conditions other than gastrointestinal 
disorders were used in the study.   
Gastric biopsies were obtained from dyspeptic patients undergoing routine upper 
gastrointestinal endoscopy in Azadi hospital/ Dohuk city, Kurdistan region, Iraq 
and found not to have peptic ulcer disease. A total of 35 H. pylori-infected adults 
(age: 17-70 years) underwent upper gastrointestinal endoscopy using a GIF XQ 40 
endoscope (Olympus Optical Company, Tokyo, Japan) under topical lignocaine 
anaesthesia. During gastroscopy, two biopsies from the antrum and two from the 
corpus were taken and fixed in 10 ml buffered 10% formalin for histopathological 
examinations.  
The study protocol was approved by the Ethics and Research Committees of the 
hospital, and all patients gave informed consent to the study.  
2.2.2 Culture 
Each biopsy specimen was spread on both sheep blood and Dent agar plates, then 
incubated under microaerobic conditions generated by a Campypack (Becton, 
Dickinson and company) in an anaerobic jar at 37°C for 2 to 4 days. The organisms 
were identified as H. pylori by colony morphology; Gram stain; and urease activity. 
Cultures were harvested and stored in 1 ml nutrient broth containing 15% glycerol 
at - 80°C. 
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2.2.3 Antigen Preparation for ELISA 
A lysate of 5 Iraqi stains (all of which were cagA-positive) was prepared. The 
lysate was prepared by sonicating a suspension of a pool of the 5 Iraqi strains in 
PBS. This procedure was performed on ice using 6 cycles of 30 seconds, followed 
by 30 seconds cooling. The protein concentration was determined using a modified 
Lowry protein assay kit (Bio-Rad).   
2.2.5 Serum IgG subset ELISA  
As described previously (Robinson et al., 1997), Wells of a 96-well ELISA plate 
(NUNC maxisorp) were coated with 50 µl H. pylori sonicate antigen diluted to 
3ng/ml in 0.1M carbonate/bicarbonate coating buffer (pH 9.6). The plates were 
then incubated overnight at 4°C. 100 µl of blocking solution (3% bovine serum 
albumin in PBS-Tween) was added to each well. Sera were tested in a twofold 
dilution series, including replicate wells of a 1/50 dilution of a pool of negative 
control sera from 4 uninfected donors on every plate.  50 µl of diluted (1/50,000) 
anti-human IgG-HRP (Sigma A8667) was added before development using Tetra 
methylbenzidene substrate (eBioscience). The optical density of the samples was 
measured using a microplate reader (Labsystems iEMS Reader MF) at a 
wavelength of 450nm with a reference wavelength of 650nm.  Then, curves of 
dilution against mean OD for each sample were plotted (Figure 2.1).  
2.2.4 Validation of the ELISA 
To validate our results, a commercial kit (Biohit Plc) was used to do the ELISA for 
25 randomly selected samples as per manufacturer s instructions. 
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2.2.6 Histological Examination 
Paraffin-embedded biopsies were cut (4 µm thick) and stained with hematoxylin 
and eosin (Anim et al., 2000). The histological findings from the sections were 
scored according to the updated Sydney system of classification and grading of 
gastritis(Price, 1999). Slides were examined microscopically (Olympus Optical 
Company, Tokyo, Japan) using X40 magnification by a single pathologist. These 
slides were graded for the following features: H. pylori density, neutrophilic 
activity, lymphocytic infiltration, and glandular atrophy. A visual analogue scale 
was used to assess the severity of the inflammatory changes and grading was done 
as follows: l: mild, 2: moderate and 3: severe.  
2.2.7 Statistics 
Data were analyzed using the Minitab 15 software program. The Chi squared test 
was performed to study the difference in positivity rate between age groups. The 
Mann-Whitney test was used for the comparison of histopathological data. 
Spearman s test was used to study the relationship between age and 
histopathological changes. Differences were considered statistically significant at a 
p-value of less than 0.05.        
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2.3 Results
2.3.1 ELISA Assay Validation
Current commercial ELISA kits are based on antigens extracted from diverse H. 
pylori strains but we were unsure whether these included strains from the Middle 
East. Since our study involved assaying serum samples from Iraq, we decided to 
develop our own ELISA and use antigens prepared from strains in the local 
community.  In addition, commercial kits measure anti-H. pylori IgG from one 
dilution of serum and compare this with a standard curve. We therefore designed an 
assay based upon a serial dilution method to give an antibody titre. This approach 
provides information on the level and the specificity of the response.   
The assay cutoff score for positivity was determined by calculating the mean 
response of 5 sets of H. pylori negative sera (negative by CLO test) at 1/50 dilution 
plus 3 standard deviations. Any titre above that was regarded as seropositive 
(Figure 2.1). For the commercial kit, the cutoff scores for a positive result were 
based on the recommended values provided by the manufacturers. The values 
which were seropositive by the commercial kit were all positive by our ELISA and 
the values which were negative by the commercial kit were all negative by our 
ELISA, giving accuracy for our ELISA of 100%, when the commercial kit was 
used as gold standard (Figure 2.2).  
In further support of our ELISA, we found that the distribution of anti-H. pylori 
IgG titres was bimodal. One group had values less than 500; this included all those 
who were H. pylori negative by the commercial kit. No patient had a titre between 
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500 and 2000. The titres of all the others were more than 2000, including all those 
that were seropositive by the commercial kit (Figure 2.2 and 2.3).   
2.3.2 Sero-prevalence
 
The prevalence of H. pylori in children of different ages varied (age: percentage, 
6months:0%; 6-24months:27%; 2-18years:58%) with an overall prevalence of H. 
pylori in children of 37% (44/120). 79% (128/163) of adults were infected with H. 
pylori, a significantly higher proportion than children (p<0.0001). The prevalence 
of H. pylori increased markedly with age with the maximum colonization (81.5%) 
occurring in adults (18-40years) (Figure 2.4). 63% (97/153) of males were infected 
with H. pylori, while 58% (76/130) of females were H. pylori-seropositive (p=ns).   
2.3.3 Histological Analysis
Samples for histopathology were obtained from 35 adult subjects with dyspepsia 
and without peptic ulceration. Samples taken from one subject were considered 
inadequate for histopathology. Four subjects were negative for H. pylori. These 30 
H. pylori-positive samples were available for detailed histopathology.   
Pathological changes were observed in biopsies from 29/30 patients; biopsies from 
1/30 were histologically normal despite H. pylori being cultured. Amongst the 29 
patients with inflammation in gastric biopsies, lymphocyte infiltration was more 
prominent in the antrum (Mann Whitney U test p=0.01, Table 2.1). There was no 
significant difference in H. pylori density, neutrophil infiltration, or mucosal 
atrophy between antrum and corpus (Table 2.1). However, neutrophil infiltration 
was mild, and was virtually absent (score 0) in 41% antral biopsies and 59% corpus 
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biopsies. Furthermore, histological evidence of mucosal atrophy was seen in only 
1/30 antral biopsies (patient age=40 years) and 1/30 corpus biopsies (patient 
age=64 years); in both cases it was mild. No association could be found between 
age and histopathological changes including atrophy and metaplasia.               
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Table 2. 1 H. pylori-associated gastritis in biopsies taken from gastric antrum and body. * Significant p value measured by Mann Whitney U test    
Antrum Corpus  
Variables Score 0 Score 1 Score 2 Score 3 Score 0 Score 1 Score 2 Score 3 p-value 
Lymphocyte infiltration (n) 0 10 14 5 0 20 7 2 0.0164* 
Activity of inflammation (n) 12 15 2 0 17 11 1 0 0.191 
Intestinal metaplasia (n) 27 1 1 0 26 3 0 0 0.6883 
Atrophy (n) 28 1 0 0 28 1 0 0 1 
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Figure 2. 1 An example of multiple dilution series showing the optical density measured by 
anti-human IgG ELISA and the corresponding dilution factor of 5 subjects.  
The dilution titre for patient 3 was 4000 and for patient 4 was 4500.  The average ODs for 
patient 1, 2 and 5 were around 100.  The broken line indicates the OD cutoff (the mean 
response of 5 sets of H. pylori negative sera at 1/50 dilution plus 3 standard deviations).             
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Figure 2.  2 Correlation between the multi-serum dilution titres of anti-human IgG and 
the titres of the commercial kit for 25 Kurdish Iraqi subjects   
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Figure 2.  3 Histogram showing the distribution of anti-H. pylori IgG in Kurdish 
Iraqi subjects. 
The titre of all H. pylori-negative subjects is < 500 ng/ml. Notice that there is a 
window between titres for H. pylori-negative patients and H. pylori-positive 
patients.        
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Figure 2.  4 The seropositivity of Helicobacter pylori infection in relation to age.              
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2.4 Discussion 
Although H. pylori organisms have been isolated worldwide, they are more 
frequently recovered from patients in developing countries (Atherton, 2006). Our 
cross-sectional population-based serosurvey demonstrated that the prevalence of H. 
pylori infection among hospitalised patients in Dohuk city was 61%. The 
seropositivity was not related to gender. In agreement with other studies (Al-
Moagel et al., 1990, Staat et al., 1996) a significant increase in the seroprevalence 
of H. pylori infection among asymptomatic children by age was found. The 
prevalence of H. pylori infection in Kurdistan region, Iraq is higher than reported in 
Iran (33%) (Nassrolahei and Khalilian, 2004) where the gastric cancer rate is very 
high and lower than Turkey (64.4%) where the gastric cancer rate is intermediate 
(GLOBOCAN, 2002). Thus, there is not a simple positive association between H. 
pylori and gastric cancer rate in these three countries, and the lower gastric cancer 
rate in Iraq is not due to low prevalence of H. pylori.  
Asaka et al. argued that acquiring H. pylori infection at an early age usually results 
in pangastritis in adulthood. This pattern of gastritis in adults is often associated 
with mucosal atrophy - a precancerous condition (Asaka et al., 1997, Atherton, 
2006). In support of this, early acquisition of H. pylori in childhood is a recognised 
risk factor for the development of gastric cancer (Asaka et al., 1997, Atherton, 
2006, Blaser et al., 2007).  The acquisition of H. pylori occurs in early childhood in 
most developing countries (Neale and Logan, 1995). According to our IgG based 
ELISA, none of the under 6 month children were found to be seropositive. These 
might be false negative results as the immune system in children of this age is not 
fully mature. However, 27% of the subjects aged 6 months-2 years were 
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seropositive in our assay and so appear to have acquired the infection. 
Unfortunately, we do not have individual ages of children in the 2-18 year age 
group, so we cannot comment further on the most common period of infections 
between these ages. However, it is clear from our results that at least a quarter of 
children are infected very early in life, and most infections in Kurdistan occur 
during childhood. Thus our study suggests that the low cancer rate in Kurdistan is 
unlikely to be because H. pylori is acquired late in life.  
Greater inflammation of the gastric corpus compared with the antrum results in a 
greater risk of development of gastric adenocarcinoma (Meining et al., 1998). In a 
study conducted in Iran, where the gastric cancer rate is very high (GLOBOCAN, 
2002), it was found that mononuclear cell infiltration was  similar throughout the 
stomach; on average, patients had pangastritis (Sotoudeh et al., 2008). In Kurdistan 
region, Iraq, we have shown that there is antral-predominant mononuclear cell 
infiltration. This could partially contribute to the difference in cancer rate between 
these two countries. Furthermore, in Iran, histological evidence of mucosal atrophy 
was seen in 39% and 22% of antral and corpus samples, respectively (Malekzadeh 
et al., 2004). In another study conducted in another province in Iran (where only 
antral biopsies were examined) atrophic changes was found in 25% (Hashemi et al., 
2006). In another study conducted in Turkey, it was found that  43% of the H. 
pylori-infected subjects had atrophic gastritis (Fikret et al., 2001). In our study, 
glandular atrophy was found in only one (3%) specimen taken from antrum and one 
from the corpus. Thus despite the early acquisition of H. pylori, the presence of 
atrophy appears rare in this region of Iraq. We speculate that this might contribute 
to the low cancer rate. Why gastric mucosal atrophy is uncommon in Kurdistan 
 64
needs further study. However, our results raise the possibility that it may in part be 
due to the antral-predominant infiltration pattern seen in H. pylori infected Kurdish 
people.   
Our study has limitations; in particular the sample size used for our histopathology 
study is small. However, because of the low rate of atrophy and intestinal 
metaplasia it is unlikely to be misleading.    
To conclude, H. pylori infection is common in Kurdistan and acquired at young 
age. However, in adults lymphocyte infiltration is more predominant in the antrum 
than the corpus (an antral predominant gastritis). Furthermore, gastric mucosal 
atrophy is uncommon.  This may help explain the low cancer rate in Kurdistan, 
particularly when compared with Iran.  Further work is now needed to study 
bacterial virulence factors, host genetics and environmental factors in this region of 
Iraq, to understand why infection results in an antral predominant gastritis with 
little atrophy.            
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3. Differences in Virulence Markers between Helicobacter pylori
Strains from Kurdistan Region (Iraq) and Iran: Potential 
Importance for Regional Differences in H. pylori-associated 
Disease. 
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Abstract 
Helicobacter pylori causes peptic ulceration and gastric adenocarcinoma; the latter 
is common in Iran but not Iraq. We hypothesised that more virulent H. pylori 
strains may be found in Iran than Iraq and so compared established and newly-
described virulence factors in strains from these countries. We studied 59 
unselected dyspeptic patients from Iran and 49 from Kurdistan region, Iraq. cagA 
was found in similar proportions of strains (Iran 76% vs Iraq 71%) and was 
significantly associated with peptic ulcer disease (PUD) in Kurdistan region, Iraq 
(p<0.01) but not Iran. cagA alleles encoding four or more tyrosine phosphorylation 
motifs were found in 12% Iranian but no Iraqi (Kurdish) strains (p=0.02). There 
were no significant differences in vacA signal, mid or intermediate region types 
between Iranian and Iraqi strains. In Iran, vacA genotypes showed no specific 
peptic ulcer associations, but in Kurdistan vacA i1 strains were associated with 
gastric ulcer (p<0.02), mimicking their previously demonstrated association with 
gastric cancer in Iran. dupA was found in similar proportions of Iranian and Iraqi 
strains (38% vs 32%) and was associated with peptic ulceration in Iraqi (p<0.01) 
but not Iranian patients. H. pylori strains from Iraq and Iran possess virulence 
factors similar to those in western countries. The presence of cagA with more 
phosphorylation motifs in Iranian strains may contribute to the higher incidence of 
gastric cancer. However, the association between strain virulence markers and 
disease in Iraq but not Iran suggests that other host and environmental factors may 
be more important in the disease-prone Iranian population. 
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3.1 Introduction 
Helicobacter pylori is a spiral-shaped, Gram-negative bacillus which causes 
gastritis and peptic ulceration (Marshall and Warren, 1984, Marshall and Warren, 
2001, Whitfield, 2003). Its treatment has become pivotal in the management of 
peptic ulcer disease.  H. pylori infection is also an important risk factor for gastric 
adenocarcinoma, the second highest cause of cancer deaths worldwide.  Gastric 
cancer is thought to have a multifactorial etiology, and bacterial strain type, host 
genotype, and environmental conditions, are all thought to contribute (Peek and 
Blaser, 2002). Despite the geographical proximity of Iraq and Iran the incidence of 
gastric cancer differs hughly between these countries; in Iran it ranges from 38-
69/105 (GLOBOCAN, 2002, Nouraie et al., 2004, Sadjadi et al., 2003, Sadjadi et 
al., 2005, Yavari et al., 2006) compared to 5/105 in Iraq (GLOBOCAN, 2002). We 
hypothesised that this difference may be due to differences in virulence of 
circulating H. pylori strains and so set out to type strains from these countries for 
virulence. We considered both well-established and more recently-described 
virulence determinants.  
Many strains of H. pylori produce the CagA protein, encoded by the cagA gene 
within the cag pathogenicity island (PAI). H. pylori strains possessing cagA are 
associated with a significantly increased risk for the development of atrophic 
gastritis, peptic ulcer disease (PUD) and gastric cancer (Rokkas et al., 1999, Tomb 
et al., 1997). The cag PAI encodes a type IV secretion system that facilitates the 
translocation of CagA into the host epithelial cytosol where it becomes tyrosine 
phosphorylated at specific phosphorylation motifs by Src family kinases (Selbach 
et al., 2002, Stein et al., 2002). Phosphorylated CagA forms a physical complex 
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with SHP-2 phosphatase and stimulates cell signalling pathways, cytoskeletal 
changes and abnormal cell proliferation (Tsutsumi et al., 2003). Based on the amino 
acid sequence of the SHP-2 binding site, CagA proteins can be sub-categorised into 
Western and East Asian types. Both have type A and B phosphorylation motifs 
(usually one of each) but western types have additional C motifs (1-3) and the East 
Asian type has no C motifs but a D motif. The East Asian type CagA possesses 
stronger SHP-2 binding and transforming activities than the Western-type CagA 
(Higashi et al., 2002a). Western-type CagA has a variable number of type C 
phosphorylation motifs, and the extent of cytoskeletal changes induced by CagA is 
dependent on this. Strains possessing CagA with greater numbers of type C 
phosphorylation motifs are more closely associated with gastric carcinogenesis 
(Azuma et al., 2002). Thus, determination of the degree of CagA phosphorylation 
or the number of phosphorylation motifs appears to be more important than 
detection of cagA alone (Argent et al., 2004, Argent et al., 2005)   
The vacuolating cytotoxin (VacA) is a well-established H. pylori virulence factor 
which has multiple effects including vacuolation of cultured epithelial cells, 
inducing apoptosis, increasing permability of epithelial monolayers, forming pores 
in cells and suppressing immune cell function (Atherton, 2006, Iwamoto et al., 
1999). The vacA gene is polymorphic within its signal, intermediate and mid 
regions. For the signal region, two distinct allelic sequences have been recognised, 
s1 and s2. For the mid region, alleles can be categorised into two classes, m1 or m2. 
The vacA genotype is associated with in vitro cytotoxin activity (s1> s2 and m1> 
m2) (Atherton, 2006).  Rhead et al  have recently described a novel determinant of 
VacA toxcity, the intermediate or i-region  (Joanne et al., 2007). They showed that 
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two allelic variants of this region exist, i1 and i2. Furthermore, they showed that 
only s1/m2 strains varied in i-type; s1/m1 and s2/m2 strains were exclusively i1 and 
i2, respectively. This novel region determines vacuolating activity among these 
s1/m2 strains. Most importantly, a significant correlation was found between i1 
type vacA and gastric cancer in Iran  (Joanne et al., 2007).  
The duodenal ulcer promoting gene A (dupA) is a recently described virulence 
factor which comprises both jhp0917 and jhp0918 (Lu et al., 2005a). Lu et al. 
found a significant relationship between dupA and DU, and the presence of dupA 
was related to neutrophil infiltration and a high level of IL-8 production by 
epithelial cells. Surprisingly, possession of this gene appeared protective against 
gastric adenocarcinoma (Lu et al., 2005a).   
The object of this study was to type the virulence of unselected strains from 
dyspeptic patients in Iran and Iraq (Kurdistan region). We aimed to compare 
virulence of strains from these neighbouring countries with very different gastric 
cancer incidences and to assess the association of virulence markers with peptic 
ulcer disease in each country.   
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3.2 Materials and Methods 
3.2.1 Patient-derived Samples 
Gastric biopsies were obtained from 49 and 59 unselected H. pylori+ patients from 
Iraq and Iran respectively undergoing routine upper GI endoscopy to investigate 
dyspepsia. Mean age ± standard deviation of Iraqi patients was 35±17 years and of 
Iranian patients was 40±14 years.  All Iraqi patients were from the 5 districts of 
Dohuk city, Kurdistan region. The majority (48/59, 81%) of Iranian patients were 
from Tehran city; others were referred from different regions in Iran. Endoscopic 
diagnoses were: duodenal ulcer (DU) Iraq 15, Iran 8; gastric ulcer (GU) 5, 9; no 
ulcer (NUD) 29, 42. During gastroscopy, biopsy samples were taken and either 
placed in 1 ml of isosensitest broth (Oxoid, Basingstoke UK) containing 15% (v/v) 
glycerol and stored in liquid nitrogen or cultured immediately for H. pylori. In 
some cases, following prolonged storage and shipping to the UK, re-culture was not 
possible. In these cases, DNA was extracted directly from the biopsy specimens 
and used for PCR-based H. pylori typing.  
The study protocol was approved by the Ethics and Research Committees of the 
individual hospitals and all patients gave informed consent to the study. 
    
3.2.2 Culture 
Each biopsy specimen was spread onto horse blood or Dent agar plates, then 
incubated under microaerobic conditions generated by a CampyPak (Becton 
Dickinson, Baltimore, USA) in an anaerobic jar at 37°C for 2 to 4 days. The 
organisms were identified as H. pylori by colony morphology, Gram stain, and 
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urease activity. Cultures were harvested as sweeps rather than single colonies and 
stored in isosensitest broth containing 15% (v/v) glycerol at -80°C.  
3.2.3 DNA Isolation from Bacteria 
Two methods were used to extract genomic DNA. DNeasy tissue kits (QIAGENE) 
was used to extract DNA from biopsies following the manufacturer instructions.   
In the second method, genomic DNA was prepared from confluent blood agar plate 
cultures. Bacteria were harvested and suspended in 500 µl PBS. The suspension 
was then centrifuged at 13000g for 5 min. The supernatant was discarded and the 
pellet was resuspended in TE buffer (10 mM Tris-HCl, pH 8.0, and 1 mM EDTA). 
Then 500 µl GES (60g guanidine HCl, 20ml EDTA, pH 8.0, and 10% 5 ml 
sarcosyl)  was added and the mixture was incubated at room temperature for 5 min. 
Following the addition of 250 µl of ice cold 7M ammonium acetate, the mixture 
was incubated on ice for 5 min. This was followed by adding 600 µl chloroform 
and the mixture was centrifuged at 13000g for 5-10 min. The top aqueous layer 
containing DNA was removed into a fresh tube using cut end tips. Chloroform step 
was performed twice, and the DNA precipitated from the aqueous phase with 0.54 
volume of propan-2-ol. The DNA- propan-2-ol mixture was centrifuged at 13000g 
for 5 min. The supernatant was discarded and the pellet washed twice with 70% 
500µl ethanol. The pellet was resuspended in 100µl TE buffer, and stored at 4°C.     
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3.2.4 Genotyping of H. pylori 
Thermal cycling for amplifying cagA was  95 °C for 30 s, 50 °C for 1 min , and 72 
°C for 2 min, for a total of 35 cycles. PCR amplification of cagA used previously 
described primers cag2 (5 GGAACCCTAGTCGGTAATG 3 ) and cag4 (5 
ATCTTTGAGCTTGTCTATCG 3 ) to amplify about 500-bp product from the 
middle of cagA (PAI) (Rudi et al., 1998).  PCR amplification of the cag PAI empty 
site was performed as previously described (Akopyants et al., 1998). In the empty 
site PCR, primers anneal to sequences adjacent to the cag PAI insertion site in the 
genome and only allow amplification of a DNA fragment of the expected size in 
the absence of a complete or partial cag PAI at this locus. Determination of the 
number of CagA phosphorylation motifs, and the types of motifs, was carried out 
by using the forward primer cag2 and the reverse primers cagA-P1C, cagA-P2CG, 
cagA-P2TA (the B motif is polymorphic: the two reverse primers are designed to 
recognise all types described to date), and cagA-P3E as previously described 
(Argent et al., 2005) (Figure 3.2).  
For vacA signal and middle region, thermal cycle conditions were 30 s at 95°C, 60 
s at 56°C, and 90 s at 72°C were performed for 35 cycles. Primers used for the 
middle region were vagF (5 CAATCTGTCCAATCAAGCGAG 3 ), and vagR (5 
GCGTCTAAATAATTCCAAGG 3 ).  For the signal region, A3436 (5 
ATGGAAATACAACAAACACAC 3 ) and C1226 (5 
CTGCTTGAATGCGCCAAAC 3 ) primers were used (Atherton et al., 1995).   
The PCR conditions for vacA i region were as follows: the template mixtures were 
amplified 35 cycles with primers VacF1 (5 GTTGGGATTGGGGGAATGCCG 3 ) 
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and C1R (5 TTAATTTAACGCTGTTTGAAG 3 ) for i1 region and VacF1 and 
C2R (5 GATCAACGCTCTGATTTGA 3 ) for i2 region, at 95 °C for 30 s, 53 °C 
for 1 min, and 72°C for 30 s  (Joanne et al., 2007).  
The dupA was amplified by using standard protocols with the following block 
cycler conditions:  35 cycles, each consisting of denaturation at 95°C for 30 s, 
annealing at 50°C for 1 min, and elongation at 72°C for 2 min. 4 primers were used 
DupAF113 (5 GACGATTGAGCGATGGGAATAT 3 ), DupAR1083 (5 
CTGAGAAGCCTTATTATCTTGTTGG 3 ), DupAF1202 (5 
TAAAATCACAAGGGGAAAAGATC 3 ) and DupA918R (5 
AAGCTGAAGCGTTTGTAACG 3 ) (Argent et al., 2007, Lu et al., 2005a) (Figure 
3.2).  
Amplification of above mentioned genes started with an initial denaturation at 95°C 
for 30 s and a final elongation step of 5 min at 72°C. Reactions were performed in 
25 µl volume. 1 µl of H. pylori genomic DNA, 1 µl primer, 0.5 µl of Taq DNA 
polymerase, 0.5 µl dNTP, and 2.5 10X PCR buffer.  
5µl of the PCR products were electrophoresed in 1.5% agarose gels for others for 
40 minutes at 80 V in 1X TAE buffer. All gels were stained with ethidium bromide 
(1 mg/l) and photographed under UV light. 1 kb DNA ladder (Gibco, Paisley, UK) 
was used as a size marker (M) in all gels.   
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The resulting H. pylori strains vacA genotypes compared with 8823 (s1/i1/m1) and 
Tx30a (s2/i2/m2) lab strains. For cagA and dupA, 8823 and J99 were used as a 
positive control respectively.   
3.2.5 Data Analysis 
Statistical analysis of data was performed by using logistic regression, chi-square 
test and Fisher s exact test with significance set at a p value of < 0.05. Genotypes 
with mixed status for vacA were excluded from the calculations of association.  
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Figure 3. 1 Characterisation of one Kurdish Iraqi (A) and one Iranian (B) strain for 
cagA variable-region tyrosine phosphorylation motifs.  
Genomic DNA samples from H. pylori strains were used to PCR amplify the cagA 
variable-region EPIYA motifs, using the forward primer cag2 and the reverse 
primers cagA-P1C (A motif), cagA-P2CG and cagA-P2TA (B motif), or cagA-P3E 
(C motif). No Iraqi strain was found to have more than 3 phosphorylation  motifs.                         
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Figure 3. 2 Characterisation of Kurdish Iraqi (A) and Iranian (B) strains for dupA 
using PCR. Image shows results of PCR typing of dupA using primers DupAF113 
and DupAR1083. 
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3.3 Results
3.3.1 Prevalence of cagA+ Strains among Dyspeptic Iranian and 
Iraqi (Kurdish) Populations 
First, whether the prevalence of cagA+ strains was similar or different between 
Iraqi (Kurdish) and Iranian populations was assessed. Among unselected Iranian 
and Iraqi patients with dyspepsia, cagA+ strains were present in 76% (45/59) and 
71% (35/49) H. pylori strains respectively (Table 3.1). To exclude bias from 
disease association, we also compared subgroups without peptic ulceration: cagA 
was found in a higher proportion of Iranian than Iraqi strains (76% vs 55%) 
although this did not quite achieve formal statistical significance (p=0.06). In both 
countries, all cagA positive strains also typed positive for cagE. Amongst 14 cagA-
negative Iraqi strains, 7 were cag PAI empty site-positive (implying that the whole 
cag Pathogenicity Island was absent) and 7 were empty site negative (implying that 
there was still a partial cag PaI at this locus). Among 14 cagA-negative Iranian 
strains, 9 were cag PAI empty site-negative. Thus overall, the cag PAI appeared to 
be incompletely deleted in 16 strains.    
No significant association was found between cagA status and clinical outcome in 
Iranian patients, but a significant correlation was found between cagA and peptic 
ulcer diseases (p< 0.01, OR 16.4) in Iraqi patients (Table 3.1). Considering 
duodenal and gastric ulcer separately in the Iraqi population, 14/15 (93%) patients 
with DU had cagA-positive strains, compared with 16/29 (55%) with no ulcer (p< 
0.02). All Iraqi GU patients had cagA-positive strains (p= not significant compared 
with no ulcer, perhaps due to the low number of GU patients).    
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3.3.2 CagA Phosphorylation Motif Numbers 
Next, cagA polymorphisms was studied, and in particular the number of CagA 
phosphorylation motifs, which we assessed using our recently-described PCR-
based typing system (Argent et al., 2005). Among cagA+ strains, 12% (7/49) from 
Iran carried a cagA variable region >550bp (when amplified using primers cag2 and 
cag4) indicating the presence of more than 3 CagA phosphorylation motifs. This 
was a significantly higher proportion than found in Iraq, where all strains possessed 
cagA with a variable region size of 550bp indicating the presence of CagA with 3 
phosphorylation motifs (p= 0.02) (Table 3.1). In the analysis confined to patients 
without ulcers, 22% (7/32) cagA+ Iranian strains had >3 phosphorylation sites 
compared with no Iraqi strains.  Previous studies in other populations have linked 
multiple CagA phosphorylation motif numbers with increased cancer risk but not 
with increased ulcer risk (Azuma et al., 2002, Kidd et al., 1999): in agreement with 
this, no strains with > 3 phosphorylation motifs were found in the ulcer group in 
Iran (Table 3.1).   
3.3.3 vacA Polymorphism 
Then, vacA polymorphisms in Iranian and Iraqi strains were studied, examining 
both established s and m genotypes, and also the recently described polymorphic i 
region type. Since individual H. pylori isolates possess only a single copy of vacA, 
the presence of more than one vacA s, i, or m genotype in a DNA sample indicates 
colonisation by two or more strains with different vacA genotypes (Atherton et al., 
1995). In Iraqi isolates, a single vacA signal region was observed in all samples, but 
8/49 (16%) of the specimens examined possessed both mid region types, and 9/49 
(18%) possessed both i region genotypes. In Iranian samples, all isolates possessed 
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a single signal region type, but 2/59 (3%) carried both m region types and 7/59 
(12%) possessed both i region types. There was no difference in the prevalence of 
strains with different vacA genotypes in the unselected dyspeptic populations from 
Iran and Iraq, whether strains with multiple genotypes were excluded (planned 
analysis, Table 3.2) or classified as the more pathogenic or the less pathogenic type 
(exploratory analyses).  
Next, the associations between vacA allelic variation and peptic ulceration within 
the Iranian and Iraqi populations were studied. For Iranian strains, no significant 
associations were found. For Iraqi strains, no significant association was found for 
duodenal ulceration, but 80% (4/5) strains isolated from gastric ulcer patients were 
of the vacA i1 genotype, significantly more than the 13% (4/29) strains from 
patients without ulcers (p< 0.02). This subgroup analysis, although exploratory, is 
interesting, given the described association between vacA i1 genotype and gastric 
cancer and the similarities in epidemiology and pathogenesis between gastric ulcer 
and gastric cancer.  Associations were not seen between gastric ulceration and vacA 
s and m type, again supporting the recent finding that vacA i type is a better marker 
of strain virulence (Joanne et al., 2007)  
3.3.4 dupA Status
Thirdly, I examined strains for the recently-described putative virulence gene dupA. 
Similar proportions of Iranian and Iraqi strains possessed dupA (Table 3.1). Among 
Iranian patients, no association between dupA and clinical outcome was found. 
However, among Iraqi patients, 55% (11/20) peptic ulcer patients carried dupA+ 
strains, significantly more than the 17% (5/29) non-ulcer patients  (p< 0.01, OR 6.2, 
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Table 1). When I looked at DU and GU separately, 60% (9/15) H. pylori isolates 
from DU patients were dupA-positive (p< 0.01 vs non-ulcer patients) and 40% (2/5) 
H. pylori isolates from GU patients were dupA-positive (p= not significant vs non-
ulcer patients, but note small number of GU patients).   
3.3.5 Associations between Virulence Factors, Particularly for cagA
Phosphorylation Motif Number 
Next, associations between virulence factors in strains from Iran and Iraq were 
assessed. As in virtually all strain populations worldwide, I found cagA+ strains 
were more likely to be vacA s1 than s2: in Iran, 37/45 (82%) cagA+ strains were 
vacA s1 versus 5/14 (36%) cagA-negative strains (p< 0.005); in Iraq, all cagA+ 
strains typed s1 compared with 10/14 (71%) of cagA-negative strains (p<0.005). 
No significant associations were found between cagA status and other vacA 
polymorphisms or between cagA status and dupA status. As strains with larger 
cagA are thought to be more pathogenic than those with smaller cagA, I examined 
the association between the size of cagA and other virulence factors among Iranian 
strains. This analysis was not possible for Iraqi strains as all had the same number 
(3) of CagA phosphorylation motifs. Seven of 45 (15%) cagA+ Iranian strains 
carried a larger size cagA (with more than 3 phosphorylation motifs). In the 
association analysis with vacA genotypes, patients with mixed genotypes were 
excluded. The small numbers of strains studied meant that most associations were 
not statistically significant, but for the vacA m region, 6/7 (86%) strains with >3 
motifs were type m1, significantly more than the 10/37 (27%) with 3 motifs only 
(p= 0.01). Lastly I examined the association between size of cagA and dupA status: 
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6/7 (86%) strains with >3 motifs were dupA+, significantly more than the 14/38 
(36%) with 3 motifs only (p= 0.03). 
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% (No.) positive for   
cagA positive   > 3 cagA phosphorylation motifs strains   dupA positive 
PUD                              NPUD Total PUD      NPUD  Total  PUD                               NPUD     Total  
  
Iraq 95%(19/20)a 55% (16/29) 71% (35/49) 0% (0/20) 0% (0/29) 0% (0/49) 55%(11/20)a 17%(5/29) 32%(6/49) 
Iran 76%(13/17) 76%(32/42) 76%(45/59) 0%(0/17) 17%(7/42) 12%(7/59)b 35%(6/17) 40%(17/42) 39%(23/59) 
a
 P < 0.05 for comparison between PUD and NPUD 
b
 The presence of cagA alleles with > 3 phosphorylation motifs was significantly higher among Iranian than Iraqi strains (p< 0.01)  
Abbreviations: PUD, peptic ulcer disease, NPUD, no peptic ulcer disease.   
Table 3. 1 cagA status, cagA phosphorylation motif number and dupA status among H. pylori strains from unselected Iranian and Kurdish 
Iraqi patients with dyspepsia. 
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Table 3. 2 Distribution of vacA allelic types among H. pylori strains isolated from unselected dyspeptic patients from Iraq (Kurdistan region)  
and Iran   
s1/i1/m1 s1/i1/m2 s1/i2/m1 s1/i2/m2 s2/i2/m2 mixed 
Iraq 8/49(16.3%) 2/49(4.1%) 1/49(2.0%) 20/49(40.8%) 4/49(8.2%) 14/49(28.5%) 
Iran 15/59(25.4%) 4/59(6.7%) 1/59(1.7%) 16/59(27.1%) 16/59(27.1%) 7/59(11.9%) 
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3.4 Discussion 
H. pylori virulence factors are important to study in populations, as they contribute 
to disease risk. For example, in Japan, where gastric cancer is common, more than 
90% of H. pylori strains are cagA positive (Maeda et al., 1998). The gastric cancer 
rate in Iraq is lower than that in Iran; I hypothesised that difference in virulence 
factors of H. pylori strains between these two countries may partially explain this 
difference. I found no difference in prevalence of cagA+ strains between unselected 
dyspeptic populations from these countries, although among patients without ulcers 
cagA+ strains were 21% more prevalent in Iran (p= 0.06). Furthermore, Iranian 
patients with cagA+ strains were more likely to have the more pathogenic forms of 
cagA encoding 4 or more tyrosine phosphorylation sites, and among patients 
without ulcers this difference was 27%. Taking these results together, this 
represents a considerable difference in potential cagA-associated pathogenicity 
which could contribute to the differences in gastric cancer rates seen between these 
communities: both cagA status and the number of cagA phosphorylation motifs 
have been linked with cancer prevalence in a number of populations (Argent et al., 
2004, Higashi et al., 2002a). However, I found no significant differences between 
Iranian and Iraqi populations in vacA types, and in particular in the i region type 
which has recently been linked with gastric cancer risk in Iran (Joanne et al., 2007). 
Also I found no difference in dupA status, which I studied because dupA has been 
reported to have a negative association with gastric cancer (Lu et al., 2005a) 
although recent data from us dispute this (Argent et al., 2007).   
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In the present report, I have shown that 71% and 76% of H. pylori strains isolated 
from Iraqi and Iranian samples respectively were cagA positive. This figure is 
closer to Western countries and Turkey than East or South East Asia (Arents, 2001, 
Kersulyte et al., 2000, Saribasak H, 2004, Stephens et al., 1998). Thus it appears 
that the high cancer rate in Iran is not due to the presence of East Asian type strains 
in that country.  
I looked within the Iranian and Iraqi populations for associations between virulence 
factors and peptic ulcer disease. Among Iraqi strains, but not Iranian strains, I 
observed an association between cagA positive status and PUD. Reports from a 
neighbouring country, Turkey, have shown similar results to Iraq (Saribasak H, 
2004). No Iraqi strains had cagA with >3 phosphorylation motifs so I could not 
examine for disease associations here. The situation in Iran was interesting: no 
strains with >3 phosphorylation motifs were found in patients with peptic ulcer. 
This may imply that the presence of > 3 phosphorylation motifs is protective 
against ulcers rather than specifically predisposing to cancer, as previously reported 
(Argent et al., 2004, Higashi et al., 2002a). For vacA polymorphisms I found no 
association between vacA i region and clinical outcome in Iranian samples. 
However, in Kurdish Iraqi specimens, a novel association was found between vacA 
i1 strains and gastric ulcer. This is not unexpected as gastric ulcer and gastric 
cancer are epidemiologically similar. However, our results need confirmation in 
other populations as only small number of gastric ulcer patients were enrolled in 
this study. For dupA, a significant link with PUD was present in the Iraqi 
population, but no association was found in Iranians. Thus overall, I showed that 
the Iraqi population was similar to western populations in terms of the association 
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of many virulence factors with ulcer disease. In contrast, these associations were 
not seen in the Iranian population. This may imply that factors other than bacterial 
virulence are most important for ulcer risk in Iran.  
Many previous reports have shown clustering of active virulence factors within H. 
pylori strains, for example associations between cagA+ status and the vacA s1 
genotype (Xiang et al., 1995). In agreement with these reports, I found a significant 
correlation between cagA+ status and vacA s1 genotype in Iran and Iraq. In 
addition, I showed a significant association between greater number of cagA 
phosphorylation motifs and both the vacA m1 genotype and dupA+ status. This 
further supports the concept of clustering of virulence factors, such that the 
majority of H. pylori strains possess either many or few, and that it is favourable for 
H. pylori to be either strongly pathogenic or non-pathogenic.   
To summarise, virulence factors of both Iraqi and Iranian H. pylori strains appear 
more closely related to Western countries than to Asian countries. Iranian strains 
appear more virulent, but the difference appears unlikely completely to explain the 
difference in disease prevalence between these countries. This suggests that 
unidentified strain, host and environmental factors may contribute to these 
differences. In the absence of East Asian type cagA and almost universally virulent 
strains (as found in Japan and parts of China) the very high gastric cancer rate in 
Iran remains largely unexplained. Similarly, the cancer rates in Iraq appear lower 
than would be expected from the circulating H. pylori strain types - an enigma 
similar to that reported (controversially) in Africa (Holcombe, 1992).   
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4. The Gastric Mucosal Cytokines Response in Kurdish Iraqi 
Patients, and Particularly T helper Differentiation. 
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Abstract  
Introduction: H. pylori induces adaptive immunity, but the balance of the T-helper 
(Th) response varies between individuals; a more pro-inflammatory T-helper 
1(Th1) response has been associated with the development of gastric 
adenocarcinoma. In Kurdistan region, Iraq, the incidence of gastric cancer is 
unusually low. Thus we now studied the T-helper response in patients from Iraq by 
measuring the Th subset-associated cytokines in gastric biopsy samples and IgG1/ 
IgG2 responses. We also investigated associations of smoking and gender with Th 
responses because being a smoker is linked to an increased risk of peptic ulcer and 
gastric cancer, and gastric cancer is more common in men. We have checked these 
associations in an independent population from the UK.   
Materials and Methods: Gastric biopsies were collected from 44 (35 H. pylori-
infected) and 27 (14 H. pylori-infected) Kurdish Iraqi and UK patients, 
respectively. Real-time PCR was performed to quantify the mRNA levels of IFN
and interleukin-12 p35 (IL-12) (typically Th1 cytokines), IL-4 and IL-10 (Th2 
cytokines), and FOXP3 (Treg response). Serum IgG subclasses were measured by 
ELISA to confirm Th subset data.  
 Results: For Iraqi samples, the levels of IFN , IL-12 p35, IL-10, IL-4 and FOXP3 
mRNA was found to be elevated in gastric mucosal samples from H. pylori-
infected patients compared to those from H. pylori-negative patients (median 
increase 7-fold p=0.001; 17-fold p=0.002; 1320-fold p=0.001; 1184-fold p=0.001; 
and 3-fold p=0.01, respectively, confirming a predominant IL-4 and IL-10 (Th2) 
response). Interestingly, IFN mRNA levels (Th1) were 16-fold higher in tissues 
taken from 17 smokers than found in tissues taken from 18 non-smokers (p=0.009), 
and IL-4 mRNA levels (Th2) found in tissues taken from 20 females were 40-fold 
higher than found in tissues taken from 15 males (p=0.005). To confirm our results, 
we studied serum IgG subclass responses to H. pylori. The results showed that there 
was a 4-fold decrease in the H. pylori-specific IgG1:IgG2 levels in smokers 
compared to non-smokers (p=0.0013), consistent with a biased Th1 response 
amongst smokers, although no associations were found with gender. To further 
address whether smoking enhances a Th1 response, the effect of smoking on gastric 
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IFN mRNA levels was studied in an independent population from the UK. Levels 
of IFN mRNA were 6-fold higher in gastric biopsies from 5 smokers than from 9 
non-smokers (p=0.02).   
Conclusion: The predominant Th2 response to H. pylori in Kurdistan, Iraq may 
contribute to the low cancer incidence. The association between a Th1 response to 
H. pylori and smoking suggests that smoking may promote a pro-inflammatory Th1 
response and we speculate that this may help explain the association between 
smoking and gastric cancer.                    
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4.1 Introduction  
Helicobacter pylori infection causes peptic ulceration and gastric adenocarcinoma. 
In Iraq, despite the early acquisition of H. pylori infection (Hussein et al., 2008b), 
gastric cancer is rare (GLOBOCAN, 2002). Three factors interact to determine the 
clinical outcome of H. pylori infection; the virulence of the infecting H. pylori  
strain, the type and extent of the host immune response to infection, and modulating 
cofactors such as smoking, gender and diet (Atherton, 2006). Virulence factors of 
Iraqi H. pylori strains appear more closely related to Western countries and unlikely 
to explain the low cancer rate completely (Hussein et al., 2008c).   
H. pylori strains can induce both arms of adaptive immunity: local and systemic 
antibody production and cell-mediated responses (Atherton, 2006). T-helper 1 
(Th1), Th2 and regulatory T (Treg) cells are activated by H. pylori (Robinson et al., 
2008, Robinson et al., 2005). Studies in animal models and supportive data in 
humans show that a strong Th1 response increases the severity of gastritis and the 
risk of gastric cancer (Akhiani et al., 2002, Bamford et al., 1998, Blaser, 1992). In 
contrast, a Th-2 response is associated with mild gastritis and a lower risk of gastric 
cancer (Atherton, 2006, Robinson et al., 2005). Observational data from humans 
show that gastric T cells in gastric ulcer patients are more polarized to Th1 than in 
duodenal ulcer patients, suggesting that a distinct immune response to H. pylori 
may be associated with different disease outcomes (Itoh et al., 2005).   
Regulatory T-cells (Tregs) are thought to be important in suppressing deleterious 
immune and inflammatory responses (Bamford et al., 1998, Mohammadi et al., 
1996). Tregs are reduced in patients with peptic ulceration. FOXP3 is a marker for 
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Tregs: it encodes a transcriptional repressor and acts as a master regulator in their 
development and function (Hori et al., 2003, Robinson et al., 2008).  Th-1 cells, 
whose differentiation is triggered by interleukin-12 (IL-12) secretion, 
predominantly secrete interferon gamma (IFN ) and IL-2, while Th-2 cells, whose 
differentiation is stimulated by IL-10 secretion, secrete IL-4, IL-5, IL-9, and IL-13 
(Atherton, 2006, Bergman et al., 2004, Robinson et al., 2008, Smythies et al., 
2000). 90% of H. pylori-infected individuals develop H. pylori-specific IgG 
antibodies particularly IgG1 and IgG2 (Blaser, 1992, Bontkes et al., 1992). While 
Th1 responses are associated with reduced IgG1 and/or increased IgG2, the 
association of Th2 with IgG responses is weak in human (Mitchell et al., 2001, 
Vorobjova et al., 2006).   
As well as determining the nature of the Th cytokine responses in gastric biopsies 
from Kurdish patients, we were interested in the potential drivers of that response. 
The main potential drivers that we were able to study were bacterial virulence 
factors (in particular the major virulence factors CagA and VacA) and 
environmental factors (particularly smoking and gender (Atherton, 2006, Stoicov et 
al., 2004, Walker and Taylor, 1979)). Little is known about the relationship 
between virulence factors and Th differentiation. In a recent study in vivo in 
humans we showed no association between H. pylori virulence factors and specific 
Th responses (Robinson et al., 2008). However, in vitro studies have shown that 
VacA can supress T cell proliferation (Schmees et al., 2006, Sundrud et al., 2004).   
Smoking is a risk factor for a wide range of diseases including lung and prostate 
cancer (Batty et al., 2008). In addition, it has been shown that smokers are more 
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prone to peptic ulceration and gastric cancer than non-smokers (Ko and Cho, 2000, 
Maity et al., 2003, Sonnenberg, 1988, Walker and Taylor, 1979). One possibility is 
that, smoking is associated with these diseases because it modulates the immune 
system. In an in vitro, study it was shown that tobacco-exposed lymphocytes have 
reduced proliferative capacity (Barbour et al., 1997). In a study conducted using 
lung biopsies, smoking was associated with increased expression of IFN (Di 
Stefano et al., 2004). Thus we hypothesised that smoking might be associated with 
Th1 responses.   
As sex hormones differ between genders, many researchers have studied the effect 
of sex hormones on the immune response.  It has been shown that women produce 
a stronger Th2 cellular and humoral immune response and suffer from a higher 
incidence of Th2-associated autoimmune diseases e.g. multiple sclerosis (Ansar et 
al., 1985). Faas et al. argued that the production of IL-4 is significantly higher in 
the luteal phase of the menstrual cycle as compared with the follicular phase (Faas 
et al., 2000). On the other hand, it is agreed that T lymphocyte counts are lower in 
males than in females. This may be due to increased testosterone concentrations, as 
testosterone is associated with apoptosis in T cells (McMurray et al., 2001). Hence, 
we hypothesised that female gender might be associated with Th2 responses to H. 
pylori in the stomach.   
Thus we studied Th1/Th2 responses in H. pylori-infected subjects in Kurdistan 
region in northern Iraq and factors that might affect such responses. We found that 
smoking was associated with a Th1 response. Because of the importance of this we 
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confirmed our results by another methodology (IgG subclass ELISA) and in a 
different (UK) population.  
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4.2 Materials and Methods 
4.2.1 Patients and Serum Samples 
Gastric biopsies were obtained from 44 Kurdish Iraqi patients (35 were H. pylori+: 
duodenal ulcer (DU) 11; gastric ulcer (GU) 5; no ulcer (NUD) 19, all non-infected 
were NUD) and 27 UK patients (14 H. pylori+: GU 3; DU 3 and NUD 8, all non-
infected were NUD) undergoing routine upper GI endoscopy to investigate 
dyspepsia with approval from Hospitals Ethics Committees. Mean age ± standard 
deviation of the patients from Iraq was 37±18 years and from the UK was 56±11. 
During gastroscopy, 2 biopsy samples were taken from the antrum and either 
placed in 1 ml of isosensitest broth (Oxoid, Basingstoke, UK) containing 15% (v/v) 
glycerol and stored in liquid nitrogen or placed in RNAlater solution and preserved 
for mRNA analysis. DNA was extracted directly from the biopsy specimens and 
used for PCR-based H. pylori typing. At the time of endoscopic examination 15 ml 
of blood was drawn from each Iraqi patient. Serum was separated and samples were 
stored at -20 °C until use in the IgG subclass enzyme linked immunosorbent assay 
(ELISA).  
4.2.2  cDNA Synthesis 
Total RNA was extracted and purified from gastric biopsies using the total RNA 
Isolation System (Qiagen, Crawley, UK). RNA in the samples was quantified using 
a Nanodrop ND-1000 spectrophotometer (Nanodrop Technologies Wilmington, 
DE, USA). The synthesis of cDNA from 50 ng RNA was conducted by using 
SuperScript II reverse transcriptase (Invitrogen) with oligo(dT) primer (Invitrogen) 
as per the manufacturer s instructions.   
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4.2.3 Real Time PCR 
RT-PCR was performed on a Rotor-Gene 3000 (Corbett Research, Mortlake, 
Sydney, Australia) by using the DyNAmo HS SYBR green qPCR kit (GRI, 
Braintree, Essex, UK). A reaction volume of 20 µl was used. No-template controls 
were included in each cycle and a melting curve analysis was performed to ensure 
the specificity of primers (Figure 4.1). To ensure that products were not amplified 
from contaminated genomic DNA, first stage RT-PCR samples produced in the 
absence of reverse transcriptase from each RNA template were tested in parallel. 
Samples were run in duplicate and results were analysed according to the method 
described by Pffafl (Pfaffl, 2001).  Relative expression levels of the gene of interest 
IL-4, IL-10, IFN , FOXP3 (Lundgren A et al., 2003, Robinson et al., 2008)  and IL-
12 p35 were determined by normalising against a housekeeping gene (GAPDH) 
(Walker et al., 2003), and then comparing this value to the normalised level in 
cDNA made from a pooled RNA preparation from 5 H. pylori-negative patients to 
obtain a fold difference.  A commercial pooled human cDNA standard (BD 
Biosciences, San Diego, CA) was included as a positive control in all assays. 
Amplification of IL-4, IL-10, IFN  and FOXP3 was carried out over 45 cycles of 15 
seconds at 95oC, 30 seconds at 61oC and 30 seconds at 72oC. IL-12 amplification 
was carried out over 45 cycles of 15 seconds at 95oC, 30 seconds at 62oC and 30 
seconds at 72oC. Commercial primers were used for human IFN (SuperArray RT, 
Tebu-Bio, Peterborough, UK). Other PCR primer sequences are shown in Table 
4.1.    
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Table 4. 1 Primer sequences and efficiencies for real-time PCR 
Gene Forward primer 5 -3 Reverse primer 5 -3 Efficiency 
GAPDH(Walker et al., 2003) CCACATCGCTCAGACACCAT GGCAACAATATCCACTTTACCAGAGT 1.72 
FOXP3 (Lundgren A et al., 2003) CAGCACATTCCCAGAGTTCCT GCGTGTGAACCAGTGGTAGAT 2.07 
IL-4 (Robinson et al., 2008) GCCCTGCAGAAGGTTTCCTT AACAGCCTCACAGAGCAGAAGAC 1.73 
IL-10 GCTGGAGGACTTTAAGGGTTACCT CTTGATGTCTGGGTCTTGGTTCT 1.94 
IL-12 p35 CTGAGGAGAGTCTGCCCATTG TGGGTGGGTCAGGTTTGATG 3.18 
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Figure 4. 1 Pffafl equation and examples of melt and amplification curves produced by 
IL-4 RT-PCR rotor.  
This plot shows the intensity of fluorescence at different temperatures. Product of the 
same size show a fluorescence peak at the same temperature.  (A) Pffafl equation (B) 
melting temperature for IL-4, (C) amplification for IL-4. Small arrows indicate CT 
values (Cycle number at which the set threshold crosses). Norm. Fluoro: Normalised 
Fluorescence; deg: C° degree. 
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4.2.4 Efficiency Calculation 
To calculate relative expression levels of the gene of interest relative to the level of 
housekeeping gene transcript using the Pfaffl method (Pfaffl, 2001), the reaction 
efficiency of each PCR was calculated (Table 4.1).  The PCR efficiencies were 
calculated by serially diluting the positive control cDNA  (BD Biosciences, Oxford, 
UK) and calculating the gradient from plots of dilution against CT value, which is 
the cycle number at which the threshold was crossed.  Examples of plots calculated 
are shown in figure 4.2.                       
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Figure 4. 2 Efficiency runs for IL-10 (A) and IL-12 (B) PCRs.  
The PCR efficiencies were calculated by serially diluting the positive control 
cDNA  (BD Biosciences, Oxford, UK) and calculating the gradient from plots of 
dilution against CT value, which is the cycle number at which the threshold was 
crossed.  The efficiency of IL-10 reaction was 1.94 (R2=0.98) and the efficiency of 
IL-12 reaction was 3.2 (R2=0.96).        
12.5                      25           50              100      200
Concentration (ng/reaction)
A
12.5                      25           50              100      200
Concentration (ng/reaction)
B
 100
4.2.5 Antigen Preparation for ELISA 
A lysate of 5 Iraqi stains (all of which are cagA-positive) was prepared. The optical 
density of 5 separate bacterial suspensions was equalized and samples were then 
pooled together. Then, the lysate was prepared by sonicating a suspension of a pool 
of the 5 Iraqi strains in PBS. This procedure was performed on ice at 10 amplitude 
microns in six cycles of 30 seconds, followed by 30 seconds cooling. The protein 
concentration was determined using a modified Lowry protein assay kit (Bio-Rad) 
and BSA as a standard curve.   
4.2.6 Serum IgG Subclass ELISA  
A multiple serum dilution series ELISA method based on that of Robinson et al 
(Robinson et al., 1997) was used to quantify anti-H. pylori IgG. Wells of a 96 well 
plate (NUNC maxisorp, Roskilde, Denmark) were coated with 50 µl H. pylori 
sonicate antigen diluted to 10µg/ml in 0.1M carbonate/bicarbonate coating buffer 
(pH 9.6). The plates were then incubated overnight at 4°C. After washing with 
PBS-Tween (PBS with 0.05% Tween 20), 100 µl of blocking solution (3% BSA in 
PBS-Tween) was added to each well and the plates were incubated for one hour at 
room temperature. After washing as previously described, 50 µl serum samples 
were added in duplicate in a doubling dilution series of up to 1/12800. The diluent 
used was 1% BSA in PBS-Tween. Plates were then incubated for 90 minutes at 
room temperature then washed three times followed by two one minute soaks in 
PBS-Tween. 50 l per well of diluted (1/3,000) anti-human IgG1-biotin conjugate 
(Sigma Aldrich, St. Louis, MO, USA) in PBS/Tween or diluted (1/100000) anti-
human IgG2-biotin conjugate (Sigma Aldrich, St. Louis, MO, USA) was added to 
the wells and they were incubated for a further 90 minutes. The plates were then 
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washed three times followed by two one minute soaks in PBS-Tween then 50 l 
diluted streptavidin peroxidise (1/1000) (Sigma Aldrich, St. Louis, MO, USA) was 
added and the plates were incubated for 30 minutes. The plates were washed three 
times followed by two one minute soaks in PBS-Tween then 100 µl of Tetra 
methylbenzidene substrate (eBioscience) was added to each well. After incubation 
for 15 min, the reaction was stopped by adding 50µl of 2M H2SO4. The optical 
density of the samples was measured using a microplate reader (Labsystems iEMS 
Reader MF, Helsinki, Finland) at a wavelength of 450nm with a reference 
wavelength of 650nm.  Then, curves of dilution against mean OD for each sample 
were plotted.  
A pool of negative control sera from 4 uninfected donors was applied to 5 replicate 
wells at a 1/50 dilution on each plate. The average of these wells was used as a cut 
off point to calculate the end point titre for each sample. No serum, no secondary 
antibody or no streptavidin horseradish peroxidase were included as assay controls, 
where diluent was used instead.          
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4.2.7 Statistics 
Data were analyzed using the Minitab 15 software program. Boxes represent the 
range of the first and third quartiles, the median values are shown as horizontal 
lines within the bars and the whiskers depict the lowest and highest observations 
within 1.5 times the first to third inter-quartiles ranges. Statistical tests of unpaired 
data were carried out using the the Mann-Whitney U-test. A significant difference 
was taken at p 0.05 unless otherwise stated.   
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4.3 Results
4.3.1 Gastric Immune Response in Kurdish Iraqi Samples
H. pylori can induce Th1, Th2 and regulatory T cell responses (Robinson et al., 
2008). We investigated the likely responses in the stomachs of Iraqi patients by 
performing real-time PCR on mucosal biopsy specimens. In infected compared to 
uninfected biopsies, there were significantly increased levels of IFN , a Th1 
cytokine, (median± standard error, H. pylori+: 8.6±63; H. pylori-: 1.2±0.1, median 
increase 7-fold, p=0.001) (Figure 4.3A). To confirm the Th1 biased responses, 
levels of IL-12p35 mRNA, were studied in H. pylori-infected and non-infected 
samples. A 17-fold increase was observed in H. pylori-infected specimens (H. 
pylori+: 30.9±9; H. pylori-: 1.8±0.3 p=0.002) (Figure 4.3B). Next to assess whether 
there was a higher or a lower Th2 response, we measured levels of IL-4 mRNA, a 
Th2 cytokine in infected and uninfected biopsies. Levels of IL-4 mRNA were also 
consistently higher in H. pylori-infected patients than uninfected patients, but 
differences were more marked (H. pylori+: 153±177; H. pylori-: 0.26±0.1, 1320-
fold, p=0.001) (Figure 4.3C).  To confirm the Th2 biased responses, IL-10 mRNA 
levels, which may also be associated with a Th2 response, were measured. A 1184-
fold elevation in IL-10 mRNA level was found in H. pylori-positive samples (H. 
pylori+: 54±39; H. pylori-: 0.04±0.28 p=0.001) (Figure 4.3D). Individual specimen 
samples showed a mixed Th subclass response. However, in most specimens a 
well-polarized Th response was found (Figure 4.4).   
Because IL-10 is secreted by Tregs as well as Th2 cells, we examined a separate 
Treg marker (FOXP3 mRNA levels) in gastric mucosa.  The levels of FOXP3 
mRNA were found to be elevated in samples from H. pylori-infected patients 
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compared to those from H. pylori-negative patients but only by 3-fold (H. pylori+: 
3.7±1.7; H. pylori-: 1±0.1 p=0.01) (Figure 4.3E). This suggests that the main source 
of IL-10 in gastric mucosa may be Th2 cells.                  
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Figure 4. 3 Relative IFN , IL-12p35, IL-4, IL-10 and FOXP3 mRNA levels in gastric biopsies from 35 H. pylori-positive Kurdish Iraqi and 9 H. pylori-
negative subjects. * Outlier value.  
A
ED
CB
p=0.001 p=0.002 p=0.001
p=0.001 p=0.01
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Figure 4. 4 IL-4 and IFN mRNA level in gastric biopsies taken from 35 H. pylori-
positive Kurdish Iraqi patients. Lines represent the results obtained from individual 
biopsies. Some patients showed extremely polarised T-helper responses.             
0
50
100
150
200
250
300
350
400
450
500
IL-4                                                                             IFNg
Re
la
tiv
e
 E
x
pr
e
s
s
io
n
 L
e
v
e
l
IL-4 IFN-gamma
Re
la
tiv
e
 E
x
pr
e
s
s
io
n
 L
e
v
e
l
 107
4.3.2 Association between Gastric Cytokines and Clinical Outcome
To test whether expression levels of specific cytokines correlated with the 
development of GU, DU, and NUD, data are re-stratified according to these clinical 
outcomes. No significant associations were found between disease status and 
expression of any of the genes we studied. However, IFN mRNA was numerically 
increased by 10-fold amongst the DU samples (median DU: 65; GU: 15; NUD: 6 
p=0.19).  
4.3.3 Relationship between Gastric Cytokines and H. pylori
Virulence Factors
Having shown that there is a well-polarised immune response in most of the 
samples, we next examined whether the immune responses were associated with 
bacterial virulence factors. Thus we re-stratified our data according to cagA and 
vacA status. The levels of IFN mRNA were 2-fold higher in tissues infected with 
cagA+ strains compared to cagA- samples but the difference was not significant 
(median cagA+: 12.6; cagA- : 6.3 p=ns). In addition, the levels of IL-12 mRNA 
were 5-fold higher in tissues infected with cagA+ strains compared with cagA- 
samples, but still this was not significant (cagA+: 20.8; cagA- : 3.9 p=ns) (Figure 
4.5). No differences were found in the levels of IL-4, IL-10 and FOXP3 mRNA 
between tissues infected with cagA+ and cagA- H. pylori. No significant 
associations were found between vacA signal, mid and intermediate region type 
mucosal levels of any of the cytokines mRNAs studied (Figure 4.6).  
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Figure 4. 5 Relative FOXP3 mRNA levels in gastric biopsies from H. pylori-infected Kurdish Iraqi patients in relation to different virulence factors.  
Real-time quantitative PCR analysis of FOXP3 gene expression relative to GAPDH expression in 35 H. pylori-infected patients.  No significant 
difference (NS) was found between cagA-positive versus cagA-negative infected patients (A), or vacA i1 versus vacA i2  infected patients (B). * 
Outlier. 
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Figure 4. 6  Relative IFN  mRNA levels in gastric biopsies from H. pylori-infected Kurdish Iraqi patients in relation to different virulence factors.  
Real-time quantitative PCR analysis of IFN gene expression relative to GAPDH expression in 35 H. pylori-infected patients.  No significant difference 
(NS) was found between cagA-positive versus cagA-negative infected patients (A) or vacA i1 versus vacA i2  infected patients (B). * Outlier. 
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4.3.4 Effect of Smoking and Gender on Gastric Cytokines
As virulence factors could not explain the bias in immune responses, we decided to 
study other factors that might affect the immune responses: smoking and gender. 
IFN mRNA levels were 16-fold higher in tissues taken from 17 smokers than 
found in tissues taken from 18 non-smokers (smokers: 111±524; non-smokers: 
5.3±5.8 p=0.01) (Figure 4.7A). Levels of IL-12 mRNA were 6.6-fold higher in 
smokers than non-smokers (p=0.07) (Figure 4.8). These results suggest a 
correlation between Th1 responses and smoking.   
Next we assessed whether Th1 cytokine was associated with male sex. We found 
no association for IFN or for IL-12. However, IL-4 mRNA levels found in tissues 
taken from 20 females were 40-fold higher than IL-4 mRNA levels found in tissues 
taken from 15 males (p=0.005) (Figure 4.9A). Additionally, we found the levels of 
IL-10 mRNA were 89-fold higher in female than male (p=0.01) (Figure 4.10). 
FOXP3 mRNA was not found to be associated with either smoking or gender.            
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4.3.5 IgG subsets ELISA
To confirm the correlation between smoking and gender and the immune response 
using another technique, serum IgG subclass responses to H. pylori were examined. 
Th1 responses are associated with reduced IgG1 and increased IgG2 (Mitchell et 
al., 2001). We found a 4-fold decrease in the H. pylori-specific IgG1:IgG2 ratio in 
smokers compared to non-smokers (smokers: 0.3±0.2; non-smokers: 1.4±0.5 
p=0.0013) confirming a predominant Th1 responses (Figure 4.11). No relationship 
between gender and IgG subclass could be found. To explore these results the 
relationship between IgG subclass and gastric cytokines was studied. As expected, 
a significant inverse relationship was found between IgG1:IgG2 ratio and IFN
mRNA levels (p=0.047 Rs=-0.34). No correlation between IgG subclass and Th2 
cytokines could be established.              
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4.3.6 Effect of Smoking and Gender in the UK
Finally, we addressed whether our results were confined to our Iraqi population or 
found more generally. We had a small amount of cDNA available from gastric 
biopsies of patients from the UK. Thus we decided to do RT-PCR for IFN and IL-
4 mRNA. In agreement with the Iraqi data, we found that IFN mRNA levels were 
6-fold higher in tissues taken from 5 smokers than found in tissues taken from 9 
non-smokers (p=0.02) (Figure 3B). IL-4 mRNA levels were similar between these 
groups. With regard to gender, no differences in IFN or IL-4 mRNA levels were 
found between 7 males and 7 females (Figure 4B).                 
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Figure 4. 7  Relative IFN mRNA levels in gastric biopsies from 17 H. pylori-infected smokers and 18 non-smokers in Kurdistan region, Iraq 
and 5 smokers and 9 non-smokers in the UK.  * Outlier value.  
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Figure 4. 8 IL-12p35 mRNA level in gastric biopsies taken from Kurdish Iraqi 
patients, 17 smokers and 18 non-smokers. * Outlier.  
 115
     
Figure 4. 9 Relative IL-4 mRNA levels in gastric biopsies from 15 H. pylori-infected males and 20 females in Kurdistan region, Iraq  and 7 
males and 7 females in the UK patients. * Outlier. ns= no significant difference. 
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Figure 4. 10  IL-10 mRNA level in gastric biopsies taken from Iraqi patients, 20 
females and 15 males. * Outlier.            
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Figure 4. 11 Anti-H. pylori serum IgG1 and IgG2 responses of 17 smokers and 18 non-
smokers amongst the group of infected Iraqi patients.             
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4.4 Discussion  
In this study, the levels of FOXP3, IFN , IL-12, IL-4 and IL-10 expression were 
significantly higher in infected than uninfected Kurdish Iraqi patients. This agrees with 
Robinson et al. who found a mixed T-helper immune response against H. pylori 
(Robinson et al., 2008),  and D Elios et al. (D'Elios et al., 2003). Surprisingly, the 
increase in Th1 and Th2 cytokines was not similar. We found a 7-fold increase in IFN
and 17-fold increase in IL-12p35 mRNA levels compared to 1320-fold increase in IL-4 
and 1184-fold increased IL-10 mRNA levels suggesting a predominant Th2 responses. 
As FOXP3 mRNA levels increased by 3-fold only, the IL-10 is likely to be secreted 
mainly from Th2 cells rather than Tregs. A study conducted in the UK suggested a 
more balanced Th1/Th2 responses in this country: in infected compared to uninfected 
tissues, there were significantly increased levels of IFN  (119-fold) and IL-4 (231-fold) 
mRNA (Robinson et al., 2008). This provides some evidence that Th2 cell responses 
might be the main responses to H. pylori infection in Kurdistan region, Iraq. This 
agrees with a study conducted in Africa where Th2 responses were found to 
predominate. In Africa, like Iraq, gastric cancer is thought to be rare (Mitchell et al., 
2002).   
Several studies have addressed the role of the balance between induction of 
proinflammatory cytokines and stimulation of anti-inflammatory cytokines in disease 
outcome. However, results are conflicting. Hida et al. showed that there was increased 
expression of IL-12 mRNA in the majority of patients with duodenal ulcer (Hida et al., 
1999). In contrast, Itoh et al. showed that the Th response in GU patients was more 
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polarized towards Th1 than in DU patients (Itoh et al., 1999). In our study, no 
significant correlation was found between Th subset response and peptic ulcer disease.  
However, the levels of IFN mRNA were 10-fold higher in DU than non-peptic ulcer 
disease, implying that a true association could have been missed in our study due to the 
small number of patients we used (a type II error).  
The trend in most patients in our study was towards a strongly polarised Th response to 
either Th1 or Th2 and this led us to examine factors which may drive Th 
differentiation. First we looked at the bacterial virulence factors CagA and VacA. 
Trends were toward higher levels of both IFN and IL-12 mRNA in tissues infected 
with cagA+ than cagA- strains, suggesting a possible role for CagA in the polarization 
of Th responses. This seems reasonable because of the epidemiological relationship 
between CagA and gastric diseases (Stephens et al., 1998). Neither our study nor the 
UK study showed significant correlations between VacA and Th cell polarization.  
The association between smoking and increased risk of gastric cancer is well 
established, but the mechanism underlying this is unclear. In an epidemiological study 
conducted in Portugal, smoking was shown to be associated with gastric intestinal 
metaplasia, a precancerous condition (Peleteiro et al., 2007). In other studies, 
epidemiological evidence linking smoking and gastric cancer has been described (De 
Stefani et al., 1998, Gonzalez et al., 2003). We hypothesised that smoking may be 
associated with a more pro-inflammatory Th1 response, potentially explaining these 
associations. In accordance with this hypothesis, we found that levels of IFN mRNA 
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were higher in smokers than non-smokers in Kurdistan region, Iraq. These results were 
confirmed by studying IgG subclasses in sera taken from Kurdish Iraqi subjects. To 
confirm our results in a different population, we studied the levels IFN mRNA in UK 
patients, and again found that the levels of IFN mRNA were higher in smokers than 
non-smokers. We speculate that smoking may direct the immune response toward Th1 
biased immunity and increase IFN and other proinflammatory Th1 cytokines that may 
predispose to pre-malignant pathology including atrophy and metaplasia.   
A strong association between sex hormones and Th differentiation has been found in 
several studies (Ansar et al., 1985). In a study conducted in female gerbils, estradiol 
treatment increased the intensity of inflammation in response to H. pylori infection, 
whereas progesterone decreased it (Saqui-Salces et al., 2006). In a study conducted in 
mice, estradiol exerted a protective effect against H. pylori-induced gastric cancer 
(Ohtani et al., 2007).  In another study conducted in Japan, interleukin-10 production 
from human PBMCs was significantly higher in women than in men (Ono et al., 2005). 
In our study, the levels of IL-4 and IL-10 mRNA expression were higher in Iraqi 
females than males. However, IgG subclass ELISAs could not confirm these results. 
This might be because Th2 responses have only a small effect on IgG subclass levels 
(Fox JG et al., 2000, Mitchell et al., 2002). Also, the association of gender with 
cytokine mRNA expression was not confirmed in our UK population. However, this 
might have been an artefact due to the small sample size. More studies are needed to 
explore the correlation between female gender and predominant Th2 response.    
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This study has several limitations: in particular the sample size. However, this is likely 
to hide true positive associations rather than produce false positives. Additionally, 
when using RT-PCR to investigate immune responses, the levels of cytokine mRNA 
are measured, but this does not always accurately reflect levels of cytokine protein 
expression and does not define the cellular sources of the cytokines. However, the 
absolute levels of cytokines, especially IFN , are likely to be the crucial determinant 
for the disease process. For example, intestinal metaplasia developed in the stomach of  
mice transfused with IFN , even without H. pylori infection (Cui G, 2003). In addition, 
Robinson et al. have shown previously that cytokine RT-PCR and flow cytometry 
(which is an accurate method for determining numbers of Th1 and Th2 cells present) 
largely agree when performed on gastric biopsy specimens (Robinson et al., 2008). In 
our study, we did not depend completely upon RT-PCR: our smoking results were 
confirmed by studying the levels of IgG subclasses in serum.  
To conclude, low Th1 responses may contribute the low cancer rate in Kurdistan 
region, Iraq. The association between high Th1 response and smoking suggests that 
smoking may promote a pro-inflammatory Th1 response: such a response is known to 
induce precancerous gastric atrophy and metaplasia. Our study is robust in supporting 
the association by two separate methodologies and in two distinct populations. The 
association between female gender and a higher IL-4 (Th2) response in Kurdistan 
region, Iraq may help to explain the lower gastric cancer incidence in women.  
However, these results need further confirmation.  
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5. Helicobacter pylori dupA is Naturally Polymorphic and Induces 
Cytokine Secretion from Peripheral Blood Mononuclear Cells but not 
from Gastric Epithelial Cells
 123
Abstract 
The duodenal ulcer promoting gene (dupA) is a recently discovered Helicobacter 
pylori virulence factor, shown to stimulate with interleukin-8 (IL-8) secretion by 
epithelial cells and to be associated with duodenal ulcer. Nucleotide sequencing of the 
dupA 3' region from 32 strains showed that dupA commonly had additional single base 
insertions or deletions that either truncated or extended the open reading frame. We 
have therefore classified dupA into two main groups: the common extended ORF 
within jhp0917-19 (dupA1), and dupA with an early stop codon to truncate the ORF 
(dupA2). We aimed to study effects of DupA polymorphisms on inflammatory 
responses, examining cytokine responses of epithelial cells and blood mononuclear 
cells.  Four pairs of parental (2 dupA1 strains and 2 dupA2 strains) and dupA mutant H. 
pylori strains, all possessing a functional cag pathogenicity island, were co-cultured 
with human gastric epithelial cell lines (AGS, ST16, MKN45, and MKN28) and 
peripheral blood mononuclear cells (PBMCs) from 5 H. pylori-negative healthy 
donors. IL-8, IL-12, IL-4, IL-10, interferon- (IFN ), and tumour necrosis factor- 
(TNF ) concentrations in co-culture supernatants were assayed by ELISA. cagE and 
dupA double mutants were constructed in two strains and tested in co-culture. RT-PCR 
was performed to measure the level of IL-12 and IL-10 mRNA in biopsies taken from 
patients infected with dupA-positive H. pylori (n=13) and dupA-negative H. pylori 
(n=22).  Whereas strains possessing cagE induced significantly more IL-8 secretion 
from gastric epithelial cells than those lacking this locus, there was no significant 
difference between strains that possessed or lacked dupA irrespective of its 
polymorphisms.  While disrupting dupA1 significantly reduced IL-12, IFN , TNF and 
IL-8 production by PBMCs, disrupting dupA2 showed no effect on cytokine secretion.  
cagE mutation had no effect upon cytokine production by PBMCs. There were trends 
towards higher levels of IL-12 and IFN mRNA in biopsies taken from patients 
infected with dupA-positive H. pylori, although these differences were not statistically 
significant. I therefore hypothesise that dupA1 is a major determinant of H. pylori-
induced mononuclear cell-associated inflammation.   
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5.1 Introduction 
Helicobacter pylori infects approximately half the world's population and is the major 
cause of gastric and duodenal ulceration and gastric adenocarcinoma. H. pylori strains 
possessing the cag pathogenicity island (PaI) induce high levels of pro-inflammatory 
interleukin (IL)-8 secretion in vitro and also in the stomach in vivo (Atherton et al., 
1995, Censini et al., 1996, Crabtree and Lindley, 1994, Keates et al., 1997). The cag 
PaI encodes a type IV secretion system that facilitates the translocation of CagA and 
soluble components of the H. pylori cell wall peptidoglycan into the host cell cytosol 
(Asahi et al., 2000, Odenbreit et al., 2000, Segal et al., 1999, Stein et al., 2000, Viala et 
al., 2004). Both translocated molecules activate signalling pathways that result in the 
activation of NF- B and the secretion of IL-8 from the cell (Brandt et al., 2005, Viala 
et al., 2004). Although the cag PaI is the major pro-inflammatory H. pylori virulence 
factor, OipA has also been shown to contribute to IL-8 secretion (Kudo et al., 2005, Lu 
et al., 2005b, Yamaoka et al., 2002a, Yamaoka et al., 2000, Yamaoka et al., 2006), 
although some have failed to show this (Akanuma et al., 2002, Ando et al., 2002, 
Brandt et al., 2005, Dossumbekova et al., 2006, Odenbreit et al., 2002).   
More recently, a novel virulence gene, dupA, has been identified that may also play a 
role in IL-8 secretion (Lu et al., 2005a). dupA has homology to virB4 and comprises 
two overlapping genes (jhp0917 and jhp0918) in genome sequence strain J99, but Lu 
et al. (Lu et al., 2005a) showed that dupA formed a single open reading frame (ORF) in 
H. pylori strain C142, and 23 other strains, due to a single nucleotide insertion (at 
position 1386), and they showed that the presence of dupA was significantly associated 
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with duodenal ulceration, but negatively associated with gastric cancer in populations 
from South Korea, Japan, and Colombia, and appeared to increase IL-8 secretion by 
epithelial cells. Populations from northern India and Iraq also exhibited a significant 
association between the presence of dupA and duodenal ulceration, although no 
patients with gastric cancer were included in these studies (Arachchi et al., 2007, 
Hussein et al., 2008a), whereas populations from Brazil and Iran had no significant 
association between dupA prevalence and ulceration or cancer (Gomes et al., 2008, 
Hussein et al., 2008a). We have recently found, however, that dupA was not 
significantly associated with duodenal ulceration in populations from Belgium, South 
Africa, China, and the USA, but was significantly associated with gastric cancer 
development (Argent et al., 2007). This association with duodenal ulceration in some 
populations and gastric cancer in others is similar to the association of the cag PaI with 
disease The cag PaI is thought to induce increased gastric inflammation largely 
through increasing IL-8 secretion from epithelial cells.   
High levels of chemokines (IL-8, GRO alpha, ENA-78, RANTES, MCP-1) (Hida et 
al., 1999, Shimoyama et al., 1998) have been detected in the H. pylori infected gastric 
mucosa along with pro-inflammatory cytokines such as TNF , IL-1 , IL-6, IL-7, IL-
12 and IL-18 (Bauditz et al., 1999, Dzierzanowska-Fangrat et al., 2008, Yamaoka et 
al., 1995, Yamaoka et al., 1997). Increased levels of many of these factors are 
predicted to increase the risk of disease (El-Omar et al., 2003, Macarthur et al., 2004). 
Anti-inflammatory cytokines such as IL-10 and transforming growth factor- have also 
been detected (Hida et al., 1999, Lindholm et al., 1998). H. pylori has been shown to 
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disrupt the tight junctions of gastric epithelial cells in vitro, possibly through 
intraepithelial injection of CagA protein (Amieva et al., 2003). Such effects in vivo 
would open the paracellular route for bacterial penetration deep into the mucosa. 
Recent investigations by Necchi et al., suggested that H. pylori penetrates normal, 
metaplastic, and neoplastic gastric epithelium in vivo, intracellularly or interstitially to 
generate a strong immune-inflammatory response and promote gastric carcinogenesis 
(Necchi et al., 2007). Such reports indicate that studying the interaction of H. pylori 
with epithelial cells is only part of the story. The responses of immune and 
inflammatory cells should also be investigated when studying the role of H. pylori 
virulence factors. This prompted us to study the sequence of dupA in detail, determine 
the influence of dupA on the immune response, studying the responses of gastric 
epithelial cell lines and leukocytes in vitro as well as examining cytokine expression in 
gastric biopsies of donors infected with dupA+ and dupA- H. pylori strains.    
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5.2 Materials and Methods 
All chemicals and reagents were obtained from Sigma-Aldrich (Poole, Dorset, UK) 
unless otherwise stated.  
5.2.1 Patients  
Biopsy specimens were donated by patients undergoing upper gastro-intestinal 
endoscopy at Azadi teaching hospital Dohuk, Kurdistan region, Iraq with approval 
from Hospitals Ethics Committee (35 H. pylori-infected patients: 13 infected with 
dupA+ strains and 22 infected with dupA- strains). The mean age ± standard deviation 
of the patients from Iraq was 37±18 years. During gastroscopy, 2 biopsy samples were 
taken from the antrum. One was placed in 1 ml of isosensitest broth (Oxoid, 
Basingstoke, UK) containing 15% (v/v) glycerol and stored in liquid nitrogen for 
future isolation of H. pylori. The other was placed in RNAlater solution, and preserved 
for mRNA analysis. DNA was extracted directly from the biopsy specimens using a 
DNeasy Blood and Tissue Kit (QIAGEN, Crawley, West Sussex, UK) and used for 
PCR-based H. pylori typing as previously described (Hussein et al., 2008a).   
5.2.2 Culture of H. pylori 
Each biopsy specimen was spread on both sheep blood and Dent agar plates, then 
incubated under microaerobic conditions generated by a Campypack (Becton, 
Dickinson and company) in an anaerobic jar at 37°C for 2 to 4 days. The organisms 
were identified as H. pylori by colony morphology; Gram stain; and urease activity. 
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Cultures were harvested and stored in 1 ml nutrient broth containing 15% glycerol at - 
80°C.  
5.2.3 Culture of Escherichia coli 
Single colonies of DH5 (White et al., 1988) were inoculated into Luria-Bertani (LB) 
(Oxoid) media supplemented with appropriate antibiotics where necessary. Broths 
were then incubated overnight at 37ºC with shaking at 200 rpm. The bacteria were then 
used for plasmid minipreps.  
5.2.4 PCR Amplification and Nucleotide Sequencing of dupA 
(performed by Richard Argent) 
Initially, the full-length dupA gene (based on the nucleotide sequence from H. pylori 
strain C142 - GenBank accession number AB196363) was PCR amplified from the 8 
strains used to construct isogenic mutants (strains 93-67, 93-68, A101, AB21, AB31, 
AB43, J178 and J123), using primers dupA-WXF (5'-
GATATACCATGGATGAGTTCYRTAYTAACAGAC) and DAR1. The amplified 
genes were sequenced on both strands using BigDye1.1 on a Perkin-Elmer ABI Prism 
3130 fluorescent DNA analyser. It was apparent from the sequence analyses that some 
dupA genes had single nucleotide insertions close to the 3' end of the gene that 
extended the open reading frame. Therefore, a reverse primer was designed within 
jhp0919 to include the next predicted stop codon, based on the nucleotide sequence 
from H. pylori strain J99. This reverse primer, JHP0919R2 (5'-
GCCCACCAGTTGCAAAAACAAATGAAC) was successfully used with primer 
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dupA918F (Argent et al., 2007) to PCR amplify the extended region. Nucleotide 
sequencing of additional strains was performed following PCR amplification of the 
"extended" dupA gene using primers dupA-WXF and JHP0919R2.  
5.2.5 Construction of Mutants 
According to the sequence results, seven strains (J123 with a complete 1839 bp 
ORF similar to strain C142 as used by Lu et al. (Lu et al., 2005a); AB21, AB31, 
AB43 and 93-68 with a complete ORF extending into jhp0919; 93-67 and A101 
with a stop codon in jhp0917 truncating the ORF) were chosen for the construction 
of isogenic dupA insertion mutants (Figure 5.1). Five of these possessed a 
functional cag PaI (strains 93-67, J123, A101, AB21, and AB31) and two lacked 
this locus (AB43 and 93-68). I also constructed isogenic cagE insertion mutants in 
dupA-deficient mutants of strain 93-67 and AB31.   
1 kb of dupA was amplified from H. pylori strain 93-67 using primers DAF1 (5'-
GACGATCTATTGAATTTATACGCTG) and DAR1 (5'-
TTAAATACTCTTCCTTATAAGTTTCTTGG) and PCR products were purified 
and cloned into pGemT-Easy (Promega, Southampton, UK) to form pGEM®-9367. 
pGEM®-9367 was transformed into the DH5 strain of E. coli. This was followed 
by extracting the plasmid  and inverse PCR was used to engineer XhoI and XmaI 
sites into dupA using primers NHDA2R (5'-
CTATATCCCGGGAGCTTGAAAATTGAAAAAGTG) and NHDA3F (5'-
CAATACCTCGAGGCTAATACAGATGGTGGT). The chloramphenicol 
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resistance cassette from pBSC103 (Wang and Taylor, 1990) was excised using 
XhoI and XmaI and ligated into the dupA genes via the same sites to create plasmid 
pCDA723 (disrupted dupA from strain 93-67). Restriction products were run on 
agarose gels and the 4kb fragment containing dupA and the 1kb catR fragment were 
extracted and purified. H. pylori strains were transformed with plasmids by natural 
transformation and allelic exchange mutants were selected by marker rescue on 
blood agar plates (Oxoid) containing 30 g/ml chloramphenicol. Disruption of 
dupA and confirmation of double crossover were determined by restriction 
digestion and determination of product size (Figure 5.2).   
5.2.6 Gel Extraction and Purification of PCR Product 
A QIAEX II Agarose Gel Extraction Kit (QIAGEN, Crawley, UK) was used for 
extraction of PCR products from 1.5% agarose gel, according to the manufacturer s 
instructions. A QIAquick PCR Purification Kit (QIAGEN, Crawley, UK) was used for 
the purification of the PCR product, according to the manufacturer s instructions. PCR 
fragments were purified from primers, nucleotides, polymerases, and salts by binding 
the DNA to a silica-gel membrane in the presence of high salt while contaminants pass 
through the column.      
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5.2.7 Ligation of DNA Fragments 
PCR products were cloned into vector DNA (pGEM -T Easy vector) at an 
approximate molar ratio of 3:1 insert to vector DNA. Reactions were carried out in a 
final volume of 20 l in the presence of 3U T4 DNA ligase and buffer containing 
adenosine-5 triphosphate (ATP). Ligation reactions were incubated overnight at 4 C.  
5.2.8 Isolation of Plasmid DNA 
A QIAprep Spin Miniprep Kit (QIAGEN, Crawley, UK) was used to extract plasmid 
DNA following the manufacturer s instructions. Plasmid DNA was purified from 5 ml 
overnight cultures of E. coli in LB medium by binding the DNA to a membrane, 
washing to remove contaminants and eluting in water.  
5.2.9 Growth Curves 
H. pylori strains were cultured for 48 h on blood agar plates and the growth of 2-3 
plates harvested then resuspended in 3 ml Brucella broth (Sigma). The cell pellets were 
equalised according to an optical density (OD) of 0.1 at 600nm.  A 75 cm2 tissue 
culture flask containing 50 ml sterile Brucella broth was then inoculated with 500 l of 
the bacterial suspension and incubated at 37 C in a microaerobic environment within a 
MACS-VA500 workstation. At various time points a 1 ml sample was taken from the 
flask and the OD measured at 600 nm.     
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5.2.10 Eukaryotic Cell Culture 
AGS and ST16 cell lines were grown in nutrient mixture F12 Ham (Invitrogen, 
Paisley, UK) containing 10 % (v/v) foetal bovine serum (FBS). MKN45 cells were 
grown in RPMI1640 medium, supplemented with 10% FBS, and 200mM l-
glutamine (Invitrogen). MKN28 cells were grown in DMEM/Ham's F12 mixture, 
with 10% FBS and 200mM l-glutamine. All cell lines were cultured at 37 C in a 5 
% CO2 humidified atmosphere.   
5.2.11 Peripheral Blood Mononuclear Cell (PBMC) Isolation 
20 ml blood samples from 5 H. pylori-negative volunteers were collected into 
K3EDTA vacutainer tubes (Greiner Bio-One GmbH, Kremsmunster, Austria). PBMCs 
were immediately purified by density gradient centrifugation using Histopaque 1077 
and cultured in RPMI1640 medium supplemented with 10% FBS and 200mM l-
glutamine.  
5.2.12 Co-culture of Cells with H. pylori 
As described previously, AGS, ST16, MKN45, MKN28 cells (Reyes-Leon et al., 
2007) were seeded into multi-well tissue culture plates and grown to 80-90% 
confluence. PBMCs were plated at 2 x 106 cells per well in 24-well plates. H. pylori 
strains, grown on blood agar for 24 h, were harvested into 5 ml cell culture media 
and the OD standardized to 0.1 at 600nm. H. pylori was added to cultures at a 
bacteria:cell ratio of 100:1 for AGS, ST16, MKN45 and MKN28 cells and 20:1 for 
PBMCs. Co-culture assays were performed in 5 replicates per condition. 
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Supernatants were removed after 6 and 48 hours of culture for assay of cytokines 
by ELISA.  
5.2.13 Cytokine ELISA 
Cytokine responses in co-culture supernatants was measured using human IL-8 (R&D 
Systems DuoSet), IL-10, TNF , IFN (eBioscience) and IL-12 (Autogen Bioclear) 
ELISA kits. All samples were assayed in 5 replicates at a 1/2 dilution with a standard 
curve on each plate. Assay sensitivity was determined as the mean plus three times the 
standard deviation of six control wells containing no cytokine. The optical densities 
were measured using a microplate reader at 450nm and 620nm. The cytokine 
concentration in each sample was calculated by reference to the standard curve.  
5.2.14 cDNA Synthesis 
Total RNA was extracted and purified from gastric biopsies using the QIAGEN kit 
(QIAGEN, Crawley, UK). Samples were quantified using a Nanodrop ND-1000 
spectrophotometer (Nanodrop Technologies Wilmington, DE, USA). The synthesis of 
cDNA from 50 ng RNA was conducted by using SuperScript II reverse transcriptase 
(Invitrogen) with oligo(dt) primer as per the manufacturer s instruction.   
5.2.15 Real Time PCR 
RT-PCR was performed on a Rotor-Gene 3000 (Corbett Research) by using the 
DyNAmo HS SYBR green qPCR kit (GRI). A volume of 20 µl was used for the 
amplification reaction. No
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curve analysis was performed to ensure the specificity of primers. To ensure that 
products were not amplified from contaminated genomic DNA, first stage RT-PCR 
samples produced in the absence of reverse transcriptase from each RNA template 
were tested in parallel. Samples were run in duplicate and results were analysed 
according to the method described by Pffafl (Pfaffl, 2001).  Relative expression levels 
of the gene of interest IL-4, IL-10, IFN , (Lundgren A et al., 2003, Robinson et al., 
2008) and IL-12 were determined by normalising against a housekeeping gene 
(GAPDH) (Walker et al., 2003), and then comparing this value to the normalised level 
to cDNA made from a pooled RNA preparation from 5 H. pylori-negative patients to 
obtain a fold difference.  A commercial pooled human cDNA standard (BD 
Biosciences) was included as a positive control in all assays. Amplification of IL-4, IL-
10 and IFN was carried out over 45 cycles of 15 seconds at 95oC, 30 seconds at 61oC 
and 30 seconds at 72oC. IL-12 amplification was carried out over 45 cycles of 15 
seconds at 95oC, 30 seconds at 62oC and 30 seconds at 72oC. Commercial primers 
were used for human IFN (SuperArray RT, Tebu-Bio, Peterborough, UK). Other PCR 
primer sequences are shown in Table 4.1. Efficiencies of the IL-12 and IL-10 RT-PCR 
were tested using serial dilutions of a commercial human cDNA preparation (BD 
Biosciences).  
5.2.16 Statistics 
Data were analyzed using the Minitab 15 software program. A Student s t test was 
used to compare the growth rate between wild-type and parental strains of H. pylori 
and to compare the cytokines responses in co-culture supernatant.  Statistical tests of 
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unpaired data were carried out using the Mann-Whitney U-test. Box and whisker plots 
are shown, where boxes represent the range of the first and third quartiles, the median 
values are shown as horizontal lines within the bars and the whiskers depict the lowest 
and highest observations within 1.5 times the first to third inter-quartiles ranges. A 
significant difference was taken at p 0.05 unless otherwise stated.                    
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Figure 5. 2 Characterisation of H. pylori mutant using PCR and restriction enzymes  
1. Wild-type AB31: dupA amplification using dupA flanking primers (amplifying 
most of the dupA 1800bp) 
2. Mutant-type AB31: dupA amplification using dupA flanking (amplifying most of 
the dupA and  chloramphenicol cassette 2800bp) 
3. Mutant type AB31: chloramphenicol cassette amplification using one primer 
located within chloramphenicol cassette (Wang and Taylor, 1990) and the other 
located out side the Chloramphenicol cassette (amplifying chloramphenicol cassette 
and part of dupA  2000bp) 
4. Wild-type AB31: chloramphenicol cassette amplification using chloramphenicol 
cassette flanking primers (No product) 
5.  Mutant-type AB31: dupA amplification using dupA flanking primers (amplifying 
most of the dupA and  chloramphenicol cassette 2800bp) 
6. Mutant-type AB31: dupA amplification product after 2 hours incubation with XhoI 
and XmaI restriction enzymes showing the cut chloramphenicol cassette ( 1000bp)  
M 1 2 3 4 5 6
3000 bp
1600 bp
1000 bp
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5.3 Results
5.3.1 Natural Polymorphisms within dupA
Lu et al. (Lu et al., 2005a) showed that dupA comprised two overlapping genes 
(jhp0917 and jhp0918) in genome sequence strain J99, due to a single nucleotide 
deletion. This base (at position 1386) was present in strain C142, and in 23 other dupA 
genes sequenced by them, producing a continuous ORF of 1839 bp. We sequenced the 
entire dupA gene from eight further H. pylori clinical isolates (A101, J178, 93-67, 
J123, AB21, AB31, 93-68 and AB43) to determine if they possessed a 1839 bp gene 
dupA, and not two overlapping genes. We found that all strains indeed possessed a 
cytosine or thymidine at position 1386.   
Surprisingly we found that the most common form of dupA (4/8 strains) incorporated 
nucleotide insertions (relative to strain C142) that extended the coding region beyond 
1839 bp (Figure 5.3). All 8 strains had a variation at the 3' end of dupA that was not 
present in dupA from strains C142.  The regions from nucleotide position 1738 to 
position 1800 were altered due to an adenine insertion (within a polyadenine stretch), 
and changed the deduced amino acid sequence from ICKNYFIFLIAMLVIEKSSMI 
(present in dupA from strains C142) to DLQELLYILDSNAGNRKILND in all 8 
strains we sequenced. To determine the position of the stop codon in our extended 
dupA genes, the 3' region of dupA and the 5' region of the adjacent gene jhp0919 was 
PCR amplified using primers DupA918F and JHP0919R2, and sequenced. This 
showed that the extended dupA was predicted to terminate after 1884 bp, 5 bp after the 
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start codon of jhp0919. Of the 8 dupA genes sequenced, three had single nucleotide 
deletions that introduced early stop codons.    
Nucleotide sequencing of the dupA 3' region of 26 other strains from Belgium, South 
Africa, China, and USA (Argent et al., 2007), showed that 21 strains possessed the 
extended form of the dupA gene. Three strains (J133, GC5, and GC77) probably 
comprised two separate jhp0917 and jhp0918 genes, and two strains (32385 and J188) 
had truncated dupA genes of 1500 bp and 1635 bp, respectively. Taking into account 
all sequenced strains, the most common form of dupA (25/34 sequences in total) is the 
extended form. I have therefore classified dupA into two main groups: the common 
extended ORF within jhp0917-19 (dupA1), and dupA with an early stop codon to 
truncate the ORF (dupA2). I consider that strains C142 (as used by Lu et al.(Lu et al., 
2005a)) and J123, with a shorter dupA ORF in jhp0917-18 could be a less common 
subgroup of dupA1.           
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Figure 5. 3 Schematic representation of dupA gene.  
Gene sequencing revealed a frame shift resulting in truncated dupA in the J178, 
J99, 93-67 and A101 strains, C142 and J123 carry the complete open reading frame 
and AB31 and AB12 carry the extended complete open reading frame. * indicates 
strain from which dupA mutant was derived, § indicates cagE also mutated, 
indicate the presence of stop codon  
jhp0917 jhp0918 jhp0919 cagPaI
C142
J123
AB21*
AB31*§
AB43
93-68
+
-
-
+
+
93-67*§
+
A101*
+
J178
+
J99
+
+
dupA coding sequence
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5.3.2 Growth Comparisons of Wild-type and dupA Mutant H. pylori
Strains
To exclude any difference in growth rate between wild-type and mutant strains, the 
growth rate was compared. Student s t test showed no significant difference in the 
growth rate between any wild-type and mutant strain (Figures 5.4 shows an example 
for strain AB31).  
5.3.3 Interleukin-8 Secretion from Gastric Epithelial Cells
 
5.3.3.1 Impact of dupA on Gastric Epithelial Cell IL-8 Responses
(Richard Argent contributed partly to this part)
To assess quantitative effects of dupA and its polymorphisms on epithelial cell IL-8 
production, parental and dupA mutants of strains 93-68, AB43, 93-67, AB21, AB31 
and J123 were co-cultured with AGS cells before IL-8 quantification (Figure 5.5 
A). No significant differences were observed between the paired wild-types and 
isogenic mutants. In order to test this more thoroughly, strains AB21, AB31 and 
J123 were co-cultured with the gastric epithelial cell lines ST16 and also MKN45 
(as used by Lu et al. (Lu et al., 2005a)) (Figures 5.5 B and 5.5 C). A slight 
significant reduction in IL-8 was induced by the dupA mutant of J123 but this was 
only after 6 hours culture with ST16 cells (1.2-fold reduction; p=0.004). No 
difference was found after 48 hours with these cells, or at either time-point with 
MKN45 cells. No significant differences were observed with AB21 or AB31 
strains.  
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These results conflicted with those published by Lu et al. (Lu et al., 2005a), who 
found a significant reduction in IL-8 release by MKN45 cells incubated with a 
dupA-deficient mutant of strain C142. In order to more thoroughly test this in our 
hands, a second set of dupA mutants derived from strains 93-67, A101, AB21 and 
AB31 were compared with the isogenic parental strains in co-cultures with MKN45 
and AGS cell lines as before, but also MKN28 gastric epithelial cells (Figures 5.5 
D-F). As before, for all pairs of H. pylori strains (wild-type and dupA mutant), the 
presence of dupA did not have any effect on IL-8 production by these gastric 
epithelial cell lines.       
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Figure 5. 4 Comparison of the growth rate of wild-type AB31 and its dupA isogenic 
mutant strain. Each point represents the mean of 3 reading.  Error bars indicate 
standard deviation. OD: Optical Density.           
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Figure 5. 5 Mean levels of IL-8 secretion from AGS (A & D), ST16 (B), MKN45 (C & E), 
and MKN28 (F) cells co-cultured with H. pylori strains (93-68, 93-67 AB43, AB21, AB31, 
J123, and A101) and their isogenic dupA mutants for 6 and 48 hours.  
Data from 6 hours cultures is depicted as wild-type: plain white bar; isogenic dupA mutant: 
dotted white bar, and 48 hours as wild-type: solid black bar; isogenic dupA mutant: dotted 
black bar. The concentrations of IL-8 in the medium were determined by ELISA. Grey bars 
represent results obtained from cells cultured without H. pylori (6 hours: plain bar; 48 
hours: dotted bar). Error bars indicate standard deviations.  
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5.3.3.2 Impact of the cag PaI on Gastric Epithelial Cell IL-8 
Responses
As a control, and to prove that I could detect differences in IL-8 responses if they were 
present, I compared the effect of dupA mutation on IL-8 release by epithelial cells with 
disruption of the cag PaI. To do this we constructed cagE mutants in AB31 and 93-67 
wild-type and dupA mutant strains (double and single gene knock-outs) and incubated 
them with AGS cells for 48 hours. The dupA mutants elicited the same level of IL-8 as 
the wild-type strains but, as expected, cagE mutation dramatically reduced the 
production of this chemokine (AB31: Wild-type: 4475 800 pg/ml; dupA mutant: 
4079.1 159.8 pg/ml; cagE mutant 1041.7 106 pg/ml; dupA and cagE double knock-
out 1162 130.9 pg/ml, 93-67: wild-type: 3945.8 136 pg/ml; dupA mutant: 
3995.8 271 pg/ml; cagE mutant: 988 111 pg/ml; dupA and cagE knock-out 1050 62 
pg/ml) (p<0.01 for all) (Figure 5.6).            
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Figure 5. 6  IL-8 secretion from AGS cells at 48 hours.  
Cells were co-cultured with H. pylori strains: wild-type (plain black bars), isogenic 
dupA mutants (dotted black bars), isogenic cagE mutants (vertically striped bar) 
and isogenic double (cagE and dupA) mutants (horizontally striped bar) for 48 
hours before the concentration of IL-8 in the medium was determined by ELISA. 
Error bars indicate standard deviation.         
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5.3.4 Effect of dupA on Inflammatory Cytokine Responses of 
Mononuclear Cells
 
5.3.4.1 Effect of dupA on H. pylori-induced IL-12 Release
It has been reported that dupA is associated with increased risk of H. pylori-induced 
disease and that dupA+ strains induce increased inflammatory cell infiltration into the 
gastric mucosa (Arachchi et al., 2007, Hussein et al., 2008c, Lu et al., 2005a). I 
therefore hypothesised that dupA might interact with other categories of cells to 
stimulate higher levels of inflammation. There have been several recent reports 
concerning the penetration of H. pylori through the epithelium into underlying tissues 
(Aspholm et al., 2006, Necchi et al., 2007, Robinson et al., 2008) and effects of the 
bacteria and their virulence factors on immune and inflammatory cells are well-known 
(Amieva et al., 2003, Sundrud et al., 2004). I therefore investigated the effect of dupA 
on innate immune responses of human mononuclear cells, comparing inflammatory 
cytokine responses of PBMCs from five uninfected normal donors to dupA mutant and 
wild-type strains.    
Co-culturing PBMCs with H. pylori strains and their isogenic dupA mutants for six 
hours resulted in minimal IL-12 production and consequently no significant differences 
were found between any of the strains and mutants. The IL-12 response of PBMCs 
cultured for 48 hours with wild-type strains carrying the extended ORF (dupA1) was 
significantly higher (Strain: mean±sd, AB31: 405.8±15.7 pg/ml, AB21: 447±42 pg/ml) 
than that induced by wild-type H. pylori carrying the truncated form (dupA2), (93-67 
244±21 pg/ml, A101 271±60 pg/ml; p<0.01) (Figure 5.7). In addition, the mutants 
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derived from AB21 and AB31 induced only approximately half the IL-12 
concentrations stimulated by the corresponding wild-types after 48 hours (AB31: wild-
type 405.8±15 pg/ml; mutant 197±63 pg/ml; p=0.002, AB21: wild-type 447±42 pg/ml; 
mutant 162±7 pg/ml; p=0.001). No significant difference in IL-12 secretion was 
observed between dupA2 wild-type and isogenic mutant strains, however (93-67: wild-
type 244±21 pg/ml; mutant 235±41 pg/ml, A101: wild-type 271±60 pg/ml; mutant 
271±65 pg/ml) (Figure 5.7).   
5.3.4.2 Comparative Effects of dupA and the cag PaI on PBMC IL-12 
Responses
To examine the strength of the effects on inflammation of dupA in comparison to 
the cag PaI, I incubated PBMCs with cagE and dupA single and double mutants 
that had been prepared from AB31 and 93-67 wild-type strains. Although it was 
clear that dupA mutation dramatically reduced the IL-12 response, unlike the results 
from co-cultures with gastric epithelial cells, disruption of cagE had no discernible 
effect on the level of IL-12 production (AB31: Wild-type: 481.7 58 pg/ml; dupA 
mutant: 293 99 pg/ml; cagE mutant 471.4 38 pg/ml; dupA and cagE double 
knock-out 281.8 37 pg/ml, 93-67: wild-type: 286 33.7 pg/ml; dupA mutant: 
289.7 21.7 pg/ml; cagE mutant: 288.5 21.7 pg/ml; dupA and cagE knock-out 
270 12 pg/ml) (p<0.05 for all) (Figure 5.8).    
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Figure 5. 8 IL-12 production from PBMCs at 48 hours.  
PBMCs were co-cultured with H. pylori strains (e.g. AB31 in this figure): wild-
type (plain black bars), isogenic dupA mutants (dotted black bars), isogenic cagE 
mutants (vertically striped bar) and isogenic double (cagE and dupA) mutants 
(horizontally striped bar) for 48 hours before the concentration of IL-8 in the 
medium was determined by ELISA. Error bars indicate standard deviation. ns: no 
significant difference.  
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5.3.4.3 Effect of dupA on the Production of Other Pro-inflammatory 
Cytokines by PBMCs 
To confirm the IL-12 results, other cytokines (IFN , TNF and IL-8) associated with 
Th-1 responses and inflammation were examined in PBMC cultures with strains AB31 
and AB21 (dupA1).  The level of IFN was significantly higher in response to wild-
type compared to dupA mutant strains (AB31: wild-type 96.9±8.6 pg/ml; mutant 
71.9±6.9 pg/ml; p=0.007, AB21: wild-type 95.5±3.7 pg/ml; mutant 87.5±2.7 pg/ml; 
p=0.003) (Figure 5.9 A).  Also in agreement with the IL-12 results, the level of TNF 
was significantly higher in response to wild-type compared to dupA mutant strains 
(AB31: wild-type 1384.3± 24.5 pg/ml; mutant 1329.1± 30.3 pg/ml; p=0.02, AB21: 
wild-type 1802.3±30.7 pg/ml; mutant 1677±74.4 pg/ml; p=0.009) (Figure 5.9 B). 
Similarly, a significant reduction in the IL-8 response to AB31 and AB21 strain 
mutants was also found (AB31: wild-type 3043.2± 102 pg/ml; mutant 2815.6±46 
pg/ml; p=0.02, AB21: wild-type 3756.4± 109 pg/ml; mutant 3518±43 pg/ml; p=0.02) 
(Figure 5.9 C). The differences in IL-8, TNF  and IFN  responses attributable to dupA 
were less dramatic than observed for IL-12, but the trends were the same.  No 
significant differences were found when the wild-types and mutants derived from 93-
67 and A101 strains were compared for IFN , TNF and IL-8.  
Further assays were performed to investigate IL-10 and IL-4 responses as these 
reportedly correlate with reduced inflammation and disease in vivo (Fox JG et al., 
2000, Robinson et al., 2008). No significant differences were observed with any of the 
strains, however (Figure 5.9 D&E).    
 152
5.3.5 Associations of dupA Status with Inflammatory Cytokine 
Expression in vivo.
To investigate whether the enhanced inflammatory responses induced by dupA1 strains 
in vitro could be supported by observational in vivo data, real-time RT-PCR analyses 
were carried out on human gastric biopsy tissues (13 dupA+, 22 dupA-). In 
confirmation of the in vitro data, trends were found showing that in dupA+ H. pylori-
infected gastric tissue, the levels of IL-12 and IFN mRNA were higher than in tissues 
infected with dupA- H. pylori (Figure 5.10). These differences (1.2- and 1.6-fold 
respectively) did not achieve statistical significance, but I do not have information on 
the dupA sequence types from these samples. In dupA- H. pylori-infected compared to 
dupA+ H. pylori-infected tissues, there were 11 and 10-fold increased levels of IL-10 
(p=ns) and IL-4 mRNA (p=0.06), respectively (Figure 5.10).    
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Figure 5. 9 Cytokines production from PBMC cells at 48 hours.  
PBMC cells were co-cultured with H. pylori strains (AB31 and AB21). IFN (A), TNF (B), IL-8 (C), IL-10 (D) and IL-4 (E) were measured 
by ELISA after co-culturing PBMCs with AB31 and AB21 H. pylori strains possessing dupA (plain black bars) and their isogenic dupA mutants 
( dotted black bars) for 48 hours. Dotted grey bars represent results obtained from cells only. Error bars indicate standard deviation. ns: no 
significant difference.
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Figure 5. 10 Relative IL-12 (A), IFN (B), IL-10 (C) and IL-4 (D) mRNA levels in gastric biopsies from 13 dupA+ H. pylori -infected 
tissues and 22 dupA- H. pylori-infected tissues. No significant differences were found * Outlier 
p=ns
p=nsp=ns
p=ns
A
C D
B
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5.4 Discussion 
dupA is a recently described virulence factor associated with an increased risk for 
DU and reduced risk for gastric atrophy and cancer (Lu et al., 2005a). Studies from 
different parts of the world have confirmed or disputed these disease associations 
(Arachchi et al., 2007, Argent et al., 2007, Gomes et al., 2007, Hussein et al., 
2008a, Lu et al., 2005a). Nucleotide sequencing of dupA revealed that this gene is 
naturally polymorphic and dupA polymorphisms might explain the regional dispute 
in results. Currently it is unknown which forms of the gene are expressed, which 
probably confounds such disease association studies. From our sequencing work 
and examination of published dupA sequence data I found that the most common 
form of the gene (dupA1) was extended to encompass jhp0917, jhp0918, and small 
part of jhp0919.  
Co-culture of H. pylori strains with epithelial cell lines showed that there was no 
difference in the production of IL-8 induced by wild-type and the isogenic dupA 
mutant strains. This was tested rigorously using four different cell lines and seven 
panels of isogenic mutants, and by two independent members of our team. The 
mutant derived from J123 strain (with the same form of dupA as C142, used by Lu 
et al. (Lu et al., 2005a) previously) induced slightly less IL-8 than the parental 
strain but this was only observed with ST16 cells at the 6-hour time-point. The 
results with all other strains and cell lines did not detect a difference in IL-8 
response due to the presence or absence of dupA, which is in conflict with the data 
of Lu et al. (Lu et al., 2005a). To validate our assays I performed comparisons of 
parental strains with cagE-deficient mutants and clearly showed that the cag PaI 
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stimulates IL-8 release from epithelial cells (as shown by many others (Brandt et 
al., 2005, Fischer et al., 2001, Viala et al., 2004)).   
Many of the strains used in this study had a different form of dupA from that in 
C142 (used by Lu et al. (Lu et al., 2005a) to demonstrate associations with IL-8 
secretion), which may explain the difference in our results, but our sequence data 
analyses showed that this is not a common dupA type. AB31 and AB21 strains 
(dupA1) had a variation at the 3' end of dupA that was not present in dupA from 
strains C142 or J99. The regions from nucleotide position 1738 to position 1800 
were altered due to an adenine insertion (within a polyadenine stretch), and 
changed the deduced amino acid sequence from ICKNYFIFLIAMLVIEKSSMI 
(present in dupA from strains C142 and J99) to DLQELLYILDSNAGNRKILND in 
our strains. In support of our findings, Schmidt et al. (Schmidt et al., 2008) recently 
reported that, in a study of responses of AGS cells to clinical isolates from 
Malaysia and Singapore, the presence of dupA was not associated with elevated  
IL-8 release.   
dupA+ strains have been reported to be associated with increased risk of gastro-
duodenal disease. Ulceration and carcinogenesis are processes that are driven by 
inflammation (reviewed in (Atherton, 2006)) and increased levels of inflammatory 
cell infiltration have been reported with dupA+ strain infections (Lu et al., 2005a). I 
therefore examined the effects of dupA on leukocytes, which are another major 
source of inflammatory cytokines and chemokines in the infected gastric mucosa. 
Interestingly it was found that wild-type strains carrying dupA1 had a greater effect 
on the production of IL-12 by PBMCs than wild-type strains carrying the truncated 
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form of dupA (dupA2). Mutation of dupA1 in strains AB31 and AB21 resulted in a 
significant reduction in IL-12 production compared to the parental strains. For other 
strains carrying dupA2, I could not find any differences in IL-12 induction which 
implies that the dupA1 form of the gene is responsible for increasing levels of 
inflammation and disease. To confirm that presence of a dupA1 gene is associated 
with increased stimulation of proinflammatory cytokines, the levels of IFN , IL-8 
and TNF were measured. It was found that the levels of these cytokines were also 
higher in response to wild-type compared with dupA isogenic mutant strains.   
Correlations between virulence factors and immune responses have previously been 
investigated. Although the role of the cag PaI in inducing IL-8 from epithelial cells 
is clear, its importance in inducing inflammatory responses from inflammatory cells 
remains inconclusive. In a study conducted in China, it was shown that CagA+ 
strains were associated with the development of a T-helper 1 (Th1) human 
peripheral blood T-cell response (Wang et al., 2007).  Such a response has been 
shown to be linked with premalignant gastric mucosal pathology and disease 
(Atherton, 2006, Cui G, 2003).  Guiney et al. (Guiney et al., 2003) showed that 
mutagenesis of cagE reduced the IL-12 response of dendritic cells in vitro. In 
another study however, no relationship could be established between cagA 
expression and IL-12 production by monocytic cell lines (Odenbreit et al., 2001). 
Using PBMCs (consisting mainly of lymphocytes and monocytes) in this report I 
showed that dupA1 plays an important role in stimulating IL-12 production whilst 
the cag PaI had no significant effect. H. pylori is able to simulate the immune 
response, and experiments in mice indicate that the quality of the T-helper response 
is critically important for eradication/persistence of the infection and 
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induction/prevention of H. pylori-mediated pathology (Akhiani et al., 2002, Lucas 
et al., 2001). This report puts forward the hypothesis that dupA plays an important 
role in increasing gastric inflammation and pathology by acting upon infiltrating 
leukocytes rather than epithelial cells, and increases the risk of disease by 
stimulating the development of a more pronounced Th1 immune response.   
In support of this hypothesis, mucosal IL-12 and IFN mRNA levels were higher in 
gastric biopsy specimens obtained from patients infected with jhp0917-0918 dupA+ 
strains compared with those with dupA- strains. This trend did not achieve 
statistical significance however, probably because sequence data were not available 
to determine the polymorphic forms of dupA.  The levels of IL-10 and IL-4 mRNA 
were lower in biopsy specimens taken from patients infected with dupA+ than 
dupA- strains, indicating the presence of fewer Th2 and regulatory T-cells which 
suppress Th1-mediated immune and inflammatory responses. In this study, a clear 
trend towards a higher inflammatory Th1 and a lower Th2 response in dupA+ H. 
pylori infected tissues could be seen. Together, these findings suggest that a 
functional dupA gene plays an important role in enhancing inflammation possibly 
by skewing the immune response towards a Th1 response.   
There are still many unknowns to be addressed concerning dupA. Almost all studies 
have so far merely compared disease incidence with dupA presence or absence by 
PCR genotyping, but our data have shown the gene to be highly polymorphic. To 
date it remains unknown which forms of the gene are expressed and active, 
although in this study I could only find a pro-inflammatory phenotype with dupA1+ 
strains. The next step for our research will therefore be to generate an antibody 
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against recombinant DupA, as to our knowledge no one else has successfully 
prepared a specific antiserum (Yamaoka, personal communication). With DupA-
specific serum I will then be able to assess which forms of the dupA gene are 
expressed as protein, and begin to address our hypothesis that dupA1 is expressed 
and active whereas dupA2 is not. I can also investigate the shorter dupA1 forms, as 
found in C142 and J123. Such advances will allow us to further investigate 
associations between dupA status and gastric mucosal inflammatory cytokine 
responses in vivo.  
We have not yet determined the mechanism by which DupA stimulates immune 
and inflammatory cells to secrete higher levels of cytokines. Bioinformatic analyses 
show that it has a high degree of homology with virB4-homologue ATPases such as 
cagE and comB, suggesting that it may be a component of an additional type IV 
secretion system. As such it is a possibility that dupA is a marker for the delivery of 
some other inflammatory factor to cells, which would make sense as dupA is not 
predicted to be secreted or surface exposed. As a first step in this direction, lysates 
from wild-type and dupA-deficient mutants must now be tested on PBMCs to 
ascertain whether live bacteria and therefore an active ATPase function is necessary 
to mediate pro-inflammatory effects. Further investigations are also necessary to 
determine which cell types within PBMCs are induced by DupA to secrete more 
IL-12. Since this factor is not secreted by lymphocytes we propose that monocytes 
are likely to be the source. Future experiments will use flow cytometry to determine 
this, and the effects of dupA+ strains and mutants on purified cell populations will 
then be determined.  
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In conclusion, we propose that the dupA gene is polymorphic and expression of the 
dupA1 form may skew the differentiation of T-helper cells towards a Th1 response. 
This activity of dupA on inflammatory cells probably plays an important role in 
guiding the immune response to H. pylori infection, the level of inflammation and 
thus disease development.                      
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6. Conclusions and Recommendations  
Interestingly, in Kurdistan region, Iraq, despite a high prevalence of H. pylori 
infection, the prevalence of more serious H. pylori related disease and in particular 
gastric cancer is reported to be extremely low (GLOBOCAN, 2002). Indeed, 
examination of the medical records for the period 2005-2006 at the Sulaimanyia 
hospital (a hospital servicing 1million people in Sulaimaniya city) and Azadi 
hospital (a hospital servicing 800,000 people in Dohuk city)  showed that only 
approximately 40 gastric cancers were diagnosed during that period in both cities. 
No cancer patient from Iraq was involved in this study because it was extremely 
difficult to find patients with gastric cancer. This did not affect my study because I 
am interested in H. pylori infection related factors which might contribute to the 
low cancer rate in this community.  
First, I investigated the age-specific prevalence of H. pylori infection in Kurdistan 
region, Iraq. I showed that the seroprevalence of H. pylori in children of various 
age group was <6months:0%; 6-24months:27%; 2-18years:58%. Overall, 78.5% of 
adults were infected with H. pylori and 36.6% of children were seropositive. The 
seropositivity increases with age; however, this might be an age-cohort effect. In 
addition, individual ages of children in the 2-18 year age group were not available, 
so the age at which infection was acquired could not be determined.  This is 
important as the risk of cancer increases with early acquisition of H. pylori 
infection and acquiring the infection later in life could contribute to a lower cancer 
risk.  Future work could determine the age at which the infection is acquired by 
studying the prevalence of H. pylori infection in this age group (2-18 years) in 
detail.  
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It has previously been shown that the early acquisition of H. pylori infection in 
childhood resulted in pangastritis in adulthood. This pattern of gastritis is usually 
associated with mucosal atrophy and intestinal metaplasia in adulthood both of 
which are precancerous conditions (Asaka et al., 1997, Atherton, 2006). Therefore, 
acquiring the infection at an early age is a recognised risk factor for the 
development of gastric cancer (Asaka et al., 1997, Atherton, 2006, Blaser et al., 
2007). Additionally, antral predominant gastritis is usually associated with 
duodenal ulcer. In this project, histological changes in the anturm and the corpus 
were studied. There was no significant difference in H. pylori density, neutrophilic 
activity, intestinal metaplasia and mucosal atrophy between samples from antrum 
and corpus. Detailed scoring of gastric histopathology showed antral predominance 
of lymphocytic infiltration.  This may, partially, help explain the low cancer risk in 
this population. However, due to the small sample size, it is impossible to conclude 
that the histology is representative of the overall population. To improve this, future 
work should focus on studying the hispotopathological changes in a larger 
representative sample.   
The predominant H. pylori strains circulating in different geographic locations vary 
with regard to virulence genes (Atherton, 2006). An association of the cagA-
positive, vacA s1 genotype with peptic ulcer disease (PUD) and gastric cancer has 
been reported in Western countries (Atherton, 2006). It was previously shown that 
strains with CagA proteins possessing greater numbers of EPIYA repeats increase 
phosphorylation of the protein, increase the extent of hummingbird phenotype 
formation, and are more likely to be associated with the development of gastric 
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cancer (Azuma et al., 2002, Higashi et al., 2002a, Higashi et al., 2005, Naito et al., 
2006). Additionally, a recently described vacA i1 genotype has been shown to be 
associated with adenocarcinoma (Lu et al., 2005a). Furthermore, a strong 
association between dupA and duodenal ulcer has been reported (Lu et al., 2005a). 
Whether Iraqi strains possessed such genotypes was investigated and correlated 
with disease outcome and histological findings. The incidence of gastric cancer in 
Iraq appears lower than in Iran (GLOBOCAN, 2002). Therefore, virulence 
determinants of both Iraqi (Kurdish) and Iranian strains were studied and 
compared.   
Strains from Iraq and Iran possessing cagA were found in 71% and 76% of the 
samples analysed, respectively. cagA presence was significantly associated with 
peptic ulcer disease incidence in Iraq but not in Iran. This might be because cagA is 
ubiquitous in Iran, and therefore not a good disease indicator. The presence of cagA 
alleles with more than 3 phosphorylation motifs was significantly higher amongst 
Iranian strains than those from Iraq. The presence of cagA with more 
phosphorylation motifs in Iran may help explain the higher cancer incidence rate in 
that country. There was no association between vacA signal and mid region and 
PUD in either population. A significant association between i1 genotype and 
incidence of GU was seen amongst samples from Iraq but not Iran. Recalling the 
correlation between vacA i region and gastric cancer, a relationship with GU 
appears logical because of the epidemiological association between gastric cancer 
and gastric ulcer.  Furthermore, 33% and 38% of Iraqi and Iranian strains, 
respectively, were positive for dupA. Whilst a significant association between 
infection with dupA-positive strains and DU was observed for Iraqi patients, there 
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was no association among the Iranian subjects.  The question of why dupA is 
associated with diseases in Iraq but not Iran could not be answered because our 
knowledge about this gene is limited.   
This chapter has several limitations that can be addressed in future work. Perhaps 
most importantly we studied dyspeptic patients rather than a random community 
sample of H. pylori strains and this may have introduced bias. The reason we did 
this is that strain genotyping requires upper GI endoscopy, and so is difficult to 
perform on randomly selected asymptomatic individuals. We argue that the 
prevalence of virulent strains in the dyspeptic group without ulcer disease is likely 
to be similar to asymptomatic community members: the association between H. 
pylori infection and non-ulcer dyspepsia is controversial, and if present at all is 
weak, so any association with virulence factors is likely to be weaker still. 
Secondly, our study is not large. However, this is likely to hide true positive 
associations rather than produce false positives, and is most unlikely to have 
produced the multiple associations of virulence factors with disease that we have 
demonstrated. Thirdly, we have genotyped strains for virulence rather than 
performing virulence phenotyping. Many studies have shown good but imperfect 
associations between genotype and phenotype, but any error is likely to be in 
favour of designating a strain as virulent when in fact it is avirulent. For example, a 
seemingly virulent cagA+ strain may not be able to translocate CagA into epithelial 
cells (if it has a mutation elsewhere in the cag PAI which inactivates the type IV 
secretion system) and so may be avirulent. In contrast, a seemingly avirulent cagA 
negative strain will never be able to translocate CagA (as it lacks it) and so such a 
strain will never be virulent. Thus any errors from genotyping rather than 
 166
phenotyping are also likely to be conservative. Taken together these study 
deficiencies should encourage others to perform better studies to repeat and extend 
our investigation, but they do not negate our findings.  
The immune responses against H. pylori in Kurdistan region, Iraq were studied. 
The levels of FOXP3, IL-4, IL-10, IL-12 and IFN mRNA were found to be 
elevated in samples from infected patients compared to those from H. pylori-
negative patients. However, the increase in Th2 cytokine levels was more marked 
than for Th1 cytokines. Th2 responses are associated with mild gastritis and low 
cancer risk (Atherton, 2006). Therefore, this might help explain the cancer low rate 
in Kurdistan region, Iraq. The association between female gender and a higher IL-4 
(Th2) response may help to explain the lower gastric cancer incidence in women, 
although more studies are needed to investigate this relationship. A novel 
association between a high Th1 response and smoking was found suggesting that 
smoking may promote a pro-inflammatory Th1 response; such a response is known 
to induce precancerous gastric atrophy and metaplasia (Atherton, 2006). 
Unfortunately, no data about smoking status in Iraq was available. When using RT-
PCR to investigate immune responses, the levels of cytokine mRNA are measured, 
but this does not always accurately reflect levels of cytokine protein expression and 
cannot show the cellular sources of cytokines. However, the levels of cytokines, 
especially IFN , are the crucial determinant for the disease process. For example, in 
a US study intestinal metaplasia developed in the stomach of  mice transfused with 
IFN , even without H. pylori infection (Cui G, 2003). In addition, Robinson et al. 
used both RT-PCR and flow cytometry, which is regarded as the gold-standard
method for determining numbers of Th1 and Th2 cells present. The results from 
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RT-PCR  matched the results from flow cytometry (Robinson et al., 2008).  
Furthermore, whenever possible, we confirmed our results by studying the levels of 
IgG subclasses and their correlation with gastric cytokines. The association 
between smoking and Th responses is important. To take this work further, animal 
work might be helpful. However, current animal models of H. pylori infection are 
imperfect.  In addition, burning cigarettes contains more than 400 chemical 
compounds. Testing which compound is responsible for promoting the Th-1 
response would be extremely difficult. In addition, any human work in the future 
should consider using more samples from different regions of the world.   
dupA is a very recently described H. pylori virulence factor (Lu et al., 2005a) and 
little is known about this gene. Lu et al. suggested that its possession is protective 
against cancer (Lu et al., 2005a) while Argent et al. showed a significant 
correlation between possess of the gene and gastric cancer (Argent et al., 2007). 
Based upon its sequence, dupA can be classified into two main categories: truncated 
dupA and dupA with a full open reading frame. It was found that disruption of dupA 
had no significant effect upon the level of interleukin-8 secretion from gastric 
epithelial cells. However, knockout of dupA with a complete open reading frame 
reduced IL-12, IFN , TNF and IL-8 production by PBMCs significantly. This 
indicates that dupA might skew the immune response towards a Th-1 response. It 
was hypothesized that a functional dupA gene might be an important virulence 
factor in relation to the risk of clinically significant outcomes of H. pylori infection. 
dupA was associated with duodenal ulcer amongst Kurdish Iraqi subjects. However, 
these results raised question about which dupA polymorphism is common in this 
country.  Hence, the presence of dupA is not enough and any study of the 
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correlation between dupA and clinical outcome should be accompanied by 
sequencing the gene. Raising antibodies against the DupA protein is recommended 
which would provide information on which form of this gene is expressed. In 
addition, determining which cells are reacting with dupA, using FACS, would be 
crucially important for the understanding of the disease development process and 
the role of immune response in this process. Finally, studying the signalling 
pathway would give an insight into understanding the mechanism of action of the 
DupA protein.    
Lessons taken from this study and other studies (Atherton, 2006, Holcombe, 1992, 
Peek and Blaser, 2002, Singh and Ghoshal, 2006, Tham et al., 2001) show that H. 
pylori infection alone is not the only independent factor for the development of 
gastric cancer. Many studies conducted around the world (Archimandritis et al., 
1993, Fukuda et al., 1995, Rudi et al., 1995, Talley et al., 1991b, Webb et al., 1996) 
imply that the role of H. pylori in the carcinogenesis is trivial in these countries. H. 
pylori virulence factors, smoking, gender, host genetic, environmental, and dietary 
factors play a major role in determining whether or not a person infected with H. 
pylori will develop gastric atrophy, intestinal metaplasia and gastric cancer. Each 
factor influences other factors in a way either increases or decreases the risk index. 
This has a crucial importance in preventive strategies of H. pylori-induced diseases. 
In the near future we may be able to conclude, for each H. pylori-infected subject, 
the risk of developing gastric cancer can be estimated using mathematical 
modelling of risk index. Based on this, he or she might be advised to take 
eradication therapy. If the index is low, patients might not be offered any antibiotic 
treatment. This is important economically and also might help reduce antibiotic 
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resistance. In addition, H. pylori infection has been suggested to protect from many 
diseases such as oesophageal carcinoma and allergies (Chen and Blaser, 2007, 
Sharma and Vakil, 2003, Wu et al., 2005).  Thus, if patients could be shown to be 
of low risk of gastro-duodenal diseases, it may be beneficial not to treat H. pylori. 
Furthermore, if the index is high for all the population then rigorous development 
of a vaccination program on a population basis is justified, and all individuals with 
H. pylori related chronic gastritis should undergo eradication treatment.                               
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A Study of Helicobacter Pylori-associated Gastritis Patterns in 
Iraq and Their Association with Strain Virulence
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ABSTRACT 
Background/Aim: Helicobacter pylori (H. pylori) infection causes peptic ulceration and gastric adenocarcinoma. 
In Iraq, gastric cancer is rare. We investigated whether infected adults had the antral-predominant pattern 
of H. pylori-associated gastritis, which does not predispose to cancer. Materials and Methods: We evaluated 
histopathological changes by the Sydney scoring system in gastric biopsies taken from 30 H. pylori-infected 
adults and studied the correlation of these changes with the virulence factors. The Mann–Whitney test was 
used for the comparison of histopathological data. The presence or absence of each pathological index was 
evaluated with respect to the possession of virulence factors by the infecting H. pylori strain using the χ2 
test. Results: Gastric lymphocyte infi ltration was more prominent in the antrum (P = 0.01). Neutrophil 
infi ltration was mild and gastric mucosal atrophy was rare. No relationship was found between virulence 
factors and histopathological changes. Conclusions: The mild pathology and antral-predominant gastritis 
help explain the low cancer rate in Iraq.
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Helicobacter pylori ινφεχτιον χαυσεσ πεπτιχ υλχερατιον 
ανδ γαστριχ αδενοχαρχινοmα. Ιν Ιραθ, δεσπιτε τηε εαρλψ 
αχθυισιτιον οφ H. pylori ινφεχτιον,[1] γαστριχ χανχερ ισ υνυσυαλλψ 
ραρε.[2] Dεσπιτε τηε γεογραπηιχαλ προξιmιτψ οφ Ιραθ, Τυρκεψ 
ανδ Ιραν, τηε ινχιδενχε οφ γαστριχ χανχερ διφφερσ ηυγελψ 
αmονγ τηεσε χουντριεσ, βεινγ ! 5/105, 8.914.1/105 ανδ 
3869/105, ρεσπεχτιϖελψ.[2] ςιρυλενχε φαχτορσ οφ Ιραθι H. pylori 
στραινσ αππεαρ mορε χλοσελψ ρελατεδ το Wεστερν χουντριεσ ανδ 
υνλικελψ το εξπλαιν τηε λοω χανχερ ρατε χοmπλετελψ.[3] Νοτηινγ 
ισ κνοων αβουτ τηε διστριβυτιον οφ H. pylori-ασσοχιατεδ 
ινφλαmmατιον ιν Ιραθι πατιεντσ ορ ιτσ σεϖεριτψ. Τηυσ, ωε νοω 
αιm το ασσεσσ τηε δεγρεε ανδ διστριβυτιον οφ ινφλαmmατιον ιν 
τηε στοmαχησ οφ Ιραθι πεοπλε ανδ τηε ρελατιονσηιπ βετωεεν 
H. pylori ϖιρυλενχε φαχτορσ (vacA, cagA ανδ dupA) ανδ 
ηιστοπατηολογιχαλ χηανγεσ.
MATERIALS AND METHODS
Τηε στυδψ προτοχολ ωασ αππροϖεδ βψ τηε ετηιχαλ χοmmιττεε 
οφ τηε Υνιϖερσιτψ τεαχηινγ ηοσπιταλ ωηερε βιοπσιεσ ωερε 
χολλεχτεδ. Σαmπλεσ φορ ηιστοπατηολογψ ωερε οβταινεδ 
φροm 30 αδυλτ συβϕεχτσ ωιτη δψσπεπσια ανδ ωιτηουτ πεπτιχ 
υλχερατιον. Τωο βιοπσιεσ φροm τηε αντρυm ανδ τωο φροm 
τηε χορπυσ ωερε τακεν ανδ φιξεδ ιν 10 mΛ βυφφερεδ 10% 
φορmαλιν φορ ηιστοπατηολογιχαλ εξαmινατιονσ. Τηε ηιστολογιχαλ 
φινδινγσ φροm τηε σεχτιονσ ωερε σχορεδ αχχορδινγ το τηε 
υπδατεδ Σψδνεψ σψστεm οφ χλασσιφιχατιον ανδ γραδινγ οφ 
γαστριτισ.[4] Τηεσε σλιδεσ ωερε γραδεδ φορ τηε φολλοωινγ 
φεατυρεσ: H. pylori δενσιτψ, νευτροπηιλιχ αχτιϖιτψ, λψmπηοχψτιχ 
ινφιλτρατιον ανδ γλανδυλαρ ατροπηψ. Α ϖισυαλ αναλογυε σχαλε 
ωασ υσεδ το ασσεσσ τηε σεϖεριτψ οφ τηε ινφλαmmατορψ χηανγεσ 
ανδ γραδινγ ωασ περφορmεδ ασ φολλοωσ: λ, mιλδ; 2, mοδερατε; 
3, σεϖερε. Αλλ βιοπσιεσ ηαδ Αλχιαν βλυε (πΗ 2.5) το χονφιρm 
τηε πρεσενχε οφ mεταπλασια. Βεχαυσε ουρ mαιν αιm ωασ το 
δετερmινε τηε παττερν οφ γαστριτισ, ωε διδ νοτ υσε ανψ σπεχιαλ 
σταιν το δεmονστρατε H. pylori ανδ ωε διδ νοτ ινχλυδε H. 
pylori δενσιτψ ιν ανψ φυρτηερ αναλψσισ.
Πολψmερασε χηαιν ρεαχτιον−βασεδ γενοτψπινγ οφ H. pylori 
ισολατεσ ωασ περφορmεδ ον DΝΑ εξτραχτεδ φροm βαχτερια ορ 
διρεχτλψ φροm βιοπσιεσ.[3]
Τηε ΜαννWηιτνεψ τεστ ωασ υσεδ φορ τηε χοmπαρισον 
οφ ηιστοπατηολογιχαλ δατα. Τηε πρεσενχε ορ αβσενχε οφ 
εαχη πατηολογιχαλ ινδεξ ωασ εϖαλυατεδ ωιτη ρεσπεχτ το τηε 
ποσσεσσιον οφ ϖιρυλενχε φαχτορσ βψ τηε ινφεχτινγ H. pylori 
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στραιν υσινγ τηε χ2 τεστ.
RESULTS
Πατηολογιχαλ χηανγεσ ωερε οβσερϖεδ ιν βιοπσιεσ φροm 29/30 
πατιεντσ. Τηε βιοπσιεσ φροm 1/30 ωερε ηιστολογιχαλλψ νορmαλ 
δεσπιτε H. pylori βεινγ χυλτυρεδ. Αmονγ τηε 29 πατιεντσ ωιτη 
ινφλαmmατιον ιν γαστριχ βιοπσιεσ, λψmπηοχψτε ινφιλτρατιον ωασ 
mορε προmινεντ ιν τηε αντρυm (ΜαννWηιτνεψ U τεστ, P 
= 0.01). Τηερε ωασ νο σιγνιφιχαντ διφφερενχε ιν νευτροπηιλ 
ινφιλτρατιον ορ mυχοσαλ ατροπηψ βετωεεν τηε αντρυm ανδ 
τηε χορπυσ. Ηοωεϖερ, νευτροπηιλ ινφιλτρατιον ωασ mιλδ ανδ 
ωασ ϖιρτυαλλψ αβσεντ (σχορε 0) ιν 41% οφ τηε αντραλ βιοπσιεσ 
ανδ 59% οφ τηε χορπυσ βιοπσιεσ. Φυρτηερmορε, ηιστολογιχαλ 
εϖιδενχε οφ mυχοσαλ ατροπηψ ωασ σεεν ιν ονλψ 1/30 αντραλ 
βιοπσιεσ (πατιεντ αγε = 40 ψεαρσ) ανδ 1/30 χορπυσ βιοπσιεσ 
(πατιεντ αγε = 64 ψεαρσ). Ιν βοτη τηε χασεσ, ιτ ωασ mιλδ. 
Ιντεστιναλ mεταπλασια ωασ φουνδ ιν 2/30 (6.8%) ανδ 3/30 
(10%) βιοπσιεσ τακεν φροm τηε αντρυm ανδ τηε βοδψ, 
ρεσπεχτιϖελψ [Ταβλε 1].
Τηε ϖιρυλενχε φαχτορσ οφ Ιραθι H. pylori στραινσ ανδ 
τηειρ ρελατιονσηιπ ωιτη χλινιχαλ ουτχοmε ωερε στυδιεδ 
πρεϖιουσλψ.[3] Ιν τηισ στυδψ, ωε αιmεδ το εξπλορε τηε 
ρελατιονσηιπ βετωεεν ινδιϖιδυαλ ϖιρυλενχε δετερmιναντσ ανδ 
γαστριχ ηιστοπατηολογιχαλ χηανγεσ ιν τηε γαστριχ αντρυm ανδ 
χορπυσ. 66.6% (20/30) ανδ 30% (9/30) οφ Ιραθι στραινσ τψπεδ 
ποσιτιϖε φορ cagA ανδ dupA, ρεσπεχτιϖελψ. Τηε διστριβυτιον 
οφ vacA αλλελιχ τψπεσ αmονγ H. pylori στραινσ ισ σηοων ιν 
Ταβλε 2. Φορ τηε vacA σ, ι ανδ m ρεγιονσ ινδιϖιδυαλλψ, 28/30 
(93.3%) ισολατεσ ωερε τηε τψπε σ1, 8/30 (26.6%) ισολατεσ ωερε 
τηε τψπε ι1 ανδ 15/30 (23.3%) ισολατεσ ωερε τηε τψπε m1. Το 
τεστ ωηετηερ τηε πρεσενχε οφ σπεχιφιχ γενοτψπε χορρελατεδ 
ωιτη ηιστοπατηολογιχαλ χηανγεσ ιν τηε αντρυm ανδ τηε χορπυσ, 
ουρ δατα ωερε ρεστρατιφιεδ αχχορδινγ το τηε ηιστολογιχαλ 
χηανγεσ. Νο σιγνιφιχαντ ασσοχιατιονσ ωερε φουνδ βετωεεν 
vacA, cagA ανδ dupA ανδ ηιστοπατηολογιχαλ σχορινγ.
DISCUSSION
H. pylori ισ α ρισκ φαχτορ φορ γαστριχ χανχερ ανδ γαστριχ 
λψmπηοmα.[5] Αρουνδ τηε ωορλδ, δεσπιτε τηε ηιγη φρεθυενχψ 
οφ H. pylori ινφεχτιον, τηε ινχιδενχε οφ γαστριχ χανχερ ισ 
δισχορδαντ.[5] Τηε αννυαλ ινχιδενχε ρατε οφ γαστριχ χανχερ ισ 
ϖερψ ηιγη ιν ϑαπαν ανδ Χηινα, βυτ H. pylori σεροποσιτιϖιτψ 
ισ λοω.[5] Ιν χοντραστ, ιν Ινδια, σεροποσιτιϖιτψ οφ H. pylori 
ισ ϖερψ ηιγη βυτ τηε αννυαλ ινχιδενχε οφ γαστριχ χανχερ ισ 
λοω.[5] Ονε ποσσιβλε εξπλανατιον ισ τηε διφφερενχε ιν τηε 
γαστριτισ παττερν ασ πανγαστριτισ ανδ χορπυσ−πρεδοmιναντ 
γαστριτισ αρε ασσοχιατεδ ωιτη αν ινχρεασεδ ρισκ οφ γαστριχ 
mυχοσαλ ατροπηψ ανδ ινχρεασεδ ρισκ οφ χανχερ.[6,7] Ιν τωο 
στυδιεσ χονδυχτεδ ιν ϑαπαν ανδ Ιραν, ωηερε τηερε ισ α ηιγη 
γαστριχ χανχερ ρατε, ιτ ωασ σηοων τηατ H. pylori ινφεχτιον ωασ 
στρονγλψ ασσοχιατεδ ωιτη χηρονιχ γαστριτισ ανδ τηατ ηιστολογιχαλ 
χορπυσ γαστριτισ ωασ φουνδ ωιτη α ηιγη φρεθυενχψ.[8,9] Ον τηε 
οτηερ ηανδ, ιν Ινδια ανδ ΥΑΕ, ωηερε τηε γαστριχ χανχερ ρατε 
ισ λοω, τηε διστριβυτιον παττερν οφ γαστριτισ ωασ φουνδ το βε 
αντραλ−πρεδοmιναντ.[10,11] Ποτεντιαλλψ, τηε λοω χανχερ ρατε ιν 
Ιραθ χουλδ βε εξπλαινεδ βψ αντραλ−πρεδοmιναντ γαστριτισ βεινγ 
τηε χοmmον παττερν ανδ/ορ βψ ινφλαmmατιον βεινγ mιλδ. Ιν 
α στυδψ χονδυχτεδ ιν Ιραν, α νειγηβουρινγ χουντρψ το Ιραθ 
ωηερε τηε γαστριχ χανχερ ρατε ισ ϖερψ ηιγη,[2] ιτ ωασ φουνδ τηατ 
mονονυχλεαρ χελλ ινφιλτρατιον ωασ σιmιλαρ τηρουγηουτ τηε 
στοmαχη. Ον αν αϖεραγε, πατιεντσ ηαδ πανγαστριτισ.[9] Ιν Ιραθ, 
ωε ηαϖε σηοων τηατ τηερε ισ αντραλ−πρεδοmιναντ mονονυχλεαρ 
χελλ ινφιλτρατιον. Τηεσε φινδινγσ αρε ιν αγρεεmεντ ωιτη τηε 
ρεσυλτσ φροm Κενψα, αν Αφριχαν χουντρψ ωιτη α ϖερψ λοω γαστριχ 
χανχερ ρατε, ωηερε τηερε ισ αντραλ−πρεδοmιναντ γαστριτισ ωιτη 
σιγνιφιχαντ δισχορδανχε ιν τηε σεϖεριτψ οφ γραδεδ ϖαριαβλεσ 
βετωεεν αντραλ ανδ χορπυσ βιοπσιεσ.[12] Φυρτηερmορε, ιν Ιραν, 
ηιστολογιχαλ εϖιδενχε οφ mυχοσαλ ατροπηψ ωασ σεεν ιν 39% 
ανδ 22% οφ τηε αντραλ ανδ χορπυσ σαmπλεσ, ρεσπεχτιϖελψ.[13] Ιν 
ανοτηερ στυδψ χονδυχτεδ ιν Τυρκεψ, ιτ ωασ φουνδ τηατ 43% 
οφ τηε H. pylori−ινφεχτεδ συβϕεχτσ ηαδ ατροπηιχ γαστριτισ.[14] 
Ιν ουρ στυδψ, γλανδυλαρ ατροπηψ ωασ φουνδ ιν ονλψ ονε (3%) 
σπεχιmεν τακεν φροm τηε αντρυm ανδ ονε φροm τηε χορπυσ. 
Τηυσ, δεσπιτε τηε εαρλψ αχθυισιτιον οφ H. pylori,[1] τηε πρεσενχε 
οφ ατροπηψ αππεαρσ ραρε ιν Ιραθ. Wε σπεχυλατε τηατ τηισ αντραλ−
πρεδοmιναντ γαστριτισ ανδ λοω γλανδυλαρ ατροπηψ ρατε ιν Ιραθ 
mιγητ χοντριβυτε το τηε λοω χανχερ ρατε.
Στυδιεσ φροm Νορτη Αmεριχα ρεϖεαλεδ τηατ ινφεχτιον ωιτη 
Hussein, et al. 
Table 1: H. pylori-associated gastritis in biopsies taken from the gastric antrum and corpus
Variables                            Antrum                                          Corpus   P-value
 Score 0 Score 1 Score 2 Score 3 Score 0 Score 1 Score 2 Score 3 
Lymphocyte infi ltration (n) 0 10 14 5 0 20 7 2 0.016*
Neutrophil infi ltration (n) 12 15 2 0 17 11 1 0 0.19
Intestinal metaplasia (n) 27 1 1 0 26 3 0 0 0.68
Atrophy (n) 28 1 0 0 28 1 0 0 1
*Signifi cant P-value measured by the Mann–Whitney U test.
Table 2: Distribution of the vacA allelic types in Iraqi 
strains
 s1/i1/m1  s1/i1/m2 s1/i2/m1 s1/i2/m2 s2/i2/m2
n (%) 7/30  1/30 8/30 12/30 2/30
 (23.3)  (3)  (26.6)  (40)  (6)
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cagA−ποσιτιϖε H. pylori στραινσ ινχρεασεσ τηε ρισκ οφ ατροπηιχ 
γαστριτισ ανδ γαστριχ χανχερ.[15] Ηοωεϖερ, τηισ ωασ νοτ χονφιρmεδ 
ιν σεϖεραλ στυδιεσ ιν Ασιαν ποπυλατιονσ.[16] Ευροπεαν στυδιεσ 
σηοωεδ α στρονγ σιγνιφιχανχε οφ τηε vacA m1 γενοτψπε ωιτη 
ρεσπεχτ το επιτηελιαλ δαmαγε, νευτροπηιλιχ ανδ λψmπηοχψτιχ 
ινφιλτρατεσ, ατροπηιχ γαστριτισ ανδ ιντεστιναλ mεταπλασια. Ιν 
αδδιτιον, ιτ ωασ σηοων τηατ σεϖερε δαmαγε το τηε γαστριχ 
επιτηελιυm ισ ασσοχιατεδ ωιτη vacA σ1/m1 mοσαιχισm.[17] Ιν 
Ινδια, ιτ ωασ σηοων τηατ τηε σ1α/m1 ανδ σ1α/m2 H. pylori ϖαχΑ 
γενοτψπεσ αρε σιγνιφιχαντλψ ασσοχιατεδ ωιτη σεϖερε χηρονιχ 
γαστριτισ ανδ γαστριχ επιτηελιαλ χελλ αποπτοσισ τηαν σ2/m2.[18] 
Ιν τηισ παπερ, ωε αιmεδ το στυδψ τηε χορρελατιον βετωεεν 
ινδιϖιδυαλ ϖιρυλενχε mαρκερσ ανδ ηιστοπατηολογιχαλ χηανγεσ 
ιν Ιραθ. Ιν χοντραστ το οτηερ στυδιεσ,[17−19] νο χορρελατιον 
βετωεεν ϖιρυλενχε φαχτορσ ανδ ηιστοπατηολογιχαλ χηανγεσ 
χουλδ βε οβσερϖεδ. Ιν α στυδψ χονδυχτεδ ιν Ινδια, ρισκ φαχτορσ 
φορ γαστριχ δισεασεσ ωερε ασσεσσεδ ιν τωο ποπυλατιονσ ωιτη 
διφφερεντ ινχιδενχεσ οφ γαστριχ δισεασε. Ιτ ωασ σηοων τηατ 
διετ ωασ τηε πριmαρψ φαχτορ ρελατινγ το τηε διφφερενχεσ ιν τηε 
πρεϖαλενχε οφ δυοδεναλ υλχερ. Ιν Ιραθ, ϖιρυλενχε φαχτορσ οφ 
H. pylori ωερε στυδιεδ βυτ τηεσε χουλδ νοτ εξπλαιν τηε λοω 
χανχερ ρατε. Προβαβλψ στυδψινγ οτηερ ρισκ φαχτορσ συχη ασ διετ 
ανδ σmοκινγ mαψ ηελπ εξπλαιν τηε mιλδ πατηολογψ.
Ουρ στυδψ ηασ λιmιτατιονσ, ιν παρτιχυλαρ τηατ τηε σαmπλε σιζε 
ισ σmαλλ. Ηοωεϖερ, βεχαυσε οφ τηε λοω ρατε οφ ατροπηψ, ιτ ισ 
υνλικελψ το βε mισλεαδινγ. Wηψ γαστριχ mυχοσαλ ατροπηψ ισ 
υνχοmmον ιν Ιραθ νεεδσ φυρτηερ στυδψ. Ηοωεϖερ, ουρ ρεσυλτσ 
ραισε τηε ποσσιβιλιτψ τηατ ιτ mαψ, ιν παρτ, βε δυε το τηε αντραλ−
πρεδοmιναντ ινφιλτρατιον παττερν σεεν ιν H. pylori−ινφεχτεδ 
Ιραθι ποπυλατιον. 
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